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1. Abstract 	  
The Selective Palladium-Catalysed Decarboxylative Coupling of 
Nucleophiles in the Presence of Propargylic Electrophiles 
This thesis is submitted in partial fulfilment of the requirements for the degree 
of Doctor of Philosophy in October 2017. 	  
This thesis describes the development of a palladium-catalysed chemo- and 
regioselective decarboxylative coupling of 1,3-dicarbonyl compounds and 
nitrogen nucleophiles in the presence of propargylic electrophiles. 
 
The first part of this thesis focuses on the palladium-catalysed cross-coupling 
reaction involving two 1,3-dicarbonyl compounds in a regio- and 
chemoselective manner via an allylic linker. The reaction is applied to a wide 
range of substrates and forms two C–C bonds and installs two all-carbon 
quaternary centres. Mechanistic studies to help deduce the mechanism of the 
reaction are described, which shows that by utilising a propargyl enol 
carbonate as one of the coupling partners, the regioselectivity of this process 
can be predictably controlled. 
 
The second part of this thesis focuses on the palladium-catalysed cross- 
coupling reaction of 1,3-dicarbonyl compounds with indole, pyrrole, imidazole 
and pyrazole nucleophiles via an allylic linker. Despite the weakly acidic 
nature of N-heterocycles, the reaction proceeds with good efficiency, complete 
regio- and chemoselectivity and broad substrate scope. Mechanistic studies 
have also been carried out to help deduce the mechanism of the reaction.  
iii	  	  
The third part of this thesis centres around the development of the palladium-
catalysed cross-coupling reaction of two 1,3-dicarbonyl compounds in an 
enantioselective manner. Focus is given to the enantioselective alkenylation 
and enantioselective allylic alkylation reactions. Optimisation of the reaction 
conditions as well as the expansion of the substrate scope is described. 
 
Finally, a discussion of future work, comprehensive conclusions as well as 
experimental procedures for the preparation of new compounds, backed up by 
full analytical characterisation, are disclosed. 
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5. Introduction 
One of the most important accomplishments of organic chemistry is reflected 
in its relevance to, and application within, the pharmaceutical industry. 
Thousands of organic molecules have to be synthesised and screened for 
activity as part of the drug discovery and development process.  The industry 
is facing significant challenges, however, as drug development is often a 
lengthy and expensive process. In 2010, figures showed that the cost of 
developing a new commercial pharmaceutical was approximately US $1.8 
billion.1  
 
In light of the enormous costs associated with drug discovery, the industry is 
keen to optimise its approaches and operations. Organic synthesis can play a 
key role in facilitating this shift and to better understand how this could be 
brought about, it is important to consider the general properties and features 
of small molecule drugs. As the majority of drugs are orally administered, they 
must display high oral bioavailability for efficient absorption by carefully tuning 
the physicochemical properties of the active pharmaceutical ingredients.  
 
Lipinski has devised a set of rules as a guide to ascertain whether a drug 
molecule is likely to have desirable physicochemical properties.2 Out of 2,245 
compounds chosen from the World Drug Index, 90% were found to obey 
Lipinski’s rules,3 which are the following: 
• Log P < 5 (lipophilicity): the partition coefficient relating to the relative 
solubility of a molecule in an octanol/water mixture. 
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• No more than 10 hydrogen bond acceptor groups. 
• No more than 5 hydrogen bond donor groups. 
• MW < 500 g mol−1. 
The first three rules directly refer to the balance between water and fat 
solubility of a drug. Too little aqueous solubility results in slow absorption as 
well as slow uptake into the blood stream. On the other hand, low fat solubility 
reduces the ability of the molecule to permeate through the cellular lipid 
membrane to reach its target. Therefore, the right balance of water and fat 
solubility is required for a drug to be effective when administered orally.  
 
According to Lipinski’s rules, drug molecules should possess a molecular 
weight of < 500 g mol−1.3 It is generally found that organic compounds with a 
large molecular weight have problems permeating through the intestinal 
barrier and the blood brain barrier.4 It is, therefore, important to maintain a low 
molecular weight. On the other hand, a very low molecular weight may result 
in both promiscuous, non-selective binding, as well as lower binding affinity 
due to the lack of specific binding contacts.  
 
Further factors that could contribute to the oral bioavailability of a drug 
molecule, are its polar surface area and the number of rotatable bonds in the 
structure.5 The polar surface area describes the overall surface sum of all the 
polar atoms (mainly oxygen and nitrogen). If this is too high, then the molecule 
may not penetrate through the cellular wall efficiently,5,6 as well as having 
difficultly passing through the blood-brain barrier.7 Finally, rotatable bonds 
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enhance the flexibility of the molecule, and it has been shown that more 
rotatable bonds can reduce the permeation rate of a drug.5 In contrast, drugs 
with fewer than 10 rotatable bonds tend to have improved oral bioavailability 
profiles. In addition, a large number of rotatable bonds can incur an entropic 
penalty upon the binding of the molecule to its target.8 This entropic loss 
decreases the affinity of the drug molecule for binding to the target receptor. 
 
 Lipinski’s rule of 5 directly links to ADMET properties which are: absorption, 
distribution, metabolism, excretion and toxicity.9 Absorption and distribution 
are determined by the correct balance of water soluble groups and fat soluble 
groups within the drug molecule. Metabolism concerns the breaking down of 
the drug so that it can be excreted from the body. A lipophilic molecule is more 
likely to be more readily metabolised in the liver, due to their affinity for 
metabolic enzymes,10 potentially necessitating a larger dose, which increases 
the risk of toxic side effects.11  
 
Another important consideration is the potency of the drug. A potent drug will 
have high specificity for a target, which effectively enables the use of a lower 
dosage of the active pharmaceutical ingredient. Drugs administered at a lower 
dosage have the potential to reduce their side effects and it has also been 




If a drug molecule is chiral, then one enantiomer of the molecule is likely to 
exhibit more potent binding.14 For example, racemic succinimides 1-3 and 
enantiomerically pure succinimides 4-6 were tested as potential antifungal 
agents (Figure 1).15 It was found that enantiomerically pure succinimides 
displayed higher antifungal activity than their racemic counterparts, as shown 
by the enhancement ratio (the factor in which the antifungal activity had been 
increased using the enantiomerically pure succinimide), between the racemic 
and the enantiomerically pure succinimides.  











Figure 1: The enhancement ratio between chiral and racemic succinimides of the antifungal 
activity of Candida albicans. 
 
A further example of the effect of chirality on drug activity is the tuberculosis 
drug ethambutol (7, Figure 2). The (S,S)-isomer 7 is 500 times more potent 
than the (R,R)-isomer 8 at binding to its target, and therefore, a significantly 
lower dose of the (S,S)-isomer is required to achieve the desired effect.16 
 
                                 
 
 
















































ER (Enhancement Ratio): 2 ER: 4 ER: 4
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The factors described so far concern the general properties of potential drug-
like molecules. However, to arrive at the point of the optimal, marketable drug 
molecule, extensive screening of a large number of compounds is required. 
This involves testing for activity against the drug target until a number of lead 
compounds, which show potency and some degree of selectivity for the given 
target, as well as exhibit desirable ADMET properties, are identified. These 
lead compounds then undergo extensive optimisation, which may eventually 
result in the development of a marketed drug. Typically, the molecular weight 
of a lead compound increases during development due to the addition of new 
functionality as a means of enhancing its potency and selectivity, minimising 
toxicity and maximising oral bioavailability. Therefore, given that the molecular 
weight of small molecule drugs is often < 500 g mol−1, it is clear that the 
molecular weight of a lead compound undergoing development should be 
significantly lower, often < 300 g mol−1.17 Furthermore, introduction of 
additional structural complexity typically increases the lipophilicity of 
compounds during the lead optimisation process. As such, an optimal lead 
compound should possess a log P < 3 in order to ensure that the structure of 
the optimised drug molecule does not exceed the lipophilicity principles of a 
typical drug (log P < 5).18 
 
Chemical space is another key area for study in drug research and 
development. This concept is defined as the space spanned by all possible 
known molecules or structures.19 Compound screening libraries containing 
more varied structures have a greater ability to interrogate that chemical 
6 	  
space, which is important as only a small fraction of the vast array of chemical 
space has been explored to date.19,20 Due to the tetrahedral nature of sp3- 
hybridised carbon atoms, sp3-rich compounds typically possess greater 3D 
complexity than aromatic, flat sp2-rich molecules and, therefore, can 
potentially tap into untested areas of chemical space. This could lead to the 
identification of molecules that display interactions with new targets.21 
 
The application of synthetic chemistry methodology has underpinned the 
creation of small molecules for drug discovery and development programmes. 
However, it is believed that the chemical methods available to synthetic 
chemists have had an inadvertently negative impact on the drug discovery 
processes by facilitating the construction of molecules with undesirable 
physicochemical properties.21 This has led to a decline in the productivity of 
the pharmaceutical to the point where the number of new drugs approved per 
billion dollars spent has halved roughly every 9 years since 1950.22 The main 
reason for this is the extensive use of similar chemical processes, which are 
highly effective at constructing sp2-rich compounds (vide infra, section 4.1), 
which tend to be flat and more lipophilic. As a result, many screening libraries 
are over-populated with sp2-rich compounds of limited structural diversity.23 
Indeed, several studies have shown that only 2.6% of commercially available 
building blocks are within a lead-like defined space,24 and almost half of all 
known compounds only tap into 0.25% of the possible molecular 
frameworks.25 This highlights the lack of chemical space explored by the 
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current synthetic chemistry methodologies in the creation of small molecules 
with lead-like properties.  
 
Due to the overuse of chemical methods for the assembly of sp2-rich 
molecules, thereby contributing to a decline in the productivity of the 
pharmaceutical industry,22 there is now an increase in the demand for 
molecules with a higher degree of saturation (sp3-rich). In addition to the 
observation that sp3-rich compounds tend to be less lipophilic than sp2-rich 
ones,21 saturation can give rise not only to greater structural variation, but also 
stereoisomerism. The number of chiral centres in a molecule can correlate 
with the success of that compound in the transition from discovery through 
development to the active drug.25 When dimethylpyridine (9) and 
dimethylpiperidine (10) are compared (Figure 3),21 a clear difference in the 
ability to access chemical space by the possible isomers that can be formed 
with either molecule is apparent. Specifically, dimethylpyridine (9) is 
essentially an unsaturated, flat molecule with just five potential isomers and 
little structural complexity. In contrast, dimethylpiperidine (10), which has more 
sp3 character, is a fully saturated molecule: the ring structure of 10 is not flat 
and comprises two chiral centres, enhancing its 3-dimensionality. As a result 
of the added chirality, the number of potential isomers of 10 is significantly 
increased compared to that of 9. This enhancement of structural diversity, 
therefore, enables the exploration of greater areas of chemical space. The 
importance of sp3 centres is also apparent when the total carbon count in lead 
and drug compounds is compared: in lead compounds, the average Fsp3 
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(fraction of sp3 carbon atoms) is 0.36, whereas in drug compounds, this 
number increases to 0.47.21   




Figure 3: The effect of saturation on structural diversity. 
 
To address the diminishing access to structurally novel lead molecules, the 
concept of lead-oriented synthesis has recently emerged.24,26 Lead-oriented 
synthesis targets lead-like molecules with specific molecular properties, 
including a suitable molecular weight, polar surface area, number of hydrogen 
bond donors and acceptors, number of rotatable bonds and the amount of 
chemical space the molecule can explore.  
 
As lead optimisation tends to increase the molecular weight and lipophilicity of 
the lead molecule, some parameters have been set to estimate whether a lead 
compound could successfully be developed to a drug molecule. Typically, log 
P plays an important role (log P < 3 for lead compounds), as well as the 
molecular weight (MW < 300). In fact, it was found that just 2.6% of 4.9 million 
commercially available compounds survive the filtering process based on 
these parameters.24 
 
Nelson and co-workers devised a unified lead-oriented synthesis to produce 










11, two allylic carbonates 12,  and using ligand 14, over 50 molecules of type 
15a-15c were generated from amines of type 13. Most of the products made 
had created had the right balance of molecular weight, lipophilicity, polarity 
and a sufficient amount of sp3 character, all desirable properties for lead-like 
molecules, which could lead to the access of new areas of chemical space not 
accessible through previous methods.28 































There is sufficient evidence to suggest that molecular properties of lead 
candidates directly affect the probability of successful development of a 
candidate to a marketed drug.29 To achieve this, more efficient chemical 
processes for the synthesis of sp3-rich structures must be sourced to access 








































can be discussed, an overview of cross-coupling methodologies, which focus 
on sp2-rich molecule synthesis, is warranted. 
 
5.1. Catalytic Cross-Coupling Reactions 
Catalytic cross-coupling reactions have allowed for significant advances in the 
synthesis of complex molecules by facilitating carbon-carbon bond formation. 
These processes have been efficiently utilised in the creation of polymers,30 
agrochemicals and pharmaceuticals.31-33    
 
A typical sp2-sp2 cross-coupling reaction is mediated by a metal catalyst, most 
frequently palladium (Scheme 2). Mechanistically, palladium catalyst 16 
undergoes oxidative addition to organohalide 17 to form organopalladium 
species 18.34 Transmetallation with a second coupling partner 19 displaces the 
halide from 18 to form 20 and palladium intermediate 21. The resulting 
intermediate 21 undergoes reductive elimination to form coupled product 22 
and in turn regenerates the catalyst.   

















                                             
 
Scheme 2: Mechanism of a typical palladium-catalysed cross-coupling reaction.  
 
The first example of a palladium-catalysed cross-coupling reaction was 
reported in 1975 by Murahashi,35 providing the basis for rapid development. 
An example of a well-known cross-coupling reaction heavily utilised in the 
pharmaceutical industry, is the Suzuki-Miyaura reaction, first reported by 
Suzuki and Miyaura in 1979 (Scheme 3).34  
 
 































Scheme 3: Reaction mechanism of the Suzuki-Miyaura coupling. 
 
This process has been used extensively to couple sp2 centres together and 
requires a boronic acid or ester, and a halide as the coupling partners. 
Mechanistically, Pd0 undergoes oxidative addition to organohalide 23 to form 
intermediate 24, which reacts with a base, such as sodium acetate, to afford 
intermediate 25. In addition, the base reacts with boronic acid/ester 26 to form 
a boronate species, which undergoes transmetallation with intermediate 25 to 
form 27.  Finally, reductive elimination occurs to form cross-coupled product 
28 and regenerate the catalyst.  
 
As well as the Suzuki-Miyaura coupling, other coupling partners have also 
found utility in this general process, all of which proceed via a similar reaction 
mechanism (Scheme 4). These include Kumada,35 Stille,36 Hiyama,37 and 



































Scheme 4: Generality of the palladium-catalysed cross-coupling. 
 
The primary reason why the Suzuki-Miyaura reaction is so popular stems from 
the fact that organoboron reagents are often commercially available, tend to 
be easy to make, many are relatively stable and the reaction itself is 
operationally straightforward.34 In contrast, organotin reagents in Stille 
reactions are often toxic, and the separation of products from starting 
materials and by-products can be difficult.39 Kumada couplings use Grignard 
reagents as one of the coupling partners, which are very moisture sensitive 
and can introduce practical complexities. The Hiyama coupling utilises silicon 
reagents, which are very stable, however, basic fluorides and harsh reaction 
conditions are required to cleave the silicon-carbon bond. As such, base-
sensitive functionality may be affected by the addition of this activator. Negishi 
couplings use organozinc reagents, which are highly reactive. Therefore, the 
main drawback of the Negishi coupling is that zinc reagents have less 
functional group compatibility due to their high reactivity. In spite of this, 
Negishi couplings have been widely used for sp2-sp3 coupling.40,41   
 
In addition to the aforementioned processes, the Heck reaction is similar to 
the above in that it allows for sp2-sp2 coupling of an organohalide as one of 
R1 X R2 M R1 R2 X M
M = Mg, Kumada
       Sn,  Stille
       Si,   Hiyama
       Zn,  Negishi
29 30 31 32
Pd(0)
14 	  
the coupling partners, but the difference is that the second coupling partner is 
an unactivated alkene (Scheme 5).42,43  











Scheme 5: General mechanism for the Heck reaction. 
 
Mechanistically, palladium catalyst 16 oxidatively adds into the aryl-iodine 
bond in 33 to form intermediate 34. The palladium centre in 34 then forms a π-
complex with alkene 35 to give 36, and undergoes carbopalladation in a syn 
fashion to form intermediate 37. The next step is β-hydride elimination, which 
forms π-complex 38 from 37, at which point the palladium catalyst dissociates 
from the alkene to release product 39. The final step is the regeneration of 
Pd(0) catalyst 16 from 40 by means of a base. 
 
A number of pharmaceuticals and natural products have been accessed by 























such as an analogue of (+)-dynemicin 41, an anticancer drug, and the natural 
product pumilotoxin A (42), a toxic component in the saliva of frogs.44,45 The 
key step in the synthesis of  the dynemicin analogue (41) is a Suzuki-Miyaura 
cross-coupling between aryl boronic acid 43 and triflate 44, giving rise to 
cross-coupled product 45, which was eventually transformed to product 41.  









Scheme 6: The Suzuki-Miyaura cross-coupling in the synthesis of (+)-dynemicin (41). 
 
In pumilotoxin A (42) synthesis, a Negishi coupling between highly 
functionalised 46 and 47 was performed to generate advanced intermediate 
48, which, in several steps, was converted to pumilotoxin A (42).  



























































Indeed, the importance and broad application of cross-coupling reactions, 
mainly effective at the union of sp2 carbon centres, has resulted in the Nobel 
Prize being awarded to Suzuki, Negishi and Heck in 2010.46 However, given 
that sp2-rich molecules are recognised to have a lower probability of being 
developed into a commercially viable pharmaceutical,21 it is argued that the 
vast utility of these  processes have unintentionally facilitated the academic 
and industrial synthesis of flat, lipophilic molecules, with negative 
consequences to the pharmaceutical industry.23 It is, therefore, becoming 
apparent that new chemical methods that enable the coupling of molecules 
with greater sp3 character are highly sought after to accelerate the synthesis 
of compounds that are less lipophilic and more structurally diverse. There has 
been some recent progress made towards extending sp2-sp2 coupling to the 
union of sp3 centres.47 For example, in 2007, Phillips and Keaton 
demonstrated a palladium-catalysed sp3-sp3 cross-coupling reaction, in the 
field of natural product synthesis (Scheme 8).48 The synthesis of polyketide 
(+)-spirolaxine methyl ether (51), known to inhibit the growth of cholesterol, 
relies on a late stage alkyl-alkyl Suzuki-Miyaura cross-coupling reaction 
between borane 49 and alkyl halide 50. 
 



























The fundamental obstacle to sp3-sp3 coupling is the competing reaction of β-
hydride elimination, whereby an alkyl group bonded to the metal centre is 
converted to a metal hydride and an alkene.49 As β-hydrogens are available 
for elimination in an sp3-sp3 coupling, β-hydride elimination is more likely to 
occur in these processes compared to the sp2-sp2 cross-coupling reactions 
(Scheme 9). More specifically, the metal catalyst oxidatively adds to the C–X 
bond of alkyl species 52 to form 53. Transmetallation of 53 with metal species 
54 then follows to give coupled intermediate 55, before generating product 56 
via reductive elimination. The competing β-hydride elimination reaction can 
also occur to generate complex 57 from 53. This intermediate dissociates to 
form alkene 58 and complex 59, while the base regenerates the catalyst.  










Scheme 9: sp3-sp3 cross-coupling vs β-hydride elimination mechanism. 
 
There are strategies that can be employed to suppress β-hydride elimination. 
For example, it is possible to vary the ligand used for the cross-coupling 


























β-hydride elimination. However, these methods have their limitations, as the 
nature of the metal coordination sphere under catalytic conditions is not 
always controllable or easily predictable. Therefore, it can often be challenging 
to deduce which ligands are more suitable for suppressing β-hydride 
elimination.50 
 
The Kumada coupling has also been used extensively for sp3-sp3 coupling 
reactions,51,52 utilising an alkyl Grignard reagent as the second coupling 
partner. In 1998, Donkervoort devised a method for sp3-sp3 coupling (Scheme 
10), in which bromides 60 and Grignard reagents 61 were coupled with the aid 
of a manganese-based agent 63 and a copper catalyst, giving rise to coupled 
products 62 in 55-94% yields.52 The yields were high when either straight 
chain alkyl or branched alkyl chains were used (62a-62c), and esters were 
also readily incorporated into the products (62d). Although the reaction is 
efficient at coupling sp3-sp3 centres together, the drawback of the reaction is 



















Scheme 10: sp3-sp3 coupling via a Kumada reaction. 
 
While these reactions are efficient at forming C–C bonds, it is clear that 
functional group compatibility and competing side reactions can present 
obstacles for the broader development of the direct sp3-sp3 coupling. To 
overcome some of these difficulties, an alternative method for sp3-sp3 
coupling, known as decarboxylative cross-coupling, has emerged. This type of 
reactivity is discussed in the next section. 
 
5.2.  Decarboxylative Cross-Coupling  
The methods discussed so far involved the coupling of an organometallic 
species (M–R2) and a halide (X–R1) (vide supra, Scheme 2). To overcome 
some of the difficulties encountered previously with sp3-sp3 cross-coupling 
reactions, an efficient decarboxylative sp3-sp3 coupling process, which does 
not require the use of pre-functionalised coupling partners, was developed. In 
this reaction, a palladium(0) catalyst undergoes oxidative addition to ester 
species 64 to form 65, which is followed by decarboxylation to provide 
R Br R2 MgCl
60 61
 63 (10 mol%)















palladium(II) intermediate 66 (Scheme 11). Finally, reductive elimination forms 
coupled product 67, in which a new C(sp3)–C(sp3)  bond had been formed. 
                
 
 
Scheme 11: General decarboxylative cross-coupling mechanism. 
 
While the direct cross-coupling reactions required two coupling partners (vide 
supra, Scheme 2), this type of decarboxylative cross-coupling utilises only one 
coupling partner and the transmetallation step is replaced by decarboxylation; 
This removes the need for highly reactive or toxic coupling partners,39  and the 
use of a strong base is no longer required.34 The only waste product of the 
reaction is carbon dioxide, which is easily expelled from the reaction medium. 
 
The most widely developed decarboxylative cross-coupling reaction is the 
palladium-catalysed allylic alkylation of enolates, first reported almost 
simultaneously by Tsuji,53 and Saegusa.54 In Tsuji’s report, a number of allyl 
esters 68 were treated with a catalytic amount of palladium to form allylated 
ketones 69 (Scheme 12). Mechanistically, 70 undergoes oxidative addition 
with the palladium catalyst to form 71, which is followed by decarboxylation to 
give rise to η3-π-allylpalladium(II) intermediate 72 and enolate 73, which may 
be covalently bonded to palladium or associated with 72 as a tight ion pair. 
The highly reactive enolate is then alkylated at the terminal carbon of the η3-π-
allylpalladium(II) species at the less hindered end to form the sp3-sp3 coupled 


















69e, 24-100%),53 with some substrates giving a low yield of 69 due to the 
formation of diallylated by-products. 












Scheme 12: Palladium-catalysed decarboxylative allylic alkylation of ketone enolates. 
 
This reaction is analogous to the Carroll rearrangement, in which substrate 75 
is heated to 170 oC to form 76 (Scheme 13). 55,56 
                           
 
 
Scheme 13: The Carroll rearrangement. 
 
The Carroll rearrangement uses harsher reaction conditions and requires a 
base. This highlights the superiority of the palladium-catalysed cross-coupling 
R1O









































reaction over the Carroll rearrangement, whereby the reaction conditions are 
significantly milder and the transformation is base-free. 
 
Around the same time, Saegusa reported the decarboxylative allylic alkylation 
of ketone enolates using β-keto esters of type 77 as substrates to form 
products 78a-78f (Scheme 14).54      










Scheme 14: Saegusa’s decarboxylative allylic alkylation of cyclic ketones. 
 
In this work, ketone products were obtained in varying yields and it was found 
that cyclic substrates were less prone to diallylation than the acyclic 
substrates (Scheme 15).54 Despite only a couple of the cyclic products 
containing an all-carbon quaternary centre being reported (e.g. 78b), there 
was no diallylation observed for any of the reactions involving cyclic ketones in 
which a tertiary centre had been constructed (78a, 78c-78f). On the other 
hand, the acyclic substrates were less successful, and three out of the seven 





























contributing to a reduced yield of the mono-allylated product. Despite 80a 
being produced in a high yield, most of the linear based substrates gave yields 
lower than that of their cyclic counterparts (80a-80f). 













Scheme 15: Saegusa’s decarboxylative allylic alkylation of acyclic ketones. 
 
Concerning the mechanism of diallylation, it is postulated that following 
oxidative addition of the catalyst to 81, decarboxylation generates η3-π-
allylpalladium(II) intermediate 82, and enolate 83 addition to the terminal 
carbon of the η3-π-allylpalladium(II) intermediate gives rise to product 84 
(Scheme 16). However, the enolate generated in situ (83) can also 
deprotonate the α-position of ketone product 84, thus creating a new enolate 
85, which can undergo a second allylic alkylation with η3-π-allylpalladium(II) 













           80b (37%)
16% diallylated product
NC
           80d (69%)
16% diallylated product
O







cyclic examples contained an  α-proton in the product, and therefore, were 
susceptible to deprotonation (vide supra, Scheme 15), diallylation was not 
observed in any of the reactions. 
         
Scheme 16: Mechanism of the diallylation side-reaction. 
 
Tsuji has also reported work involving the conversion of β-keto esters 87 to β-
unsaturated ketones 88 in good yields (Scheme 17).57 It was found that one of 
two reaction pathways could be followed depending on the conditions used. 
With acetone as the solvent, the decarboxylative allylic alkylation process 
generated 88 from 87. In contrast, using other aprotic solvents, such as 
acetonitrile, decarboxylation formed intermediate 89, which is in equilibrium 
with carbon-palladium bonded complex 90, poised to undergo β-hydride 
elimination to give cyclohexenone 91.57 This stands as further evidence that as 
described earlier (vide supra, Scheme 9), when β-hydrogens are available, β-




























Scheme 17: Allylic alkylation vs β-hydride elimination. 
 
Decarboxylative allylation has been expanded to other allylic derivatives, such 
as allyl enol carbonates.58 Later, malonates were also successfully used: 
although the initial results were weak and required heating the reactions to 
above 100 oC,59 20 years later, Ito and coworkers drastically improved the 
yields of the decarboxylative allylic alkylation of malonates under mild reaction 
conditions.60 
 
The versatility of the method has allowed facile access to compounds such as 
allylic amines,61 vinyl azetidines,62 and vinyl piperidines,63 through the use of 
nitrogen-based nucleophiles such as allylic carbamates and vinyl 
oxazinanones. O-allylation has also been utilised, creating allyl ethers from 
allylic esters.63 Finally, allyl selenides could be generated from allyl 
selenocarbonates.64 Overall, these methods are effective at creating C–N, C–
























Significantly later, in 2004, the first asymmetric method for the decarboxylative 
allylic alkylation of ketone enolates was reported by Burger and Tunge 
(Scheme 18).65   It was found that high levels of asymmetric induction could be 
obtained in the palladium-catalysed decarboxylative rearrangement of allyl-β-
keto carboxylates 92 to 93 in the presence of Trost’s chiral phosphine ligand 
(94).  












Scheme 18: The first asymmetric decarboxylative allylic alkylation. 
 
Tunge compared this method to the intermolecular asymmetric allylic 
alkylation process (Scheme 19).66 In the first instance, cyclopentylacetate 95 
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conditions to form 96. The enantiomeric excess of 96 (85% ee) was then 
compared to that obtained in the intermolecular allylic alkylation reaction using 
sodium ethyl acetate 97 and allylic acetate 98 as the coupling partners. More 
specifically, product 100 was obtained via 99 in 42% ee following a Krapcho 
decarboxylation, highlighting that the level of enantioselectivity of the 
decarboxylative allylic alkylation approach is superior to that observed when 
using the intermolecular coupling variant. 
   
Scheme 19: Decarboxylative vs intermolecular asymmetric allylic alkylation process. 
 
In 2004, Stoltz and Behenna reported the first asymmetric decarboxylative 
allylic alkylation reaction to enable the formation of an all-carbon quaternary 
centre (Scheme 20).67 Enol carbonates of type 101 underwent decarboxylation 
with a palladium catalyst and in the presence of chiral ligand 103, afforded 
enantio-enriched allyl ketones of type 102 with good yields and 












A: Decarboxylative asymmetric allylic alkylation
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Tunge and Burger (vide supra, Scheme 18), gave no enantioselectivity in this 
reaction. 










Scheme 20: Enantioselective decarboxylative allylation. 
 
In 2005, Nakamura’s group explored enantioselective decarboxylative allylic 
alkylation of α-fluoroketones.68 It was found that the reaction of fluorinated allyl 
esters 104 in the presence of a source of palladium(0) and a chiral ligand 
(106) afforded products 105 in high yields and enantioselectivity (Scheme 21). 
Chiral phosphinooxazoline 106 was found to be the most efficient ligand, 
where the substitution on the oxazoline ring of 106 proved crucial to the 
observed enhancement of enantioselectivity, and it was observed that a large 
tert-butyl substituent was essential in obtaining high enantioselectivities of 
105. Using the optimised conditions, it was shown that 6-membered 
O O
O
R [Pd2(dba)3] (2.5 mol%)
    103 (6.25 mol%)
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substrates gave the best enantioselectivity in this decarboxylative cross-














Scheme 21: Chiral α-fluoroketone synthesis via decarboxylative allylic alkylation. 
 
The fluorinated products obtained through this approach were particularly 
interesting from a medicinal chemistry perspective, as fluorine has unique 
properties that can alter the physical and chemical characteristics of drug 
molecules. For example, the presence of an electron withdrawing fluorine 
atom can reduce the pKa of a molecule, which has been known to increase its 
oral bioavailability.69 In addition, fluorination of certain functional groups can 
lead to either an increase or a decrease in lipophilicity, depending on the 
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In addition to ketone enolates, other carbonyl compounds can also be 
successfully employed in this reaction. For instance, in 2011 an asymmetric 
decarboxylative allylic alkylation of oxindoles was developed (Scheme 22).71 
In this case, enantio-enriched oxindoles, containing an all-carbon quaternary 
centre (108), were generated via an sp3-sp3 coupling process involving 
oxindoles of type 107. Interestingly, using the same enantiomer of ligand 109, 
the sense of enantioinduction varied depending on the size of the R 
substituent in 108. It is thought that smaller groups direct the sterically bulky 
oxindole ring under the ‘open flap’ of the chiral ligand (108a-c), whilst a 
sterically bulky group overrides this effect and provides product 108 with the 
































Scheme 22: Asymmetric decarboxylative allylic alkylation of oxindoles. 
 
The enantioselective palladium-catalysed allylic alkylation process has been 
explored heavily, for example, in the synthesis of enantio-enriched α-tertiary 
hydroxyaldehydes, as well as allylated 2-acylimidazoles.73,74  Notably, Trost 
disclosed the asymmetric allylic alkylation of cyclic vinylogous ester and 
thioesters, showing that a wide range of ester and thioesters could be 
successfully coupled in an enantioselective manner, creating products with a 
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5.3. Palladium-Catalysed Decarboxylative Cross-Coupling of Propargylic 
Electrophiles  
So far, focus has been given to the decarboxylative allylic alkylation of 
nucleophiles with allylic electrophiles, whereby decarboxylation of allylic ester 
110 forms η3-π-allylpalladium(II) intermediate 111 and the nucleophile adds to 
the terminal carbon of η3-π-allylpalladium(II) intermediate 111 to form 112 
(Scheme 23). In this section, palladium-catalysed reactions of propargylic 
electrophiles, which have been studied less thoroughly, will be discussed. In 
this context, when a palladium catalyst oxidatively adds to propargylic 
electrophile 113, decarboxylation leads to η3-π-allenylpalladium(II) 
intermediate 114 (Scheme 23). The nucleophile generated in situ can then 
attack the η3-π-allenylpalladium(II) species to form 115 in a propargylation, 
rather than an allylation, reaction.76 However, this is not the only pathway that 
this reaction can take and the reactivity profile of propargylic electrophiles 
warrants a more detailed discussion. 





Scheme 23: Decarboxylative allyl transfer vs propargyl group transfer.  
 
Palladium-bound intermediate 114 differs from its allyl variant 111. The metal 
centre can bind to the allyl motif via two η1 modes or an η3 mode (116, 117 
and 111, Figure 4), while the propargylic system can either form η1-σ-


















119, or η3-π-allenylpalladium(II) intermediate 114. Studies have shown that 
the η3-π-allyl bound species tends to be favoured in most cases for a 
decarboxylative allylic alkylation reaction.77-79  







Figure 4: Structures of different palladium bound allyl and propargyl groups. 
 
However, during propargyl group transfer, the intermediate formed (114, 118 
or 119) is not quite as well defined. In 1982, Keinan and Bosch predicted that 
the η1-σ-propargylpalladium(II) and η1-σ-allenylpalladium(II) intermediates 118 
and 119, respectively, would be more stable than η3-π-allenylpalladium(II) 
species 114.80 However, further studies have shown that η3-π-
allenylpalladium(II) species 114 could be the preferred intermediate,81 an 
observation that has been confirmed by X-ray crystallography.82 As well as 
palladium, the η3-π-allenyl-bound intermediates with other metals, such as 
iridium, rhenium and platinum, have also been isolated.83,84  
 
Allyl and propargyl palladium cations also react differently with nucleophiles 
(Scheme 24). In the case of η3-π-allylpalladium(II) intermediate 120, the 
nucleophile attacks one of the terminal carbon atoms in 120 to form 121 or 
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122. Typically, addition at the less substituted position (C-1) in 120 occurs due 
to steric effects.85 In contrast, with η3-π-allenylpalladium(II) systems, three 
reaction pathways are possible. Hard nucleophiles, such as unstabilised 
enolates, are more likely to attack at the terminal carbon atom 1 or 3 in 114 to 
form either alkyne 123 or allene 124, respectively. Soft nucleophiles, such as 
stabilised enolates, are more likely to attack at the central carbon (carbon 2), 
which is followed by a second nucleophilic addition to form 125.  













Scheme 24: Modes of reactivity of allyl palladium and propargyl palladium intermediates. 
 
Concerning the latter reactivity mode, when the first stable nucleophile attacks 
the central carbon atom of η3-π-allenylpalladium(II) intermediate 114 (Scheme 
25), it gives rise to putative palladacyclobutene intermediate 126 (which can 
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palladacycle 126 by the second nucleophile, η3-π-allylpalladium(II) 
intermediate 128 is formed. In the final mechanistic step, nucleophilic addition 
to one of the terminal carbon atoms in 128 generates product 125 (Scheme 
25). We can only speculate the structure of palladcyclobutene 126, as there is 
a lack of empirical evidence to confirm its implication in the mechanism. It is 
possible that intermediate 126 is only transient and its formation is followed by 
immediate protonation to give η3-π-allylpalladium(II) intermediate 127 in a 
synchronous manner.82 However, given that the analogous 
metallacyclobutenes of rhenium, iridium and platinum have been isolated and 
characterised,83,84 the existence of palladacyclobutene 126 in this mechanism 
cannot be ruled out. 
                    
 
Scheme 25: Palladium-catalysed reactions of soft nuclophiles with propargylic electrophiles. 
 
The much lower extent of investigation of the palladium-mediated 
decarboxylative reactions of propargylic electrophiles as compared to allylic 
ones is likely to be due to the lower reactivity of the former with palladium 
(Scheme 26). A study comparing the deprotection of allyl groups and 
propargyl groups in the presence of dimedone (131) and [Pd(PPh3)4] found 





























temperature, propargylic analogue 130 did not react and starting carbamate 
130 was recovered.86 






Scheme 26: Deprotection of allyl and propargyl carbonates. 
 
Despite the reduced reactivity of propargylic electrophiles, significant progress 
has been made in this area over the past two decades. In 1994, Bienayme 
released a report on the decarboxylative propargylation and allenylation of 
aldehydes (Table 1).87 Mechanistically, oxidative addition to 133 and 
decarboxylation forms the η3-π-allenylpalladium(II) intermediate 134 along 
with an extended enolate 135. Given the relatively unstabilised nature of 
enolate 135, the reaction follows one of two pathways. The first is the addition 
of the enolate 135 to carbon atom 1 in 134 to form propargylated product 136, 
while the second is addition to carbon atom 3 in 134 to form allenyl species 
137. Despite some evidence that the allenylation pathway would dominate for 
steric reasons, the main reason being that addition to the less hindered end of 
the η3-π-allenylpalladium(II) intermediate forms the allenylated product,88 the 
steric effects of substituents R1, R2 and R3 were not clear cut in this study. 
While bulky groups on carbon atom 1 promoted attack at carbon atom 3 of η3-
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surprisingly, some bulky R3 substitutents also promoted addition to carbon 
atom 3 in an allenylation, rather than a propargylation reaction (entry 4, Table 
1). Propargylated aldehyde 136 was formed only when all the substituents 






Table 1: Selected examples of decarboxylative propargylation and allenylation of aldehydes. 
 
It was stated previously that, generally, unstabilised enolates would favour 
addition to the terminal positions of the η3-π-allenylpalladium(II) intermediate 
to give either propargylated or allenylated products. However, this is not 
always the case. Yoshida et al. discovered that the analogous decarboxylative 
process with monosubstituted β-ketoester 139 resulted in nucleophilic addition 
of an unstabilised ketone enolate to the central carbon atom of the η3-π-
allenylpalladium(II) intermediate (Scheme 27).89 
 
Entry R1 R2 R3 Combined yield (%) Ratio 136/137 
1 Me Me H 59 64/36 
2 H H H 64 100/0 
3 138 138 H 69 0/100 













































Scheme 27: Synthesis of tetrasubstitutued furans by palladium-catalysed decarboxylative 
cyclisation of propargyl β-ketoesters. 
 
 
Upon oxidative addition to 139 and decarboxylation, η3-π-allenylpalladium(II) 
intermediate 141 is formed, which may be in equilibrium with its ion pair 142 
and 143 (Scheme 28). Nucleophilic attack of the ketone enolate at the central 
carbon atom of 143, then leads to η3-π-allylpalladium(II) intermediate 145 via 
protonation of putative palladacyclobutene 144. Enolate 145 then undergoes 
intramolecular O-alkylation at the more substituted terminal carbon of the η3-π-
allylpalladium(II) intermediate to form 146 which isomerises to give substituted 
furan 140 (Scheme 28). Addition does not occur at the less-hindered terminal 
carbon atom of the η3-π-allylpalladium(II), in contrast to the expected reaction 
pathway, whereby the allylic alkylation of the nucleophile takes place at the 
less hindered end of the unsymmetrical η3-π-allylpalladium(II) intermediate.85 
This work demonstrates that the regioselectivity of enolate addition to the η3-
π-allenylpalladium(II) intermediate may not always be easily predicted, and it 
is shown later how different factors can affect the outcome as to what end of 
the  the unsymmetrical η3-π-allylpalladium(II) intermediate the nucleophile can 
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Scheme 28: Synthesis of tetrasubstitutued furans by the palladium-catalysed decarboxylative 
cyclisation of propargyl β-ketoesters. 
 
 
It was only in 2011 that Stoltz devised the first asymmetric palladium-
catalysed decarboxylative propargylation of ketone enolates (Scheme 29).90 
The reaction yielded ketone products 148 from 147, albeit with moderate 
levels of enantioselectivity, despite the variation of the side-chain in ligand 
149. The reaction is significant as is renders a highly congested all-carbon 
quaternary centre in an enantio-enriched form. 
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5.4. The Coupling of Soft Nucleophiles and Propargylic Electrophiles 
The examples discussed so far have focused on the reactivity of unstabilised 
enolates in, with some exceptions, decarboxylative propargylation and 
allenylation processes. In contrast, when a stabilised enolate is used as the 
nucleophile, the mechanism described in Scheme 28 is likely to be dominant, 
in which double nucleophilic addition, one at the central carbon atom and one 
at the terminal position of the propargylic electrophile, takes place (vide supra, 
Scheme 24). A few examples of the reactivity of propargylic electrophiles with 
soft nucleophiles in a direct manner, rather than a decarboxylative manner, 
are discussed next.  
 
In 1985, Tsuji described a reaction of propargyl carbonate 150 with two 
equivalents of substituted β-ketoester 151 to form 152. As the two 
nucleophiles are the same, there are no selectivity issues. This process 
enabled the formation of two new C–C bonds as well as the installation of two 
all-carbon quaternary centres (Scheme 30).91 In this process, intramolecular 
cyclisation is not possible due to the formation of an all-carbon quaternary 
centre. As a consequence, two equivalents of β-ketoester 151 are required. 
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As well as performing a cross-coupling reaction using a stabilised enolate to 
form two C–C bonds in a single process, Tsuji reported a cyclisation process 
of propargyl carbonates 153 with methyl acetoacetate 154 to afford 
dihydrofurans 155, in which a C–C and a C–O bond were created (Scheme 
31).91  
     
Scheme 31: Mechanism for the creation of a furan ring via O-alkylation. 
 
The authors proposed a mechanism in which the palladium catalyst 
oxidatively adds to propargyl carbonate 153 to form ɳ3-π-allenylpalladium(II) 
unit 156 via decarboxylation. The methoxide anion thus formed deprotonates 
methyl acetoacetate 154 to form stabilised enolate 157, which attacks ɳ3-π-
allenylpalladium(II) intermediate 156 at the central carbon atom to generate 
palladacyclobutene 158. Protonation of palladacyclobutene 158 forms enolate 
159. In the final step, intramolecular O-alkylation of the in situ generated 
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the more hindered end to afford dihydrofuran species 155. In this reaction, the 
second nucleophile is revealed by means of deprotonation only after the first 
nucleophilic addition had taken place, and therefore, there are no issues with 
selectivity. 
 
5.5. The Cyclisation of Symmetrical Bis-Nucleophiles with Propargylic 
Electrophiles 
Given that soft nucleophiles undergo a double addition process in reactions 
with propargylic compounds, namely first at the central carbon atom, followed 
by addition at the terminal carbon atom, new cyclisation reactions emerged in 
which the two nucleophiles are tethered to a bis-nucleophile. In this context, 
Geng and Lu demonstrated how cyclic products could be obtained using 
symmetrical bis-nucleophile 160, either via C-alkylation or O-alkylation, which 
depended on the conditions used (Scheme 32).92 When a 
tetrahydrofuran/acetonitrile solvent was used with [Pd(PPh3)4] as the catalyst 
at room temperature, propargyl enol carbonate 150 underwent double 
nucleophilic addition with 2,3-diacetylsuccinate (160) to form kinetically 
controlled product 161, which is remarkable considering a highly strained 4-
membered ring had been generated. In contrast, with dppe as the ligand in 
refluxing acetonitrile, thermodynamic product 162 was formed via O-alkylation. 














Scheme 32: Cyclisation with 2,3-diacetylsuccinate. 
 
The authors then explored the use of malonate-based symmetrical bis-
nucleophiles of type 163 to prevent O-alkylation from taking place and thus 
create carbocycles 164 of varying sizes (Scheme 33).93 While cyclobutane 
ring 164a did not form, more stable 5-7 membered ring products 164b-164d 
were isolated in good yields. This process created two new C–C bonds and 
two all-carbon quaternary centres in a single step in 164. 





Scheme 33: Cyclisation with soft carbon bis-nucleophiles. 
 
The previous two examples have utilised a simple, unsubstituted propargyl 
carbonate. However, selectivity issues arise if an unsymmetrical propargylic 
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165 would afford unsymmetrical ɳ3-π-allenylpalladium(II) intermediate 166 
after decarboxylation. Addition of bis-nucleophile 167 to the central carbon 
atom of 166 would form putative palladacyclobutene 168, which, after 
protonation by the second nucleophile, would generate the ɳ3-π-
allylpalladium(II) intermediate 169. Given that ɳ3-π-allylpalladium(II) 
intermediate 169 is no longer symmetrical, two products could potentially form, 
170 or 171, depending on whether the second nucleophilic addition takes 





















Scheme 34: The mechanism of the addition of a bis-nucleophile to an unsymmetrical 
propargylic electrophile. 
 
The similarity in acidity of phenols and 1,3-dicarbonyl compounds allowed 
Sinou and co-workers to explore the coupling of soft catechol bis-nucleophile 
172 with an unsymmetrical propargyl enol carbonate 165, to form either 173 or 
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Regarding the mechanism, following formation of ɳ3-π-propargylpalladium(II) 
intermediate 175, catechol 172 adds to the central carbon atom of 175, 
eventually forming intermediate 176 (Scheme 38).94 Deprotonation of catechol 
172 preceeds the second oxygen anion addition to either of the terminal 
carbon atoms of ɳ3-π-allylpalladium(II) intermediate 177 to form either product 
173 or 174. It was argued that the cationic ɳ3-π-allylpalladium(II) intermediate 
species 177 has a partial positive charge lying at the more substituted terminal 
carbon atom for electronic reasons. This means that the allylic alkylation step 
is most likely to occur at this position. This is opposite to the general 
observation that addition to ɳ3-π-allylpalladium(II) intermediates take place at 
the less substituted end of the allylic system due to steric effects.84 Indeed, 
with smaller substituents, electronic effects dominate resulting in addition at 
the more hindered end (173a-173c, pathway b). However, when the 
substituents are larger, steric hindrance takes over the electronic effects and 



































































intermediate occurs with a lower regioselectivity, or the addition occurs at the 























Scheme 36: The proposed mechanism for the palladium-catalysed synthesis of 2,3-dihydro- 
2-ylidene-1,4-benzodioxins. 
 
5.6. The Control of Selectivity through Cyclisation Reactions of 
Propargylic Electrophiles with Soft Nucleophiles 
The above palladium-catalysed reactions of propargylic electrophiles with soft 
nucleophiles utilised symmetrical bis-nucleophiles with either symmetrical or 
unsymmetric propargylic electrophiles. The utility of this process can be 
significantly broadened if two different nucleophiles could be employed. 
However, regio- and chemoselectivity issues arise when reacting propargylic 
electrophile 150 with two different nucleophiles 178 and 179 (Scheme 37). 
Firstly, the challenge of regioselectivity must be addressed, whereby the order 
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181 are possible. Secondly, the homo-coupling of one of the nucleophiles, 
forming either 182 or 183, needs to be prevented. 





Scheme 37: The control of selectivity in reactions with soft nucleophiles. 
 
One of the strategies to overcome the potential selectivity issues entails the 
tethering of one of the nucleophiles to the propargylic electrophile (Scheme 
38). In this case, following oxidative addition to 184 and decarboxylation, 
addition of the tethered nucleophile to the central carbon of the ɳ3-π-
allenylpalladium(II) intermediate 185 should be favoured over addition of the 
untethered nucleophile due to the intramolecular nature of the reaction, which 
is the entropically favoured addition. The second nucleophile should then add 
to one of the termini of the ɳ3-π-allylpalladium(II) complex 186 at the more or 
the less hindered end to yield product 187 or 188 (Pathway 1). The second 
pathway in which intermolecular nucleophilic attack occurs prior to 
intramolecular nucleophilic addition to give 190 via intermediate 189 would be 
less likely for entropic reasons (pathway 2). 






























Scheme 38: Controlling the regioselectivity through the use of tethered nucleophiles. 
 
In 2006, Guo and co-workers demonstrated that propargylic carbonates 191 
appended with a malonate nucleophile could be coupled to 1,3-dicarbonyl 
compounds 192 to afford 2,3-disubstituted indenes 193 regioselectively 
(Scheme 39).95 In this context, the alkenylation of the tethered diethyl 
malonate proceeds first due to the intramolecular nature of the reaction and 
installs an all-carbon quaternary centre in 193. The intermolecular allylic 
alkylation of the enolate of 192 then follows, occurring almost exclusively at 
the more substituted benzylic position of the η3-π-allylpalladium(II) 
intermediate due to electronic effects. While 1,3-diketones and β-ketoesters 
can be successfully used (193a-193c), malonates did not take part in the 








































Scheme 39: Palladium-catalysed carboannulation using 1,3-dicarbonyls. 
 
In 2007, Guo expanded the palladium-catalysed carboannulation process by 
using phenol nucleophiles (Scheme 40).96 Propargylic electrophile 191 was 
successfully coupled with phenols 194 to afford products 195 with complete 
regioselectivity, but in contrast to using 1,3-dicarbonyls as the external 
nucleophile, the allylic alkylation step took place at the less substituted end of 
the η3-π-allylpalladium(II) intermediate. The reaction was found to be 
amenable to both electron-rich and deficient phenols (195a-195e), however 


























































Scheme 40: Palladium-catalysed carboannulation using phenols. 
 
Similarly, the use of amines as the nucleophile gave rise to the desired 
products with full regiocontrol, in moderate to good yields (Scheme 41).96 
Each of these processes afforded a new all-carbon quaternary centre and two 
new bonds in 197 in a single step. Various secondary amines (196) could 
react with 191 to give the desired product 197a-197g in moderate to good 
yields. Aryl secondary amine 196g, also afforded its corresponding product 
197g, while linear secondary amine 196f was successfully coupled with 191, 




























































Scheme 41: Palladium-catalysed carboannulation with nitrogen nucleophiles.  
 
In 2008, Guo published an intriguing report of a reaction between a similar 
propargylic electrophile 198 and phenols as the external nucleophile, in which 
the regioselectivity of the reaction had been reversed (Scheme 42).97 In this 
case, the intermolecular O-alkylation of phenol 199 had occurred before the 
cyclisation to give product 200. Most substituents afforded cyclic product 200 
in excellent yields, however, when an o-tBu substituted phenol was used, the 
phenol was not incorporated, presumably due to steric effects, and the 
tethered nucleophile added to the terminal carbon atom of the η3-π-
allenylpalladium(II) intermediate to form exocyclic allene 201. The authors 
postulated that the switch in regioselectivity was owing to the additional 
carbon atom in the carbon chain of 200, which would have given rise to a six-
membered, rather than a five-membered ring, after intramolecular 























































rings, it was suggested that this could be the driving force for the initial 
addition of the phenol nucleophile, leading to the eventual formation of five-
membered ring product 200. The reaction was successful, with electron-
withdrawing and donating groups attached to the phenol ring (200a-200e), 
however the yields were lower when the substituent was moved from the para 
to the ortho position of the phenol ring (200e). Substrate 198b, containing a 
phenyl propargyl carbonate, was also investigated and this gave product 200a 
with a yield only slightly less than that with the ethyl propargyl carbonate 
electrophile. 













Scheme 42: Reversal of regioselectivity in the cross-coupling of two nucleophiles.  
 
It was also discovered that exocyclic allenes can be formed in moderate to 
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tethered to a propargyl carbonate in 202 (Scheme 43).98 This was achieved by 
using a variety of tethered carbonates and amines to afford products 204a-
204e in moderate to excellent yields. In this process, Michael addition of 
amine 203 to 202 gives rise to an enolate, which undergoes an intramolecular 
cyclisation to generate allene 204. As well as a high yield obtained of 204a 
with aniline, both electron-withdrawing and donating anilines were 
successfully incorporated into the products (204b-204e). The reactions 
afforded a new all-carbon quaternary centre, as well as new C–C and C–N 
bonds in 204. 












Scheme 43: Tandem Michael addition/cyclisation. 
 
Access to exocyclic allenes allowed the Liang group to exploit the reactivity of 
these products in a tandem double-cyclisation sequence to gain entry to 
unusual spirocyclic products 206 from 198 in the presence of 2-iodophenols 
OR1202
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205 (Scheme 44).99  While a good yield of 206a was obtained, 2-iodophenols 
bearing an electron-withdrawing group in the para position resulted in an 
increase in the yield of the reaction (206b and 206c), while electron-donating 
groups contributed to a decrease in yield (206d), a decrease even more 
substantial when two electron-donating groups were present (206e).  












Scheme 44: Regioselective spirocyclisation reaction. 
 
Liang and co-workers proposed a mechanism for the reaction (Scheme 45).99 
Following oxidative addition to propargylic electrophile 198b, cyclisation forms 
exocyclic allene 201 as an intermediate. At this stage, oxidative addition of the 
palladium catalyst to 2-iodophenol 205 is followed by carbopalladation of 201, 
giving rise to η3-π-allylpalladium(II) intermediate 207. The final cyclisation step 
at the more hindered end of the η3-π-allylpalladium(II) electrophile then affords 
spirocycle 206. The reaction is significant as during the enolate cyclisation 
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step, an all-carbon quaternary centre within a complex spirocyclic structure is 
formed. 







Scheme 45: The proposed mechanism for the regioselective spirocyclisation reaction. 
 
Yoshida et al. developed a palladium-catalysed cyclisation reaction of a 
propargylic carbonate tethered to a phenol (208) in the presence of a cyclic 
1,3-diketone 209 for the synthesis of benzofurans 210. In the usual way, the 
initial intramolecular cyclisation was followed by the regioselective addition of 
the enolate of diketone 209 at the less hindered site of the η3-π-
allylpalladium(II)  intermediate, thus installing an all-carbon quaternary centre 
in 212 (Scheme 46).100,101 
     
 
 
Scheme 46: Benzofuran synthesis with 1,3-dicarbonyl nucleophiles. 
 
In 2013, Hamada and co-workers reported the first example of a 
dearomatisation of a phenol tethered to a propargyl carbonate via palladium 
































60 oC, 12 h
56 	  
generates η3-π-propargylpalladium(II) unit in 212, which undergoes 
intramolecular spirocyclisation at the central carbon atom of the η3-π-
propargylpalladium(II) unit in 212 with concomitant dearomatisation and 
formation of an all-carbon quaternary centre. β-Hydride elimination then 
affords desired product 213. As well as using phenol, ortho- and meta-
substituted phenol derivatives were also effective substrates for the reaction 
(213a-213e), as well as phenyl-containing substrate 211f which formed the 












Scheme 47: Dearomatisation of phenols. 
 
The authors also observed that the same reaction conditions could be applied 
to the dearomatisation reaction of indoles 214, installing an all-carbon 
quaternary centre in spirocyclic indolenine products 215 (Scheme 48).102 
Overall, a range of tryptamines 214 were tested and the desired 
transformation resulted in the formation of spirocycles 215 in good yields. As 
PPh3 (20 mol%)
211 CH2Cl2/MeOH 4:1


































with the dearomatisation of phenols, a spirocyclic all-carbon quaternary centre 
had been constructed in the process. 
 
                
 
 
Scheme 48: Dearomatisation of indoles. 
 
Ohno and co-wokers extended this method by utilising nitrogen and carbon 
nucleophiles 217 and 220 for the dearomatisation of indoles 216 (Scheme 
49).103 Using dppb as the bidentate phosphine ligand, tetracyclic products 218 
were obtained along with a small amount of 219, which arose from β-hydride 
elimination via the aforementioned pathway without incorporation of the aniline 
nucleophile. Sulfonamides 217a-217d were generally good, producing 218a-
218d in moderate yields, even though a small amount of product 219 was 
observed in all cases. Benzylamine on the other hand, only gave a moderate 
yield of the β-hydride elimination product. When dimethyl malonate and 
acetylacetone nucleophiles 220 were used, product 221 was formed instead. 






































Scheme 49: Dearomatisation of indoles in the presence of external nucleophiles. 
 
To rationalise the formation of the observed products 218, 219 and 221, the 
authors proposed the following mechanism (Scheme 50). After oxidative 
addition to 216 and decarboxylation, intermediate 222 is formed.  The 
intramolecular spirocyclisation of the indole functionality then occurs at the 
central carbon atom of η3-π-propargylpalladium(II) intermediate 222, installing 
an all-carbon quaternary centre in intermediate 223. At this stage, β-hydride 
elimination can occur to give rise to 219 (path a). Alternatively, addition of the 
nitrogen nucleophile to the imine functionality in 223 affords intermediate 224 
(path b). The intramolecular nucleophilic attack at the more substituted 
position of the η3-π-allylpalladium(II) intermediate forms the second C–N bond 
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as the nucleophile, addition at the less hindered end of η3-π-
propargylpalladium(II) intermediate 223 is followed by cyclisation to the imine 
in 225 to form 221. The authors postulated that owing to the larger steric bulk 
of the carbon nucleophiles, the neighbouring quaternary spirocyclic centre 





























Scheme 50: Proposed mechanism for the palladium-catalysed dearomatisation of indoles in 
the presence of external nucleophiles. 
 
 
The selective coupling of nucleophiles by means of tethering of one of the 
nucleophiles to the propargylic electrophile is very broad and not limited to the 
quaternary-centre generating processes. For example, in 2009, Cacchi and 
co-workers devised a method for the palladium-catalysed synthesis of 2-



















































51).104 The process utilised two nitrogen-based nucleophiles, including an 
amine tethered to the propargylic electrophile in 226 for the intramolecular 
cyclisation, and an amine 227, which undergoes the subsequent 
intermolecular allylic alkylation process to form 228.  




Scheme 51: Palladium-catalysed synthesis of 2-aminomethyl-, 2-vinyl and 2-alkylindoles. 
 
This method has been expanded and applied to the synthesis of a range of 
novel heterocycles via the formation of new carbon-heteroatom bonds using a 
range of nitrogen based nucleophiles. This includes the synthesis of 
carbapenam,105 and 2-oxazolidinones,106 in which the palladium-catalysed 
cyclisation enabled the construction of new C–N bonds. Oxygen heterocycles 
could also be made through the palladium-catalysed cyclisation process, 
including furan derivatives, creating a new C–O bond.107 Subsequently, 
methods using tethered systems that render unsymmetrical ɳ3-π-
allenylpalladium(II) intermediates upon decarboxylation have also been 
successfully developed, such as that reported by Sinou et al., which yielded  a 
series of unsaturated dihydropyrans using an unsymmetrical propargylic 
electrophile.108  Similarly, Cacchi and co-workers devised a method for the 
synthesis of 2-alkylindoles, which involved a palladium-catalysed cyclisation 
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5.7. The Control of Selectivity through Cyclisation Reactions of Tethered 
Bis-Nucleophiles with Propargylic Electrophiles 
The above examples concern the tethering of one of the nucleophiles to the 
propargylic electrophile to control the order of addition by exploiting the 
typically much faster rate of intramolecular cyclisation. The synthetic tools are 
effective at assembling novel building blocks via the rapid construction of new 
C–C, C–O and C–N bonds, as well as all-carbon quaternary centres, in a 
single step. A second widely used strategy to control the regioselectivity of 
nucleophilic addition is to tether the two nucleophiles, provided that one of the 
latent nucleophiles can be selectively deprotonated in the presence of the 
other due to a large difference in acidity (Scheme 52). For example, if Nuc1H 
was significantly more acidic than Nuc2H in bis-nucleophile 229, then after 
oxidative addition and decarboxylation of propargylic electrophile 150, Nuc1H 
would be deprotonated by the methoxide anion. The resulting anion should 
then be more nucleophilic to undergo the first addition to the η3-π-
allenylpalladium(II) intermediate and generate palladacyclobutene 230. At the 
same time, if the nucleophile is very acidic and results in the formation of a 
very stable anion, it may not be nucleophilic enough to undergo the first 
addition. Therefore, an appropriate balance between acidity and anion 
nucleophilicity must be achieved for a successful reaction. Subsequent 
protonation of 230 with Nuc2H would give rise to the η3-π-allylpalladium(II) 
intermediate 231. The final intramolecular allylic alkylation of the second 
tethered nucleophile should afford cyclic product 232. 



















In 2011, Yoshida et al. utilised this strategy for the diastereoselective 
synthesis of bicyclo[3.2.1]octenone 235 from an unsymmetrical enone ester 
bis-nucleophile 234 in high yields and diastereoselectivity (Scheme 53).110 2-
Oxocyclohex-3-enecarboxy-late 234 successfully reacted with a range of 
propargylic acetates 233a-233e to give products 235a-235e in moderate to 
high yields. Propargylic acetates containing aromatic groups, irrespective of 
whether they contained electron-withdrawing or donating substituents, gave 
good yields of product (235a-235c), while aliphatic propargylic electrophiles 
gave bicyclo[3.2.1]octenones 235d and 235e in poorer yields. Different 2-
oxocyclohex-3-enecarboxylates 234 were reacted with 233, giving good 
results (235f and 235g), especially when using benzyl-substituted ester 234g. 
All the reactions proceed with full diastereoselectivity. 
 
 




























     Scheme 53: Diastereoselective synthesis of bicyclo[3.2.1]octenones. 
 
In this process, two new C–C bonds, as well as an all-carbon quaternary 
centre, had been formed in a single step. In terms of the proposed mechanism 
of the reaction, the palladium catalyst reacts with propargylic acetate 233 to 
form ɳ3-π-allenylpalladium(II) intermediate complex 236 (Scheme 54).  The 
acetate anion deprotonates 234 and the resulting stabilised enolate adds to 
the central carbon atom of intermediate 236 to form palladacyclobutene 237. 
Protonation of palladacyclobutene 237 at the γ-position of the enone then 
gives rise to extended enolate 238. Finally, C-alkylation of the extended 
enolate at the more hindered terminal carbon atom of the ɳ3-π-
allylpalladium(II) intermediate, shown by its more favoured transition state 
239, proceeds with high regioselectivity to generate bicyclic product 235. The 
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acidity of the two nucleophiles, with the β-ketoester proton being significantly 
more acidic than that at the γ-position of the enone.            














Scheme 54: Mechanism for the diastereoselective synthesis of bicyclo[3.2.1]octenones. 
 
Yoshida et al. developed a method for the installation of quaternary carbon 
centres in the diastereoselective tetrahydrobenzofuranone 242 synthesis 
(Scheme 55),111 in which C-alkenylation was followed by O-alkylation. In this 
work, a set of propargylic carbonates (240) were reacted with dimedone 241 
under palladium catalysis to afford bicyclic products 242a-242d with complete 
diastereoselectivity and simultaneous construction of an α-stereogenic 
quaternary all-carbon centre. A propargylic carbonate group with a 1-naphthyl 
substituent was able to react with 2-methyl-cyclohexane-1,3-dione 241a to 



































substituted 241b to give 242b in a moderate 55% yield. Meanwhile, benzyl- 
and 2-cyanoethyl-substituted substrates 241c and 241d reacted with 240 to 
deliver products 242c and 242d in 76% and 82% yields, respectively. All 
products were formed with full diastereoselectivity. 





Scheme 55: Diastereoselective tetrahydrobenzofuranone synthesis. 
 
The mechanism of the reaction is similar to that for the synthesis of 
bicyclo[3.2.1]octenones (Scheme 56). Specifically, the acidic proton of the 1,3-
diketone functionality in 241 is removed by the methoxide anion formed upon 
decarboxylation of 240 to form ɳ3-π-allenylpalladium(II) intermediate 236 and 
stabilised enolate 243. Upon addition of the stabilised enolate to the central 
carbon atom of the ɳ3-π-allenylpalladium(II) intermediate, palladacyclobutene 
244 is formed. Deprotonation of the ketone then follows to generate enolate 
245, which undergoes intramolecular O-alkylation at the more substituted 
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Scheme 56: The mechanism for the diastereoselective tetrahydrobenzofuranone synthesis. 
 
This method was subsequently extended to β-ketoesters 240 as bis-
nucleophiles for the synthesis of bicyclic systems 246 with complete 
diastereoselectivity (Scheme 57).112  Products 247a-247e, appended with aryl 
and alkyl substituents, were all readily accessed by this method. 










Scheme 57: Diastereoselective cyclisation of β-ketoesters. 
 
More recently, Rawal and co-workers developed a cyclisation reaction using 
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58).113 Depending on the nature of the amide employed, spiro-oxindole 250, or 
its regioisomer 252, was obtained when reacted with propargylic electrophile 
249. In both cases, an all-carbon quaternary spirocentre had been installed. 
The authors suggested that the nucleophilicity of the tethered nucleophiles 
played a significant role in determining which reaction pathway is followed. For 
example, with a sulfonamide (248) as one of the nucleophiles, product 250 
was formed, in which the oxindole enolate had undergone the first nucleophilic 
addition. In this case, it was postulated that although the sulfonamide 
functionality in 248 is likely to be more acidic, the nitrogen anion thus formed 
is also less nucleophilic due to the highly electron-withdrawing nature of the 
sulfonamide functionality. In contrast, product 252 was obtained in the case of 
tethered amide 251, which is not as strongly electron-withdrawing, giving rise 
to a more nucleophilic nitrogen anion upon deprotonation and results in the 
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Crucially, using a chiral Trost ligand 94, spiro-oxindole 250a could be 
generated enantioselectively (Scheme 59).113 Although the yield of 250a was 
poor and the enantioselectivity moderate, it is the only report to date of an 
enantioselective palladium-catalysed installation of an all-carbon quaternary 
centre via an alkenylation of a nucleophile with a propargylic electrophile. 





Scheme 59: Enantioselective cyclisation with an oxindole-sulfonamide bis-nucleophile.  
 
The Rawal group extended this work to the dearomatisation of tryptamine 
derivatives 253 using propargylic electrophile 249 (Scheme 60).114 After the 
nitrogen anion of the amine side-chain had undergone the initial attack, 
spirocyclisation took place to install the all-carbon quaternary centre in 254 
with complete regioselectivity. Tosyltryptamine 253a and methanesulfonamide 
253b performed well, giving products 254a and 254b, respectively, in 
excellent yields. para-Toluenesulfonamide 253c, extended by one carbon 
atom, gave a significantly lower yield although the regioselectivity was still 
complete. The high regioselectivity was thought to be due to the high acidity of 
sulfonamides, yet the sense of selectivity was opposite to that observed with 

































Scheme 60: Dearomatisation of tryptamine derivatives. 
 
The authors also disclosed the use of chiral ligand 257 to install the all-carbon 
quaternary centre in 256 in an enantioselective manner. Using tryptamine 255 
and propargyl carbonate 249, spirocycle 256 was obtained in a high yield and 
enantioselectivity (Scheme 61).113  In contrast to the previous example of a 
stereogenic all-carbon quaternary centre being formed in 250a (vide supra, 
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In an analogous process, You and co-workers found that the nitrogen 
nucleophile can be replaced by a malonate in 258, giving rise to the 
installation of an all-carbon quaternary centre in spiroindolenines 259, through 
coupling with propargylic electrophile 150, with high regioselectivity (Scheme 
62).115 The control of the order of addition is derived from the fact that the 
malonate is a lot more acidic than the NH proton of the indole moiety, resulting 
in the deprotonation and alkenylation of the malonate functionality. Methyl, 
and ethyl ester side chains were successfully incorporated in product 
structures (259a and 259b), and substitution at the 2 position of the indole 
was also tolerated (259c-259f). Very importantly, a quaternary all-carbon 
stereogenic centre in 259c was installed with an ee of 52% in the allylic 
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5.8. The Coupling of Propargylic Electrophiles with Two Independent 
Nucleophiles 
So far, regioselectivity issues have been controlled by using tethering 
strategies to control the order addition of nucleophiles. However, if two 
different nucleophiles 178 and 179 were to react in a purely intermolecular 
sense with propargylic electrophile 150, the challenges associated with the 
cross-coupling reaction would be significantly more difficult to overcome. The 
order of addition of the two nucleophiles has to be controlled to form one 
regioisomer and not the other (180 vs 181), and the homo-coupling of each 






Scheme 63: The control of selectivity with two soft nucleophiles. 
 
In 2011, Nishioka disclosed a report of a palladium-catalysed three 
component reaction of methyl propargylcarbonate 150 with phenols and other 
nucleophiles (Scheme 64).116 It was found that the regioselectivity (i.e. the 
order of addition) could be controlled if the nucleophiles were in a sequential 
manner rather than in a simultaneous manner. More specifically, after a one 
hour reaction time, two equivalents of phenol 260 with methyl propargyl 
carbonate 150, amine 261 was added, affording products 262a-262e in good 



















process, giving rise to the phenol homo-coupled product 263 as an 
intermediate of the reaction in the first instance. At the next stage, addition of 
piperidine (261) results in a palladium-catalysed substitution of phenol to 
afford the final product 262. The nitrogen based nucleophile was also replaced 














Scheme 64: Selective nucleophile addition for the cross-coupling of two nucleophiles. 
 
In 2013, our group disclosed the first selective intermolecular coupling reaction 
of two nucleophiles without the need to control the order of addition or use an 
excess of one of the coupling partners (Scheme 65).117 In this process, 
OCO2Me





1) 260 (2 eq), dioxane, 60 oC, 1 h


























































propargyl enol carbonates 266, derived from a 1,3-dicarbonyl, were coupled to 
a range of phenols (267a-267f) in a decarboxylative manner to afford products 
268a-268f with high regioselectivity in which an all-carbon quaternary centre 
had been installed. Electron-rich phenols were shown to give products 268b, 
268c and 268e in high yields and regioselectivities, while electron-poor 
phenols were less effective, forming 268d in a lower yield. Aniline-containing 
phenol was also effective, forming 268e, while fused bicyclic phenols, such as 
naphthol, efficiently afforded product 268f in a high yield and regioselectivity. It 
was postulated that the regioselectivity of the reaction was controlled due to 
the tight association of the η3-π-allenylpalladium(II) intermediate with the 
enolate in 266 after the decarboxylation step (269). This makes the addition of 
the enolate to the central carbon of the η3-π-allenylpalladium(II) intermediate 
highly favoured due to the essentially intramolecular nature of the process, 
























Scheme 65: Intermolecular coupling of 1,3-dicarbonyl compounds with phenols. 
 
While the reaction was regioselective to form 268 in most cases, the use of an 
electron-poor, and therefore, more acidic phenol, such as 267g, resulted in 






Scheme 66: Intermolecular coupling of a 1,3-dicarbonyl compound with an electron-poor 
phenol. 
 
To explain these observations, the following reaction mechanism was 
proposed (Scheme 67). The palladium catalyst oxidatively adds to carbonate 
266 to provide 271. Decarboxylation then generates stabilised enolate 269, 
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this point, two outcomes are possible. The first pathway, which is taken by the 
majority of the phenol nucleophiles, involves attack of the enolate at the 
central carbon atom of the η3-π-allenylpalladium(II) intermediate to form 
palladacyclobutene 272. Subsequent protonation of 272 with phenol 267 and 
addition of the phenolate anion to the terminal carbon atom of the η3-π-
allylpalladium(II) intermediate 273 gives rise to 268g with high regiocontrol. 
regiocontrol. However, in the case of the more acidic para-nitro substituted 
phenol 267g, protonation of the enolate occurs, resulting in the dissociation of 
the enol from the η3-π-allenylpalladium(II) cation in 269. As a consequence, 
the η3-π-allenylpalladium(II) motif is attacked by the resulting phenolate anion 
to form palladacyclobutene 274. Subsequent protonation of 
palladacyclobutene 274 with enol 275 gives rise to η3-π-allylpalladium(II) 
intermediate 276. In the final mechanistic step, allylic alkylation of the enolate 




































Scheme 67: Mechanism for the cross-coupling of a 1,3-dicarbonyl compound with a phenol. 
 
This method enables the concomitant formation of C–C and C–O bonds and 
the creation of a new quaternary all-carbon centre via an sp3-sp2 coupling 
reaction. We were, therefore, keen to extend the utility of this reaction process 











































carbon, oxygen and nitrogen functionality into the reaction, and paving the 
way to the general synthesis of sp3-rich building blocks with potential 
application in drug discovery. The research objectives aimed at expanding this 


















6. Research Project Objectives 
This thesis comprises three main areas of study: 
1. The development of a palladium-catalysed regio- and chemoselective 
cross-coupling reaction of enolates in the presence of propargylic 
electrophiles. 
2. The development of an analogous palladium-catalysed regio- and 
chemoselective cross-coupling reaction of enolates with nitrogen 
heterocycles in the presence of propargylic electrophiles. 
3. The development of enantioselective variants of the palladium-
catalysed cross-coupling of nucleophiles in the presence of propargylic 
electrophiles. 
 
1: In light of the successful regioselective decarboxylative coupling of 
enolates and phenols with propargylic electrophiles (vide supra, Scheme 
65),116 we were interested in applying this approach to the selective coupling 
of two different C-nucleophiles, namely 1,3-dicarbonyls, with propargylic 
electrophiles in a chemo- and regioselective manner (Scheme 68). This 
would involve the coupling of an enolate appended to a propargylic 
electrophile in 277 with 1,3-dicarbonyl based nucleophile 278 to give 279, 
whilst preventing the formation of regioisomer 280 and homo-coupled 
products 281 and 282. Given the recent drive to develop methodologies that 
facilitate the synthesis of sp3-rich molecules for drug discovery 
programmes,21  this process would not only result in the formation of two C–C 
79 	  
bonds, but also install two congested all-carbon quaternary centres in 279 in 











Scheme 68: The proposed palladium-catalysed decarboxylative regio- and chemoselective 
coupling of two 1,3-dicarbonyl species. 
 
 
2: The incorporation of nitrogentated molecular motifs is particularly relevant 
towards increasing the polarity of compounds.5 Therefore, we reasoned that 
the successful coupling of 1,3-dicarbonyl-derived nucleophiles with phenols 
could pave the way to the use of N-heterocycles as nucleophiles in place of 
phenols (Scheme 69). This process could lead to nitrogenated products of 
type 284 by the coupling of N-heterocycles 283 with 1,3-dicarbonyl 
compounds 277, yet avoiding the formation of side products 285, 281 and 
286. This would lead to the installation of new C–C and C–N bonds, as well as 
an all-carbon quaternary centre. There are, however, clear challenges in such 
a reaction. Firstly, analogous to the coupling of C-nucleophiles, the regio- and 
chemoselectivity of this process would need to be controlled. In addition, 
amines are significantly less acidic than phenols, which could exacerbate the 
aforementioned selectivity issues. If successful, this method would enable the 
incorporation of nitrogenated functionality products 284.  
































































Scheme 69: The proposed palladium-catalysed decarboxylative coupling of 1,3-dicarbonyl 
compounds with N-nucleophiles. 
 
 
3: Finally, having developed catalytic routes to products 279 and 284 in 
racemic form, our ultimate goal in this research will be the enantioselective 
catalytic construction of all-carbon quaternary centres in these building blocks. 
Concerning the cross-coupling of 1,3-dicarbonyl-derived enolates with 
propargylic electrophiles, we envisage addressing two key areas of 
enantioselective catalysis (Scheme 70). The first area focuses on the 
enantioselective allylic alkylation. This approach would necessitate the use of 
a propargyl enol carbonate derived from an achiral 1,3-dicarbonyl substrate 
(287) in the presence of a non-symmetrical 1,3-dicarbonyl species 288, which 
would give rise to enantio-enriched products 289 in the presence of a chiral 
palladium(0) catalyst. While there have been reports of successful 
enantioselective allylic alkylation reactions of nucleophiles with propargylic 
electrophiles in cyclisation processes (vide supra, Scheme 61),115 the 
asymmetric allylic alkylation using propargylic electrophiles in an 
intermolecular sense remains unexplored. The second area of stereoselective 
catalysis we seek to explore is the induction of enantioselectivity at the 













































enol carbonate 277 with an achiral 1,3-dicarbonyl 290 to pave the way to the 
stereoselective construction of an all-carbon quaternary centre in 291 via 
alkenylation. The enantioselective palladium-catalysed alkenylation of 
nucleophiles with propargylic compounds has only been precedented in 
tethered systems, albeit with poor yields and low levels of enantioselectivity 
(vide supra, Scheme 59).113 






Scheme 70: The proposed enantioselective decarboxylative cross-coupling reactions. 
 
However, all of these processes are likely to pose a number of challenges, 
since in addition to the induction of stereoselectivity, the simultaneous control 
of regio- and chemoselectivity, as well as reaction efficiency, will also be 
required. As such, suitable conditions, which can successfully balance the 
above control factors, would represent a remarkable achievement. The results 
from our work towards meeting these preliminary project aims are detailed in 
the next chapter. 












































7. Results and Discussion 
 
7.1. The Coupling of 1,3-Dicarbonyl Compounds: Initial Results 
In the first stage of the project we sought to investigate the purely 
intermolecular catalytic coupling of 1,3-dicarbonyl substrates 292 and 293 in 
the presence of a propargylic electrophile 150 (Scheme 71). In such a 
reaction, two new C–C bonds and two all-carbon quaternary centres in 294 
would be formed. 









The first challenge associated with the coupling of two soft carbon-based 
nucleophiles 292 and 293 in an intermolecular fashion was the control of 
regioselectivity (294 vs 295), which dictates the order of addition of 
nucleophiles (Scheme 72), and chemoselectivity, which could give rise to 
homo-coupled products 296 or 297. Our ultimate aim was to develop 
conditions that could regioselectively create either regioisomer 294 or 295, as 



































Scheme 72:	  Chemo- and regioselective coupling of enolates and 1,3-dicarbonyl compounds. 
 
 
To test this idea, an intermolecular coupling reaction of two 1,3-diketone 
nucleophiles 301a and 301h with propargyl carbonate 150 in the presence of 
a source of Pd(0) and Xantphos as the ligand ligand was investigated 
(Scheme 73). Given the similarity in both acidity and reactivity of 1,3-diketones 
301a and 301h, it was not surprising to discover that, out of the four possible 
products that could have been formed, three were isolated. Specifically, 
regioisomers 304a and 302a were obtained in a 4.8:1 ratio in 19% and 4% 
yield, respectively, whilst homo-coupled product 302h was obtained in a 13% 
yield. This indicated that a purely intermolecular process was low yielding and 
gave poor control of regio- and chemoselectivity. 










































































Scheme 73: Selectivity issues with the intermolecular coupling of two carbon-based 
nucleophiles.  
 	  
7.1.1. Optimisation of Reaction Conditions 
We, therefore, reasoned that higher levels of regio- and chemoselectivity 
could be bestowed upon the reaction by utilising a propargyl enol carbonate 
derived from the 1,3-dicarbonyl nucleophile. This has previously been shown 
to be successful when coupling 1,3-diketones 266 with phenols 267 to form 
products of type 268 (vide supra, Scheme 65).117 It is believed that the reason 
behind the observed high levels of selectivity is due to the palladium catalyst 


































1,4-dioxane, 80 oC, 2 h
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If this approach is applied to the use of two 1,3-diketones, the scrambling of 
enolates could potentially be prevented by utilising one of the 1,3-diketones as 
a propargyl enol carbonate (Scheme 74). In this way, enol carbonate 298 
would undergo alkenylation with the η3-π-propargylpalladium(II) complex. We 
reasoned that regioselectivity would be controlled by the association of the 
enolate following decarboxylation of 298 with the η3-π-propargylpalladium(II) 
intermediate, essentially making the alkenylation step an intramolecular 
process (vide supra, Scheme 65). The external 1,3-dicarbonyl nucleophile 293 
would then undergo the subsequent allylic alkylation to form 294. In addition, 
by utilising propargyl enol carbonate 299 derived from 293 in the presence of 
1,3-dicarbonyl 292, regioisomer 295 could potentially be accessed, rendering 
the reaction regioswitchable depending on the judicious choice of the 
propargyl enol carbonate. 







Scheme 74: The regioswitchable coupling of two 1,3-diketones. 
 
Indeed, when propargyl enol carbonate 300, derived from 3-methyl-2,4-
pentanedione, was reacted with 301a in the presence of a palladium(0) 









































complete regioselectivity, good chemoselectivity and in good yield (Table 2, 
entry 1). This result confirmed the superiority of using a pre-formed propargyl 
enol carbonate as one of the coupling partners, whereby the propargylic 
electrophile is temporarily tethered to one of the carbon based nucleophiles. 
The yield of 302a was improved further when the ligand dppf was used (entry 
2), and similarly good results were obtained with conventional [Pd(PPh3)4] as 
the catalyst (entry 3). Finally, the use of a large-bite-angle ligand DPEphos 
afforded 302a in a high 85% yield with complete regioselectivity and good 





aRatio determined by 1H NMR spectroscopy. bIsolated yield of major isomer 302a. 
c[Pd(PPh3)4] was used in place of [Pd2(dba3)]. 
 







Regio (302a:304a)a                   Chemo (302:302h)a 
 
Yield (302)b 
1 Xantphos > 19:1 5.9:1 59 
2 dppf > 19:1 6.4:1 73 
3 PPh3c > 19:1 5.8:1 56 





















Using DPEphos as the ligand, a solvent screen was performed next (Table 3). 
The use of polar and non-polar solvents, including toluene, acetonitrile, 
dimethylformamide and dichloromethane, reduced the chemoselectivity of the 









                               Selectivity 
Regio (302a:304a)a                Chemo (302a:302h:305)a 
 
Yield (302a)b 
    1 Toluene > 19:1 4.4:1:0 60 
2 MeCN > 19:1 1.4:1:1.4 31 
3 DMF > 19:1 1.6:1:1.6 26 
4 CH2Cl2c > 19:1 1.7:1:2.2 16 
5 Dioxane > 19:1 6.1:1:0 85 
 
aRatio determined by 1H NMR spectroscopy. bIsolated yield of major isomer 302a. cReaction 
was run at 60 °C. 
 
Table 3: Solvent screen. 
 
7.1.2. 1,3-Dicarbonyl Nucleophile Scope 
Having identified the optimal reaction conditions, the reaction scope was 
investigated by coupling a range of 1,3-dicarbonyl compounds with linear enol 











































aAll reactions were performed on a 0.24 mmol scale unless otherwise stated. bIsolated yields 
of major isomer 302.  cHomo-coupling of 300. dHomo-coupling of 301. eReaction was run on a 
0.12 mmol scale. fReaction was run for 4 hours. gHomo-coupling of nucleophile 301d was the 
main product isolated in 27% yield.  
Table 4: 1,3-Dicarbonyl scope.  	  
Cyclohexanone-based nucleophiles 301a and 301b were installed in products 
302a and 302b, respectively, in high yields and with complete regioselectivity 
and high chemoselectivity. The iso-propyl-bearing product 302c was obtained 
in a lower yield, which was caused by the reaction not proceeding to 
completion, even when reacted for longer periods of time. Unfortunately, 
diketone 301d did not react to afford desired product 302d and the homo-
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[Pd2(dba3)]  (5 mol%)
DPEphos (10 mol%)
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                   r.r. >19:1; 
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               302i  (36%)











                    302k (54%)
                  r.r. >19:1;  
          chemoselectivity 4.6:1c
               302e (70%)
                r.r. >19:1; 
        chemoselectivity 4.6:1c
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that the higher acidity of methyl-dimedone 301d leads to the formation of a 
more stable anion following decarboxylation, which is able to diffuse from the 
η3-π-propargylpalladium(II) complex, resulting in the erosion of selectivity. The 
use of acyclic diketones 301e-301g provided the products 302e-302g in high 
yields and regioselectivities, however, some homo-coupling accompanied the 
reactions in the synthesis of 302e and 302g. Phenyl- and benzyl-substituted 
acyclic diketones 301j and 301k were also incorporated in high yields and 
regioselectivities, whereas a poor yield of 302i was obtained. Diphenyl-
substituted 1,3-diketone 301l did not react and the starting material was 
recovered. Long-range HMBC correlations were used to confirm the structure 
of the major regioisomer in all cases. 
 
Having tested the reactivity of 1,3-diketones in the reaction, the use of other 
1,3-dicarbonyl nucleophiles was investigated (Table 5). 1,3-Dicarbonyls that 
possess both ester and amide functionality are less acidic than 1,3-diketones 
and we sought to explore what impact this would have on the efficiency and 








































aAll reactions were performed on a 0.24 mmol scale unless otherwise stated. bIsolated yields 
of major isomer 302. cHomo-coupling of 300. dHomo-coupling of 301. eThe reaction was 
performed on a 0.16 mmol scale. n.d. = not determined.	  
 
Table 5: 1,3-Dicarbonyl scope.  	  
β-Keto esters 302m, 302n and fluorinated β-Keto ester  302o were isolated in 
good yields and selectivities, whereas ester 301p and β-keto lactone 301q 
resulted in lower yields for 302p and 302q, despite the high regioselectivity. 
The scope was expanded to β-keto lactam and sulfone-containing compounds 
301r and 301s; the β-keto-lactam nucleophile furnished product 302r in a 
good yield and with full regioselectivity, however a small amount of the homo-
coupled product of 302r was observed. β-Ketosulfone product 302s was 
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                      r.r. >19:1;     
              chemoselectivity 4.0:1d
                   302n (58%)
                    r.r. >19:1; 
           chemoselectivity 7.4:1d
                  302r (81%)
                   r.r. >19:1;
          chemoselectivity 11:1d
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[Pd2(dba3)]  (5 mol%)
DPEphos (10 mol%)
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              r.r. >19:1;  
chemoselectivity 6.5:2.2c:1d
    302m (62%)a,b
  r.r. >19:1;  
  chemoselectivity n.d.
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minor amount of homo-coupled product 302h was also formed. However, β-
ester lactam nucleophile 301t failed to couple with enol carbonate 300 and 
only starting material 301t was recovered. Finally, Cbz protected β-keto 
lactam 301u coupled with 300 to produce 302u in a moderate yield. 
 
7.1.3. Propargyl Enol Carbonate Scope 
Considering that the enolate generated in situ from propargyl enol carbonate 
300 after decarboxylation is regioselectively alkenylated and the externally 
added partner 301 is allylated, we postulated that the regioselectivity of the 
reaction could be reversed by simply utilising a propargyl enol carbonate of 
the latter partner 303 and the neutral 1,3-dicarbonyl species 301h derived 
from the former carbonate to create species 304 (Scheme 75). 





Scheme 75: The regioswitchable coupling of two 1,3-carbonyl compounds. 
To explore this idea, a set of propargyl enol carbonates derived from a range 
of 1,3-diketones were reacted with 3-methyl-2,4-pentanedione (301h) under 



























































aAll reactions were performed on a 0.24 mmol scale unless stated otherwise. bIsolated yields 
of major isomer 304. cHomo-coupling of 303. dHomo-coupling of 301h. eReaction was run for 
4 hours.f A complex mixture of products was isolated. gThe reaction was performed on a 0.16 
mmol scale in THF at 60 oC for 2 hours. n.d. = not determined. 
 
Table 6: Propargyl enol carbonate scope. 
 
Pleasingly, the regioselectivity was high in most cases. Cyclohexanone-based 
carbonates 304a-304d were isolated in good yields and, although the identity 
of the major regioisomer could be readily confirmed by long range HMBC 
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              r.r. >19:1;
   chemoselectivity 5.0:1d
            304f (63%)
            r.r. >19:1; 
chemoselectivity 4.4:1c
         304g (46%)
           r.r. 10:1; 
  chemoselectivity n.d
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             r.r. >19:1;
     chemoselectivity 1:1c
Me
Bn
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              r.r. >19:1;
   chemoselectivtity >19:1
                  304e (43%)
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              r.r. and chemoselectivity n.d.
            304c (61%)e
             r.r. >19:1;
chemoselectivity 10:2c:1d
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proved the sense of regioselectivity of the reaction. Dimedone-derived 
carbonate 303e favoured the formation of the desired product 304e over 
homo-coupling, albeit the yield was moderate. This observation was in 
contrast to the reaction when methyl-dimedone 301d was used as the 1,3-
dicarbonyl nucleophile (vide supra, Table 4), where homo-coupling was the 
major reaction pathway. Linear 1,3-diketone products 304f and 304g were 
formed in 63% and 46% yield, respectively, with product 304g exhibited a 
lower regioselectivity. Unexpectedly, 304h was produced with low 
regioselectivity, unlike the analogous coupling of carbonate 300 with ester-
substituted 1,3-diketone 301g (vide supra, Table 4). High regioselectivity was 
achieved with benzylated enol carbonate 303i, to produce 304i, however, the 
reaction was not chemoselective. Phenyl-substituted carbonate 303j produced 
a complex mixture of products and the lack of desired reactivity may be 
attributed to the conjugated nature of the enolate formed following 
decarboxylation of carbonate 303j, affecting its reactivity profile. Carbonate 
303k, derived from unsubstituted acetylacetone also led to the formation of a 
complex mixture of products. We reasoned that the presence of an acidic 
proton in 303k enables 303k to take part in further coupling reactions, 
resulting in the formation of by-products. Finally, 304l was formed using 
tetrahydrofuran as the solvent rather than 1,4-dioxane. 
 
To further probe the regioswitchable nature of the reaction, several 
carbonates, derived from 1,3-dicarbonyls other than 1,3-diketones, were 
































aAll reactions were performed on a 0.24 mmol scale unless stated otherwise. bIsolated yields 
of major isomer 304. cHomo-coupling of 303. dHomo-coupling of 301h. eA complex mixture of 
products was observed. fThe reaction was performed on a 0.16 mmol scale. gThe reaction 
was performed in THF at 60 oC for 2 hours. n.d. = not determined. 
 
Table 7: Enol carbonate scope. 	  
Enol carbonates 303m and 303n, derived from β-ketoesters 301m and 301p, 
produced products 304m and 304n with high regioselectivities and in 
moderate yields, with some homo-coupling observed by 1H NMR analysis of 
product mixtures. Fluorinated 304o was formed with high regioselectivity, but 
a low yield of 35%, presumably due to the electron-withdrawing nature of the 
fluorine atom, which decreases the nucleophilicity of the enolate formed after 
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    chemoselectivity 10:2.0d:1c
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                  r.r. >19:1;
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          304r (21%)






            304q (53%)












              304t (33%)f
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complex mixture of products was observed. β-keto lactam 304q was 
successfully isolated in a good yield of 53%, whereas sulfone 304r was 
formed with high regioselectivity, albeit in a low yield of 21%. Finally, 304s and 
304t were formed in moderate yields under slightly different reaction 
conditions. 
 
Overall, it has been possible to demonstrate the regioswitchable nature of the 
reaction by showing that, in most cases, high levels of regioselectivity were 
maintained irrespective of which coupling partner was utilised as the propargyl 
enol carbonate. However, despite the high regioselectivity, a number of 
reactions were low or moderately yielding, indicating that the reaction 
conditions originally optimised for the coupling of other 1,3-diketones with the 
propargyl enol carbonate of 3-methyl-2,4-pentanedione require further 
optimisation in order to enhance the efficiency of the coupling of other 1,3-
dicarbonyl compounds. Nevertheless, the concept of a regioswitchable 
process has been developed in practice for the coupling of two 1,3-dicarbonyl 
compounds to form two new C–C bonds as well as two all-carbon quaternary 
centres. 
 
Given that two new all-carbon quaternary centres are installed in the product 
of the coupling reaction, the use of two unsymmetrical coupling partners would 
give rise to the formation of two chiral centres in a single step. With this in 
mind, we reacted carbonate 266 with β-keto ester 301o, giving rise to product 
304u, in which two chiral centres had been installed (Scheme 76). While the 
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regio- and chemoselectivity of the reaction was high and the yield of isolated 
304u was good, the overall process was not diastereoselective, and equal 
quantities of inseparable diastereoisomers were formed. 








aHomo-coupling of 301o.	  
 




Given that the stereogenic centres a and b in 304u are three bonds away, the 
substituents on the chiral centre a do not appear to exert sufficient steric 
influence on the allylic alkylation step of the enolate of 301o. 
 
7.1.4. Mechanistic Studies 
In order to gain an insight into the mechanism of the reaction, two deuterium-
labelling studies were performed. This required the creation of deuterium-
containing enol carbonates (Scheme 77). In the first instance, 301f was 
reacted with d3-Iodomethane to form [D3]-301h. Then, through a literature 
procedure,117 [D3]-300h was made, followed by deuterium exchange of the 
propargylic proton to form [D4]-300h. This same procedure was also used to 
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     chemoselectivity 8.2:1a















Scheme 77: The creation of deuterium based enol carbonates. 
 
 
After the deuterium based enol carbonates were made, two experimental 
procedures were carried out. First, deuterated propargyl enol carbonate [D]-
300 was reacted with 1,3-diketone 301b to form deuterated product [D]-302b 
(Scheme 78). The scrambling of the deuterium label was even across the 
vinylic and allylic position in [D]-302b. This supports the hypothesis that a 
symmetrical η3-π-allylpalladium(II) intermediate is implicated in the 
mechanism.  
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In light of the high regioselectivities observed in the substrate scope 
investigation, it can be postulated that the enolate formed following 
decarboxylation remains coordinated to the η3-π-propargylpalladium(II) 
complex. To test this hypothesis, an equimolar amount of [D4]-300 and non-
deuterated 300 were reacted with nucleophile 301b (Scheme 79). Mass 
spectrometry confirmed the presence of solely [D4]-302b and 302b, 
suggesting that there is no crossover of the enolates during the course of the 
reaction and this indicates a tight association of the enolate with the palladium 
centre following the decarboxylation step. 




Scheme 79: Enolate crossover experiment. 
 
 
With the results of the deuterated experiments obtained, a mechanism of the 
reaction can be postulated (Scheme 80).                   



























     [Pd2(dba3)] (5 mol%)
   DPEphos (10 mol%)
   1,4-dioxane, 80 oC, 2 h
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Scheme 80: Proposed mechanism. 
 
The palladium(0) catalyst undergoes oxidative addition to carbonate 300, 
which, after decarboxylation, gives intermediate 306. The strong association 
of the enolate with the palladium centre suggests an intramolecular inner-
sphere addition mechanism of the enolate to the central carbon atom of the 
η3-π-propargylpalladium(II) electrophile to form transient palladacyclobutene 
307, which determines the high regioselectivity of the reaction. Although 
several metallacyclobutenes of other transition metal have been isolated,83,84 
there is no experimental evidence for the implication of this intermediate in the 
mechanism. It is, therefore possible, that the nucleophilic addition of enolate 
306 is followed by immediate protonation of 307 in a synchronous manner to 

























allylpalladium(II) intermediate in 307 undergoes nucleophilic addition with the 
enolate to afford product 302b with complete regiocontrol and regenerates the 
palladium(0) catalyst.  
 
Overall, the coupling of two 1,3-dicarbonyl compounds in our study has been 
generally successful, resulting in the installation of two all-carbon quaternary 
centres and the formation of two new C–C bonds in a single process. A 
mechanism for the reaction has also been deduced through deuterium-
labelling studies.  
 
7.1.5. The Coupling of 1,3-Dicarbonyl Compounds with Unstabilised 
Nucleophiles 
The substrates investigated thus far have centred around stabilised enolates, 
namely those derived from 1,3-dicarbonyl compounds. To extend the utility of 
this methodology further, we sought to explore the reactivity of unstabilised 
nucleophiles, such as cyclohexanone 309a, with a propargyl enol carbonate 
300 (Table 8). If the reaction were to proceed via the previously postulated 
mechanism (vide supra, Scheme 79), then deprotonation of a much less 
acidic hydrogen atom would be required. Unfortunately, the reaction was 
unsuccessful: desired product 310a was not formed and a complex mixture of 
products was observed instead. To enhance the acidity of the carbonyl 
functionality and attempt to facilitate enolate formation, we tested the following 
substrates: cyclohexenone 309b, which has been precedented in an 
intramolecular version of the reaction (vide supra, Scheme 54),110 an α-
difluorinated ester 309c, which is more acidic than a simple ester due to the 
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electron-withdrawing nature of fluorine, and furanone 309d, which would give 
a more stable aromatic anion upon deprotonation than an enolate of a 
saturated lactone. It was then disappointing to discover that, in all three cases, 








Table 8: The use of simple carbonyl compounds as nucleophiles.  
 
 
However, we were encouraged to discover that indole (311a) was readily 
deprotonated and alkylated to afford 312a in a modest yield but with complete 
regio- and chemoselectivity, using propargyl enol carbonate 266 (Scheme 81). 
Despite the aromatic nature of the indole anion, the acidity of indole 311a (pKa 
18-20 in DMSO)118 is even lower than that of ketones (pKa 13-16) in DMSO,119 
and yet indole readily takes part in the reaction while simple carbonyl 
compounds do not. This was a remarkable result given that relatively acidic 
1,3-dicarbonyl compounds are readily coupled, while less acidic simple 
carbonyls do not react.  
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Overall, this one-pot process installs one new C–C bond and one new C–N 
bond as well as an all-carbon quaternary centre in 312a in a single step, with 
the initial result indicating that high levels of regio- and chemoselectivity are 
maintained. Inspired by the opportunity to utilise less acidic N-heterocyclic 
nucleophiles in the reaction, we set out to explore this idea further. 
 
7.2.1. The Use of N-Heterocycles: Optimisation of Reaction Conditions 
In the first instance, we tested the reactivity of propargyl enol carbonate 266, 
derived from a 1,3-diketone, and indole (311a) in the presence of a 
palladium(0) catalyst and a phosphine ligand in 1,4-dioxane at 80 °C (Table 
9). With the exception of dppe (entry 1), large-bite-angle ligands all afforded 
the desired coupled product 312a (entries 2-3), however, significant quantities 
of unreacted starting indole 311a were observed in the crude product 
mixtures. The best result was obtained with Xantphos as the ligand, which 
afforded a 1:2.0 ratio of 312a:311a and a 32% isolated yield of 312a (entry 4). 
We reasoned that the significantly lower acidity of indole 311a as compared to 
that of 1,3-dicarbonyl compounds was responsible for only partial conversion. 
The use of palladium tetrakistriphenylphosphine led to the formation of product 
312a, albeit in a poor yield (entry 5). Remarkably, all the reactions proceeded 




















aAll reactions performed on a 0.24 mmol scale. bYield of isolated 312a. cDetermined by 1H 
NMR analysis of the crude product mixtures. d[Pd(PPh3)4] was used in place of [Pd2(dba3)].e 
The results were obtained through work of Danny Kitson. 
 
Table 9: Ligand screen for the coupling of 1,3-dicarbonyls with indole. 
 
 
With Xantphos as the chosen ligand, a solvent screen was performed (Table 
10). At 80 °C, the solvent screen did not result in a significant improvement in 
reaction efficiency (entries 2-6). However, given that the reaction does not 
proceed to completion at 80 °C, as evidenced by the presence of unreacted 
indole, we wanted to explore whether deprotonation of indole prior to the 
alkylation step could be facilitated by increasing the temperature of the 
reaction. In this context, the reaction in toluene at 120 °C did in fact result in 
an increased yield of product 312a of 55% (entry 7). Increasing the 
temperature to 150 °C in xylene as the solvent, however, did not produce 




Entry Ligand Yieldb 312a:311ac 
          1a,e             dppe         No reaction              - 
2 dppf 28 1:2.1 
3 DPEphos 27 1:2.3 
4 Xantphos 32 1:2.0 
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Entry Solvent Temperature (oC)                    Yield (%)b 312a:311a ratioc 
1a 1,4-dioxane                80                                       27          1:2.0 	  
2 DMF 80 - 
Complex 
mixture 
3 MeCN 80 11 1:3.5 
4 THF 80 24 1:1.8 
5 CH2Cl2 80 35 1:1.9 
6 toluene 80 37 1:0.8 
7 toluene 120 55 1:0.7 
8 xylene 150 32 1:0.8 
 
aAll reactions performed on a 0.24 mmol scale. bYield of isolated 312a. cDetermined by 1H 
NMR analysis of the crude product mixtures. 
 
Table 10: Solvent screen for the coupling of 1,3-dicarbonyls with indole. 
 
 
Overall the N-allylic alkylation of the indole (311a) was the dominant reaction 
and no C-alkylation products were observed. This is in contrast to the 
previously reported allylic alkylation of indoles with allylic electrophiles,120 and 
the palladium-catalysed reaction of indoles with propargylic compounds 
where, due to the intramolecular arrangement of the reaction centres, the C-
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Having demonstrated already with 1,3-dicarbonyls that an intermolecular 
coupling process leads to a mixture of products (vide supra, Scheme 73), we 
also tested the efficiency of the intermolecular coupling of indole (311a) in the 
presence of methyl propargyl carbonate 150 and 1,3-diketone 301a (Scheme 
82). This reaction led to poor mass recovery, a complex mixture of products 
and highlighted the requirement for a propargyl enol carbonate in order to 
efficiently control regio- and chemoselectivity. 





Scheme 82: Selectivity issues with the intermolecular coupling of a 1,3-diketone and indole. 
 
7.2.2. Indole Scope 
To explore the scope of the reaction, a range of indoles was investigated 
under the optimised conditions (Table 11). Remarkably, all substrates were 
found to react with complete regio- and chemoselectivity. In addition to 
unsubstituted indole (311a), the presence of electron-withdrawing groups 
resulted in an increase in the yield in 312b, presumably due to the higher 
acidity of the indole NH proton. Despite containing a 3-nitrile substituent, 
product 312c was isolated in the same yield as that with unsubstituted indole 
312a. An electron-withdrawing ester side chain at the 2-position afforded 312d 
in a 59% yield and its structure was conclusively proved by X-ray 
crystallography, thus confirming the regioselectivity of the reaction. The 
presence of electron-withdrawing substitutents on the benzene ring provided 
products 312e-312g in moderate to good yields. Indoles containing electron-
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and 312i. It is likely that the reduced acidity of the indole NH proton impacts 
negatively on the reaction efficiency, as indicated by the presence of 
significant quantities of unreacted indole. Finally, we were pleased to discover 
7-azaindole and carbazole (311j and 311k) also gave rise to products 312j 














aAll reactions were performed on a 0.24 mmol scale. bYield of isolated 312. cAll reactions 
proceeded with full regio- and chemoselectivity as determined by 1H NMR analysis of the 
crude product mixtures. 
 

















    312b 












   312d








































7.2.3. Pyrrole Scope 
To the best of our knowledge there are no reports of palladium-catalysed 
cross-coupling reactions of pyrroles with propargylic compounds. Therefore, 
encouraged by the reactivity of indoles, our attention turned to the use of 
pyrroles as N-nucleophiles (Table 12). The requisite pyrroles were obtained 
from commercial sources or prepared via known methods (see the 
Experimental Section for more details). In all cases, where the desired 
products was obtained, the reactions proceeded with complete regio- and 
chemoselectivity. The use of pyrrole (313a) itself gave rise to 314a with 
complete selectivity and no C-alkylation was observed. Pyrrole, however, was 
relatively unreactive, affording 314a in a 21% yield, which is likely to be 
brought about due to the electron-rich nature of pyrrole (313a), making 
deprotonation less facile. The introduction of electron-withdrawing substituents 
at the 2-position of pyrrole drastically increased its reactivity, and 314b was 
isolated in a significantly higher yield. The regioselectivity of the reaction was 
confirmed by the X-ray crystal structure of 314b. The introduction of an 
electron-withdrawing substituent at the 3-position gave 314c in a moderate 
yield, presumably due to the cross-conjugated nature of 313c, albeit still 
higher than that with unsubstituted pyrrole 314a. Similar results were obtained 
with a pyrrole fused with a 6-membered ketone (334d). The incorporation of 
two electron-withdrawing groups at the 2- and 5-position of pyrrole afforded a 
higher yield of 314e, but surprisingly, it was not as high as that of 314b, 
potentially due to steric hindrance exerted by the two ester substituents 
(313e). Further decoration of the pyrrole motif with electron-withdrawing 
108 	  
groups at the 2- and 4-positions offered moderate to excellent results (314f-
314h). A mixture of electron-donating and -withdrawing substituents were also 
effective (314i). On the other hand, tetrasubstitution of the pyrrole nucleophile 
afforded no product (314j), presumably due to steric effects, whereas the 
incorporation of an alcohol functionality resulted in a complex mixture of 
products being formed (314k). It is plausible that, as the unprotected primary 
alcohol contains an acidic proton, competing side-reactions can occur. Finally, 
the use of an electron-rich 2,5-dimethyl also produced a complex mixture of 






































aAll reactions were performed on a 0.24 mmol scale. bYield of isolated 314. cAll reactions 
obtained full regio- and chemoselectivity. dA complex mixture was observed. 
 

















































































Having successfully coupled 1,3-diketone 266 with both indole and pyrrole 
substrates, we sought to test the regioswitchable nature of the reaction and 
investigate whether the opposite regioisomer 316 could be accessed by 
utilising a propargyl carbamate of indole 315 (Scheme 83). Instead of the 
desired product 316 being formed, homo-coupling of 1,3-diketone 301b 
exclusively took place to afford 305 in an 88% yield. It is likely that, due to the 
large difference in acidity between indoles and 1,3-diketones, the indole anion 
generated after decarboxylation readily deprotonates 1,3-diketone 301b, with 
the resulting enolate undergoing alkenylation with the η3-π-
propargylpalladium(II) intermediate. Subsequent allylic alkylation is also more 
facile with 1,3-diketone nucleophile 301b due to its high acidity. Therefore, 
overall, homo-coupling of 301b dominates. 







Scheme 83: Use of propargyl carbamate of indole. 
 
7.2.4. Propargyl Enol Carbonate Scope with Indole and Pyrrole 
Nucleophiles. 
Attention was then focused on studying the efficiency and selectivity of the 
coupling of a range of 1,3-dicarbonyl-derived nucleophiles with indole 311b 
N
OO
O O [Pd2(dba3)] (5 mol%)Xantphos (10 mol%)
toluene, 120 oC, 2 h
OO O
O







(Table 13) and pyrrole 313b (Table 14). A variety of 1,3-dicarbonyl-derived 
propargyl enol carbonates were first coupled with indole 311b and again, we 
found the reactions proceeded with full regioselectivity and no homo-coupling 
of nucleophiles (Table 13). Cyclohexanone-based carbonates 303b and 303c 
produced 317a and 317b in good yields and complete selectivity. Similarly, the 
use of propargyl enol carbonates derived from both linear and cyclic 1,3-
diketones readily generated products 317c-317f. In addition to 1,3-diketones, 
β-ketoester 303m was coupled with indole 311b to afford product 317g in a 
high yield of 81%. In an attempt to couple malonate 303t with indole 311b, 
homo-coupled indole side-product 317hb was isolated in 88% yield (Figure 5). 
Finally, carbonates 303o, 303p and 303u failed to react, with 303o and 303u 
producing complex mixtures, while the starting indole and the decarboxylated 
















































aAll reactions were performed on a 0.24 mmol scale. bYield of isolated 317. cAll reactions 
proceeded with full regio- and chemoselectivity. dMajor product was homo-coupled indole 
311b (317hb). 
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Next, we set out to explore the coupling of pyrrole nucleophile 313b with 
several propargyl enol carbonates (Table 14). In a similar fashion to reactions 
with indole nucleophiles, complete regio- and chemoselectivity was 
maintained when pyrrole 313b was coupled with 1,3-dicarbonyl compounds. 
More specifically, cyclohexanone-containing 1,3-diketones and linear 1,3-
diketones provided the desired products in good yields (318a-318e). Cyclic 
1,3-diketones 318f and 318g were also isolated in high yields. The use of β-
ketoesters and malonates afforded 318h and 318i in 55% and 61% yields, 
respectively, whereas β-ketolactone was coupled with pyrrole 313b to give 
318j in a remarkably high 99% yield. Finally, it was encouraging to discover 
that ß-amidoesters were successfully incorporated, with desired product 318k 
being produced in a 56% yield, whereas the α-fluorinated ß-ketoester 303p 





































aAll reactions were performed on a 0.24 mmol scale. bYield of isolated 318. cAll reactions 
proceeded with full regio- and chemoselectivity. dThe result was obtained through work of 
Danny Kitson. 
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 toluene, 120 oC, 2 h
303 313b 318
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7.2.5. The Coupling of 1,3-D-icarbonyl Compounds with Other N-
Heterocycles 	  
Having demonstrated the successful use of indole and pyrrole nucleophiles in 
the reaction, we set out to extend the scope and generality of this process to 
other nitrogen nucleophiles. In this context, it was found that analogous 
aromatic N-heterocycles, namely imidazole, benzimidazole and pyrazole 
(319a-319c, Table 15), all afforded coupled products 320a-320c in moderate 
yields but with complete regioselectivity. It was surprising to discover that 
indazole 319d gave product 320d in 50% yield with poor regioselectivity, 
which was in contrast to the consistently high regioselectivity of the reactions 
with other nitrogen-based nucleophiles. Benzotriazole 319e failed to couple 
with enol carbonate 266 and a complex mixture of products was observed by 
1H NMR spectroscopy. We were particularly keen to incorporate aliphatic 
amines into our products, in order to generate molecular building blocks with 
more sp3 character. Unlike unsaturated N-heterocycles, which generate an 
aromatic anion upon deprotonation, saturated amines are significantly less 
acidic and, thus, less likely to react via the usual reaction pathway. Indeed, 
saturated cyclic amines pyrrolidine (319f) and morpholine (319g) failed to 
afford the desired products 320f and 320g and only complex mixtures of 
products were isolated. The use of N-hydroxysuccinimide 319h as a 



















aAll reactions were performed on a 0.24 mmol scale. bYield of isolated 320. cUnless otherwise 
stated, all reactions proceeded with full regio- and chemoselectivity  
 
Table 15: Analgous N-heterocycle substrate scope. 
 
7.2.6. Mechanistic Studies 
To gain a better understanding of the mechanism of the reaction between 1,3-
dicarbonyl compounds and N-heterocyclic nucleophiles, as well as the origins 
of the displayed selectivity, several experiments were conducted. In a similar 
fashion to the deuterated enol carbonates made for the mechanistic studies 
for the coupling of the 1,3-dicarbonyl compounds (vide supra, Scheme 77), 
enol carbonates [D]-266 and [D]-303c were made in a similar fashion 
(Scheme 84).117  For the enolate scrambling experiments, pyrrole [D]-313b 
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Scheme 84: The creation of deuterated substrates for the mechanistic studies. 
 
The first experiment conducted was an enolate crossover experiment (Schem 
e 85), in which two structurally similar propargyl enol carbonates [D]-266 and 
303c were reacted with pyrrole 313b and the products were isolated. 1H NMR 
spectroscopy indicated 84% deuterium incorporation in [D]-314b and no 
deuterium incorporation in 318b. This observation indicates that there is no 
enolate crossover in the reaction, suggesting that the η3-π-
propargylpalladium(II) intermediate formed after decarboxylation is tightly 
bound to the corresponding enolate. A deuterium scrambling experiment was 
also performed using [D]-303c, resulting in an even distribution of the 
deuterium labels at the allylic and vinylic positions in [D]-318b. Deuterium 
scrambling also occurred when non-deuterated 303c was coupled with 
deuterated pyrrole [D]-313b. These results were further confirmed by the 
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almost equal amounts in [D2]-318b, when [D]-303c was coupled with [D]-
313b. In light of these results, it is feasible to conclude that a nitrogen 
deprotonation step and a symmetrical π-allylpalladium(II) intermediate are 
implicated in the mechanism, analogous to the mechanism proposed for the 















          
             
             
 
 



































































































Finally, a competition experiment between indoles 311a and 311b was 
performed (Scheme 86), bearing in mind that indole 311b, containing an ester 
side-chain at the 3-position, is more acidic than unsubstituted indole (311a). 
Although both indoles can take part in individual reactions with carbonate 266, 
the combination of the two only afforded product 312b and not 312a. 
Therefore, it can be postulated that the acidity of the NH proton and thus, the 
rate of deprotonation, affects the overall rate of reaction. This conclusion is 
corroborated by the fact that the more acidic indoles and pyrroles in general 
give rise to higher yields of the coupled product (vide supra, Table 11). 






Scheme 86: Competition experiment: effect of acidity. 
 
The results regarding the cross-coupling reaction of two 1,3-dicarbonyl 
compounds, as well as the cross-coupling reactions of 1,3-dicarbonyl 
compounds with N-heterocyclic nucleophiles were very positive. This 
palladium-catalysed cross-coupling reaction affords the desired products with 
high regio- and chemoselectivity in most cases, even when less acidic 
nitrogen nucleophiles are used. In addition, in the coupling of 1,3-dicarbonyl 
compounds, the reaction can be made regioswitchable by simply choosing an 



























deuterium-labelling and competition experiments, a mechanism of the reaction 
has been delineated. The flexibility of this process means that two new bonds 
can be made in a single step as well as one or two quaternary all-carbon 
centres, depending on the type of external nucleophile used.  
7.3. The Development of Enantioselective Coupling of Nucleophiles 	  
Having successfully developed the coupling of 1,3-dicarbonyl-derived enolates 
with 1,3-dicarbonyl compounds and N-heterocycles in racemic form, focus 
was shifted to the development of enantioselective variants of the reaction. 
There are two stages of this process at which enantioselectivity could be 
imported. The first involves the enantioselective alkenylation of the enolate of 
the 1,3-dicarbonyl coupling partner (Scheme 87). Specifically, the all-carbon 
quaternary centre in 322 is introduced by the addition of the enolate at the 
central carbon atom of the η3-π-propargylpalladium(II) intermediate in 321. By 
using a pro-chiral propargyl enol carbonate and a chiral ligand for palladium, 
this step could be made to proceed enantioselectively, generating enantio-
enriched product 323 following allylic alkylation of a nucleophile (Scheme 85). 
While the enantioselective alkenylation of nucleophiles with propargylic 
electrophiles has been precedented (vide supra, Scheme 60),113 the reaction 
gave a poor yield and enantioselectivity. However, to the best of our 
knowledge, it is the only known process of an enantioselective palladium-
catalysed alkenylation of an enolate in the presence of a second nucleophile 
and a propargylic electrophile to date. 






Scheme 87: The enantioselective alkenylation. 
The second chiral centre can be formed through the allylic alkylation of the 
external nucleophile (Scheme 88). By using propargyl enol carbonate 300, 
derived from a symmetrical 1,3-dicarbonyl in the presence of prochiral 1,3-
dicarbonyl 301b, η3-π-allylpalladium(II) intermediate 308 would be formed. 
With an appropriate chiral ligand for palladium, an enantioselective allylic 
alkylation could take place, generating an all-carbon quaternary centre in 302b 
in an enantio-enriched form. There are several examples of an 
enantioselective palladium-catalysed allylic alkylation using propargylic 
electrophiles,114  however, these are intramolecular processes, whereas the 
induction of enantioselectivity via allylic alkylation with propargylic 






Scheme 88: The enantioselective allylic alkylation. 
 
Given the lack of success of a diastereoselective reaction, in which two chiral 


























enantioselective variant of such a process was likely to be formidable. 
Therefore, we sought to investigate each process separately. Notwithstanding, 
there were a number of difficult challenges that needed to be overcome. 
Indeed, there is a clear lack of examples of both the enantioselective 
alkenylation and allylic alkylation of nucleophiles with propargylic 
electrophiles, suggesting that the development of such processes is an 
ambitious task. More specifically, the use of a chiral ligand for palladium 
requires the control of not only the enantioselectivity, but also the 
regioselectivity and chemoselectivity, whilst maintaining the high yield of the 
reaction. The simultaneous control of all four of these factors in an 
intermolecular coupling reaction makes this endeavour both highly challenging 
and exciting.  
 
7.3.1. Enantioselective Alkenylation 
We first focused on the alkenylation of prochiral propargyl enol carbonate 
303b in the presence of a symmetrical 1,3-dicarbonyl 301h to generate a 
quaternary all-carbon centre in 304b in enantio-enriched form via alkenylation 
(Scheme 89). 
                  
 
 












In the first instance, a screen of a broad range of chiral ligands for palladium 
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The majority of phosphine ligands with an alkyl backbone failed to push the 
reaction to completion (L2-L4), with the exception of (R,R)-DIOP (L1), which 
did invoke the desired reactivity, however, the yield and enantioselectivity was 
poor (L1,  chemoselectivity: 7.5:1, regioselectivity: > 19:1, yield: 28%, ee: 5 
%.). In addition, DUPHOS (L5) and JOSIPHOS (L6) failed to afford the 
product. Trost ligands and (S)-t-Bu-PHOX, particularly useful in the 
enantioselective allylic alkylation of enolates,67 also did not afford the desired 
product (L6-L10). 
While axially chiral (R)-BINAP afforded 304b, albeit in a low yield and 
enantioselectivity (L11, entry 1, Table 16), the rest of the BINAP family were 
unsuccessful  (L12-14, entries 2-4). The Phanephos ligand family (L15-L17) 
was noticeably more successful, producing 304b with complete selectivity and 
in good yields, however, in all cases, the enantioselectivity was low (entries 5-
7). Electron-rich (R)-P-PHOS (L18) gave a similar result (entry 8). The most 
enantioselective reaction was with (R)-Xylyl-P-Phos (L19) as the ligand, 
affording 304b in a low yield, but with the highest enantioselectivity (19% ee, 
entry 9). (R)-C3-Tunephos (L20) produced 304b in a low yield and with lower 
enantioselectivity (entry 20). The low yields were associated with poorer 






   
   
 











   1    L11 RT, 16 h 9.5:2.2d:1e > 19:1 11 5 - 
2 L12 80 oC, 2 h, - - - - - 
3 L13 80 oC, 2 h - - - - - 
4 L14 80 oC, 2 h - - - - - 
5 L15 RT, 16 h 
Full 
selectivity 
> 19:1 54 7 - 
6 L16 RT, 16 h 
Full 
selectivity 
> 19:1 62 −5 - 
7 L17 RT, 16 h 
Full 
selectivity 
> 19:1 55 −2 - 
8 L18 RT, 16 h 5.5:1.8d:1e > 19:1 34 6 - 
9 L19 RT, 16 h 2.8:1d > 19:1 17 19 1.9:1 
10 L20 
80 oC, 2 h 
120 oC, 2h 
11:4.6d: 1e > 19:1 13 13 - 
 
aDetermined by 1H NMR analysis of the crude product mixtures. b:Isolated yield. cThe 
enantioselectivity was determined by chiral HPLC. dHomo-coupling of 303b. eHomo-coupling 
of 301h. S.M. = starting material. 
 




Two of the three axially-chiral SEGPHOS ligands L21 and L22 gave rise to 
304b in 22% yield and 11% ee, and 28% and 15% ee, respectively (entries 1 
and 2, Table 17), with one of the ligands of the SEGPHOS family failing to 
O O O
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 [Pd2(dba)3] (5 mol%)








push the reaction to completion (entries 1-3). The final set of ligands that 
successfully mediated the reaction was the BIPHEP family (L24-L28, entries 
4-8). BIPHEP ligands had been previously successful in the enantioselective 
synthesis of spirocyclised oxindoles via alkenylation and allylic alkylation.113 
However, in the context of our intermolecular cross coupling reaction, while 
the yields were moderate, enantioselectivity remained low. Finally, the 
phosphoramidite ligand family, often successful in the iridium-catalysed 
enantioselective allylic alkylation reactions,121 failed to push the reaction to 
















       











1 L21 RT, 16 h 2.2:1d > 19:1 22 11 1.6:1 
2 L22 60 oC, 16 h 8.2:1d > 19:1 28 15 - 
3 L23 - - - - - - 
4 L24 - - - - - - 
5 L25 60 oC, 16 h 
Full 
selectivity 
> 19:1 53 −3 6.1:1 
6 L26 RT, 16 h 10:2d:1e > 19:1 48 10 - 
7 L27 RT, 16 h 1.4d:1.2e:1 > 19:1 11 −12 - 
8 L28 80 oC, 2 h, - - - - - 
9 L29 
80 oC, 2 h, 
120 oC, 2h 
- - - - - 
10 L30 80 oC, 2 h - - - - - 
 
aDetermined by 1H NMR analysis of the crude product mixtures. b:Isolated yield. cThe 
enantioselectivity was determined by chiral HPLC. dHomo-coupling of 303b. eHomo-coupling 
of 301h. S.M. = starting material. 
 




Overall, it was not possible to identify a ligand which afforded 304b both in a 
good yield and with high regio-, chemoselectivity and enantioselectivity. Two 
ligands were selected for further optimisation: one gave a good yield of 
product (L15) and the other gave rise to higher enantioselectivity, but a poorer 
yield (L19). In this context, a solvent screen with each ligand was performed 
O O O
O
 [Pd2(dba)3] (5 mol%)








(Table 18). Overall, six solvents were screened, from more polar solvents 
such as methyl tert-butyl ether, dimethoxyethane, tetrahydrofuran and diethyl 
ether, to non-polar solvents such as dichloromethane or toluene. Despite the 
vast array of solvents screened, the improvement of the results was not 
substantial. When using L15 as the ligand, there were some small gains in 
enantioselectivity, for instance, using dichloromethane at 40 oC and 
tetrahydrofuran as the solvent at 60 oC for 2 hours may increase the 
enantioselectivity (entries 2 and 6, Table 19), however, the increase in 
enantioselectivity was not significant enough (in addition to a low yield being 
produced in respect to using dichloromethane). While using diethyl ether, 
dimethyoxethane and toluene increased the yield (entries 4, 5 and 7) there 
was no increase in enantioselectivity. Using L19, the reaction in 
dichloromethane resulted in product 304b being formed with a higher 
enantioselectivity of 30% (entry 9), however the yield of 304b was low (13%). 
Heating the reaction in 1,4-dioxane to 80 oC did not increase the 
enantioselectivity of the reaction, although it did increase the yield to 44% 
(entry 8). Reactions in dimethoxyethane, diethyl ether, methyl tert-butyl ether 
and toluene as solvents showed no improvement in enantioselectivity (entries 
10, 11 and 12). The reaction in tetrahydrofuran with L19 as the ligand resulted 
in an enhancement in enantioselectivity by 2%, as well as an increase in yield 
by 32% (entry 13). With these improved results, (R)-Xylyl-P-PHOS (L19) in 









aDetermined by 1H NMR analysis of the crude product mixtures. b:Isolated yield. cThe 
enantioselectivity was determined by chiral HPLC. dHomo-coupling of 303b. eHomo-coupling 
of 301h.  
 
Table 18: Solvent screen for enantioselective alkenylation. 











RT, 16 h 
Full 
Selectvity  
> 19:1       54   7 
2 L15 CH2Cl2 40 oC, 2 h 2.3:1.4d:1e 3.4:1 17 8 
3 L15 DME RT, 16 h 6.2:1.8d:1e > 19:1 48 7 
4 L15 Et2O RT, 16 h 
Full 
selectivity 
> 19:1 75 5 
5 L15 MTBE    RT, 16 h 
Full 
selectivity 
> 19:1 73 4 
6 L15 THF 
RT, 16 h   
60 oC, 2 h 
Full 
selectivity 
> 19:1 61 11 
7 L15 Tol RT, 16 h 
Full 
selectivity 




80 oC, 2 h, 10:1.3 e:1 d > 19:1 44 14 
9 L19 CH2Cl2 40 oC, 2 h,  2.2:1.4d:1e > 19:1 13 30 
10 L19 DME 60 oC, 2 h, 10:3.6d:1e > 19:1 37 11 
11 L19 Et2O 40 oC, 2 h,  3.6:1.3c:1d > 19:1 42 11 
12 L19 MTBE 80 oC, 2 h, 13:1.6c:1d > 19:1 57 17 
13 L19 THF  60 oC, 2h 16:3.4c:1d > 19:1 57 21 
14 L19 Tol  80 oC, 2h 16:3.4c:1d > 19:1 51 7 
O O O
O
 [Pd2(dba)3] (5 mol%)








A substrate scope study was performed using the most effective conditions 
identified in the solvent screen (Scheme 90). When linear prochiral enol 
carbonate 303f was coupled with 3-methyl-2,4-pentanedione (301h), 304f was 
isolated in 34% yield and 19% ee, whereas the reaction of 4-chromanone-
derived propargyl enol carbonate 303s with 301h afforded 304s in 24% yield 
and 9% ee. Using 2-acetylcyclohexanone-derived carbonate 266 with linear 
1,3-diketone 301j afforded product 304l in a poor yield and low 
enantioselectivity. Finally, the coupling of the same propargyl enol carbonate 
266 with phenol and pyrrole nucleophiles 268 and 313b afforded products 268 
and 314b in 44% and 80% yields, respectively, and with low enantioselectivity 























































aHomo-coupling of the propargyl enol carbonate.  
 










(R)-Xylyl-P-PHOS (L19, 6 mol%)





          304f (34%)
            r.r. > 19:1
chemoselectivity: 1.4:1a





 [Pd2(dba)3] (5 mol%)
 (R)-Xylyl-P-PHOS (L19, 6 mol%)




















































 [Pd2(dba)3] (5 mol%)
 (R)-Xylyl-P-PHOS (L19, 6 mol%)
 THF, 60 oC, 2 h
 [Pd2(dba)3] (5 mol%)
 (R)-Xylyl-P-PHOS (L19, 6 mol%)
 THF, 60 oC, 2 h
 [Pd2(dba)3] (5 mol%)
 (R)-Xylyl-P-PHOS (L19, 6 mol%)
 THF, 60 oC, 2 h
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7.3.2. The Enantioselective Allylic Alkylation  
Following the attempted development of an enantioselective alkenylation 
reaction, attention was turned to the enantioselective allylic alkylation using a 
propargyl enol carbonate derived from an achiral 1,3-diketone, such as 300, 
and a chiral external nucleophiles, such as 301b (Scheme 91). 
     
 
 
Scheme 91: Enantioselective allylic alkylation. 
 
Using the same chiral ligands (vide supra, Figures 5 and 6), a comprehensive 
ligand screen was performed (Table 20). The first set of ligands L1-L10 failed 
to afford desired product 302b, with the exception of (R,R)-DIOP (L1), which 
gave rise to 302b in a low 37% yield, a moderate 6:2.2:1 chemoselectivity, full 
regioselectivity and 10% ee. 
Utilisation of the BINAP ligand L11-L14 family led to an increase in the 
enantioselectivity of the allylic alkylation  (Table 19, entries 1-4). (R)-Tol-
BINAP (L12) gave particularly good results, namely 68% yield of 302b and 
higher enantioselectivity (27% ee). Unexpectedly, (R)-DM-BINAP (L13), while 
giving rise to a good yield of 302b, led to negligible enantioselectivity despite 
its structural similarity to (R)-Tol-BINAP (L12). Reactions with (R)-BINAP and 
(R)-H8-BINAP (L11 and L14) were both not as enantioselective as that with 
L12, and lower yielding. The Phanephos family afforded high yields of 302b, 
but the enantioselectivity was low (L15-L17, entries 5-7). While (R)-P-PHOS 










chiral ligand (6 mol%)
           solvent
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(R)-Xylyl-P-PHOS (L19) was not enantioselective (entries 8-9). (R)-C3-
Tunephos (L20) produced 302b with the highest enantioselectivity, however, 
the product was formed in a low yield (entry 10). 
    
 











1 L11 RT, 16 h 5.3:1.4e:1d 13:1 40 11 - 
2 L12 RT, 16 h 7.9:1.3e:dc > 19:1 68 27 - 
3 L13 RT, 16 h 5.9:1.4e:1d > 19:1 49 1 - 
4 L14 RT, 16 h 6.4:1.3e:dc 18:1 22 1 - 
5 L15 RT, 16 h 12:1.1e:1c > 19:1 62 13  
6 L16 RT, 16 h 
Full 
selectivity 
> 19:1 73 12 - 
7 L17 RT, 16 h 
Full 
selectivity 
> 19:1 42 16 - 
8 L18 RT, 16 h 6.3:1.3e:1d >18:1 55 24 - 
9 L19 RT, 16 h 5.4:1.7d:1e 14:1 31 2 - 
10 L20 RT, 16 h 10:3.4e: 1d > 19:1 37 34 2.8:1 
 
aDetermined by 1H NMR analysis of the crude product mixtures. b:Isolated yield. cThe 
enantioselectivity was determined by chiral HPLC. dHomo-coupling of 300. eHomo-coupling of 
301b. S.M. = starting material. 
 
Table 19: Ligand screen for the enantioselective allylic alkylation. 
 
The SEGPHOS family provided the best results regarding enantioselectivity 
(Table 20, entries 1-3). Although axially-chiral SEGPHOS ligand L21 produced 










chiral ligand (6 mol%)
       1,4-dioxane
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SEGPHOS (L22) gave a poor ee of 302b (entry 2), whereas (R)-DTBM-
SEGPHOS (L23) provided product 302b with the best enantioselectivity 
(39%), albeit in a lower yield of 37% (entry 3). The BIPHEP family gave 
varying results (L24-L28, entries 4-8), and no improvement was observed with 
regards to the enantioselectivity as compared to (R)-DTBM-SEGPHOS (L23). 
Finally, the phosphoramidite family L29-L30 failed to push the reaction to 
















        











1 L21 RT, 16 h 8.5:2e:1d 14:1 48 32 7.1:1 
2 L22 RT, 16 h 5.7:1.4e:1d 14:1 42    6       - 
3 L23 80 oC, 2 h 5.9:1.7e:1d > 19:1 37 39 - 
4 L24 80 oC, 2 h 15:2.9e:1d > 19:1 59  21 - 
5 L25   RT, 16 h 11:1.5e:1d > 19:1 39 −4 - 
6 L26   RT, 16 h 
Full 
selectivity 
> 19:1 48 12 - 
7 L27 80 oC, 2 h 
Poor 
selectivity 
> 19:1 17 10 - 
8 L28 80 oC, 2 h - - - - - 
9 L29 80 oC, 2 h - - - - - 
10 L30 80 oC, 2 h - - - - - 
 
aDetermined by 1H NMR analysis of the crude product mixtures. b:Isolated yield. cThe 
enantioselectivity was determined by chiral HPLC. dHomo-coupling of 300. eHomo-coupling of 
301b. S.M. = starting material. 
 
Table 20: Ligand screen for the enantioselective allylic alkylation. 
 
As a result of this study, two ligands were chosen for further reaction 
optimisation via a solvent screen: (R)-Tol-BINAP (L12) gave the highest yield 
of 302b but the enantioselectivity was lower, and (R)-DTBM-SEGPHOS (L23), 
which produced 302b with the highest enantioselectivity. In this context, we 
were unsuccessful in improving the levels of enantioselectivity while 










chiral ligand (6 mol%)
       1,4-dioxane
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of solvents using (R)-Tol-BINAP (L12) as the ligand (Table 21, entries 2-6). 
Similarly, the solvent screen using (R)-DTBM-SEGPHOS L23 failed to afford 
product 302b in a yield above 30% and produced only marginal improvements 
in enantioselectivity (entries 7-13). Attempts to lower the reaction temperature 
with L23 as the ligand in a 1,4-dioxane solvent did not improve the 
enantioselectivity either (entries 8 and 9). Therefore, in both cases, 1,4-
dioxane was chosen as the optimal solvent. Given that the enantioselectivity 
with L23 as the ligand in 1,4-dioxane (39%) was only marginally higher than 
that obtained with L12 (27% ee), but the yield was significantly lower (37% for 
L23 vs 68% for L12), the remainder of this study centred around reactions 






















RT, 16 h 7.9:1.3e:1d > 19:1 68 27 
2 L12 DME RT, 16 h 2.5:4e:1d 1.5:1 13 23 
3 L12 Et2O RT, 16 h 5.8:2.4e:1d 8.1:1 37 30 
4 L12 MTBE RT, 16 h 6.5:2.3e:1d > 19:1 39 27 
5 L12 THF 
RT, 16 h then 
40 oC, 2 h 
1.7:2.0e:1d 1.4:1 18 24 
6 L12 Toluene 
RT, 16 h, then 
40 oC, 2 h 












40 oC, 16 h 6.9:1.5e:1d 11:1 26 41 
10 L23 Et2O 40 oC, 2 h 6.3:1e > 19:1 31 46 
11 L23 MTBE 60 oC, 2 h 10:1d:1e > 19:1 29 43 
12 L23 THF 60 oC, 2 h 6.7:1.6e:1d > 19:1 15 41 
13 L23 Toluene 60 oC, 2 h 7:1.5e:1d > 19:1 28 37 
 
aDetermined by 1H NMR analysis of the crude product mixtures. b:Isolated yield. cThe 
enantioselectivity was determined by chiral HPLC. dHomo-coupling of 300. eHomo-coupling of 
301b.  
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           solvent
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In the final stage of this work, focus shifted to the extension of the substrate 
scope using L12 as the ligand (Scheme 92). While propargyl enol carbonate 
300 was successfully coupled with β-ketoester 301m to afford 302m in 42% 
yield and 11% ee, we were unable to isolate products 324-327 or 302k, having 
screened several propargyl enol carbonates (300, 304i and 304h) and 1,3-
dicarbonyl compounds (301b, 301k and 301o). In most cases, either 
decarboxylation took place but no desired coupling occured (324, and 327), 
homo-coupling of one of the partners took place (326 and 302k), or a complex 
mixture of products was obtained (325). In light of these results with ligand 























































aHomo-coupling of the propargyl enol carbonate.  
 
Scheme 92: Substrate scope for the enantioselective allylic alkylation. 
Overall, this enantioselective catalysis study proved to be extremely 
challenging. Despite an extensive ligand screen and optimisation, both yields 
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     [Pd2(dba)3] (5 mol%)
     (R)-Tol-BINAP (L12, 6 mol%)
     1,4-dioxane (RT, 16 h)
                 302m (36%)
                 r.r. > 19:1
       chemoselectivity: 4:1a







     [Pd2(dba)3] (5 mol%)
     (R)-Tol-BINAP (L12, 6 mol%)
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conditions used to obtain the best result for one substrate were not readily 
transferrable to others.  
 
8. Future Work 
Having successfully developed access to a range of products via the catalytic 
coupling of nucleophiles, further functionalisation of the cross-coupled 
products needs to be investigated. In particular, all of the building blocks 
obtained by this methodology contain a disubstituted alkene, which could be 
further derivatised to enable cyclisation reactions towards novel spirocyclic 
compounds. For example, the alkene in 304a could be epoxidised to form 328, 
and treated with a base to generate spirocycle 329 (Scheme 93).  
      
 
 
Scheme 93: Functionalisation of the double bond in 304a.  
 
The double bond created in β-ketoester 304m can also be functionalised 
(Scheme 94). Hydroboration can lead to intermediates 330 and 331, followed 
by cyclisation with the ester as the intramolecular electrophile to afford 
spirocyclic product 332. Similarly, dihydroxylation of 304m would form diol 
333, followed by intramolecular cyclisation to form 334.  
 
























Scheme 94: Functionalisation of the double bond in 304a.  
 
Having developed an intermolecular coupling reaction as part of this research, 
we aim to extend this work to an intramolecular process, paving the way to the 
direct synthesis of spirocyclic and fused bicyclic molecular structures in a 
single step. For example, by utilising enol carbonate 335, containing an 
intramolecular nucleophile X, spirocyclic structures of type 336 could 
potentially be obtained, which contains an all-carbon quaternary centre 
(Scheme 95).  





Scheme 95: Mechanism for spirocycle formation via an intramolecular decarboxylative cross-
coupling reaction. 
 






































339 (Figure 8), each of which contains an appended nucleophilic side-chain 
once deprotonated: an acidic fluorinated ketone in 337, a carboxylic acid in 
338 and an amide in 339. 




Figure 8: Propargyl enol carbonates for spirocycle formation. 
 
Fluorinated enol carbonate 337 has already been prepared and the 
opportunity for spirocyclisation has been investigated by screening several 
ligands and solvents (Table 22). Unfortunately, we have been unable to obtain 
340 thus far due to either lack of reactivity or decomposition. However, 


























                         
Entry Ligand Outcome 
    1          PCy3        No reactiona 
2 Dppe No reactiona 
3 P(C6F5)3 No reactiona 
4 BINAP Decarboxylation only 
5 SPhos Decarboxylation only 
6 dppm Decarboxylation only 
7 dppp Decarboxylation only 
8 dppf Decomposition 
9 t-Bu-Xantphos Decomposition 
10 DPEphos Decomposition 
11 Xantphos Decomposition 
12 Pd(PPh3)4b Decomposition 
 
aReaction was performed at 120 °C; Oxidative addition occurred but no reaction beyond that 
step. b[Pd(PPh3)4] was used in place of [Pd2(dba3)]. 
 
Table 22: Ligand screen for spirocyclic 340 formation.  
 
Alternatively, propargyl enol carbonate of type 341 could be utilised which 
would give rise to oxygenated and nitrogenated spirocycles 342, depending on 
the nucleophilic side-chain used (Scheme 96). 
 




















Scheme 96: Palladium-catalysed spirocyclisation with tethered nucleophiles.  
 
The intramolecular coupling reaction also has the potential to lead to nitrogen 
heterocycles from linear substrates (Scheme 97). More specifically, by varying 
the nitrogen-bearing side-chain, all-carbon quaternary centre containing 
azetidines 344a, pyrrolidines 344b and piperidines 344c could be accessed. 






Scheme 97: Linear substrates for heterocycle synthesis. 
 
However, if the propargyl enol carbonate is derived from a 1,3-dicarbonyl 
containing a cyclic ketone, then trans-fused bicyclic products 346 could be 
obtained from 345 in this enolate/amine cyclisation reaction (Scheme 98). 






Scheme 98: Palladium-catalysed synthesis of fused bicycles. 
 
 





































nucleophile in 347, obtained via a Michael process (Scheme 99), a tethered 
bis-nucleophile 348 would be accessed. A palladium-catalysed cyclisation of 
347 would give rise to highly functionalised carbocycle 348, which represents 
an intramolecular variant of the coupling reaction of 1,3-dicarbonyl compounds 
presented in this thesis.  




Scheme 99: Palladium-catalysed synthesis of functionalised carbocycles. 
 
Finally, the catalytic palladium-mediated reactions would enable us to explore 
the scope of generating the quaternary carbon centre in an enantioselective 
manner. Overall, the development of these processes will not only open up 
opportunities to explore untapped areas of 3D chemical space, but this will 
also provide access to polar and sp3-rich building blocks, likely to be of 























An intermolecular regio- and chemoselective decarboxylative palladium-
catalysed coupling of two carbon nucleophiles, namely 1,3-dicarbonyl 
compounds, has been clearly demonstrated. The transformation generates 
two C–C bonds and two all-carbon quaternary centres in a single operation. 
The reaction is predictably regioswitchable, providing access to either of the 
two regioisomers of product depending on the choice of the propapgyl enol 
carbonate substrate (vide supra, Tables 4 and 6). In addition to 1,3-diketones, 
other 1,3-dicarbonyl compounds, such as β-ketoesters, lactones, lactams and 
sulfones have enabled the incorporation of oxygen, nitrogen and sulfur 
functionality. A mechanism of the reaction has been proposed based on 
deuterium labeling studies (vide supra, Scheme 79). 
 
 A decarboxylative palladium-catalysed coupling reaction of 1,3-dicarbonyl 
compounds with weakly acidic N-heterocycles under neutral conditions, which 
generates new C–C and C–N bonds and an all-carbon quaternary centre in a 
single step, has been developed. The broad scope of this transformation was 
demonstrated through the coupling of a variety of 1,3-dicarbonyl compounds 
with a range of indoles and pyrroles, as well as other N-heterocyclic 
substrates. In all cases, the reactions proceeded with full regio- and 
chemoselectivity, efficiently controlled by utilising a propargyl enol carbonate 
as one of the coupling partners. The reaction mechanism was deduced 
through deuterium-labelling studies, which is analogous to that of the coupling 
of two 1,3-dicarbonyl compounds.  
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The development of enantioselective alkenylation and allylic alkylation for the 
stereoselective construction of one of the two chiral all-carbon quaternary 
centres in the coupling of 1,3-dicarbonyl compounds with nucleophiles has 
been undertaken (vide supra, Scheme 87 and 89). In this context, a broad 
range of chiral ligands for palladium were screened. The enantioselective 
alkenylation afforded products in moderate yields and low ees. The 
enantioselective allylic alkylation was less successful: although one product 
was obtained with an ee of 40%, the yield was low and the reaction was not 
general across a range of substrates. There is a clear direction where the 
project can go next, with methods for the catalytic synthesis of novel cyclic 













10. Experimental Section 
10.1. General Experimental Section  
 
All reactions were performed under an argon atmosphere in oven-dried 
glassware. All solvents used were either purchased and kept over molecular 
sieves or passed through an activated alumina column. All other reagents and 
solvents were used as supplied and all aqueous reagents were saturated 
unless specified otherwise.  
 
Thin layer chromatography (TLC) was carried out using pre-coated Fluka 
analytical silica gel on aluminium foils, with a fluorescent indicator (254 nm). 
Column chromatography was carried out using Fisher Silica 60 Å particle size. 
Petrol refers to the fraction of petroleum ether that boils between 40-60 oC. 
Visualisation of the TLC plates was done via staining with potassium 
permanganate or aqueous acidic ammonium molybdate (IV).  
 
NMR spectra were recorded using a Bruker 400 and 300 MHz Ultra Shield 
Plus spectrometer and are reported as follows: chemical shift, δH (in parts per 
million, ppm), multiplicity, coupling constant, J, number of protons and 
assignment. Couplings are classed as singlet, s, doublet, d, triplet, t, quartet, 
q, quintet, quint, septet, sept, sextet, sext, broad, br, multiplet, m, or a 
combination of these. 13C NMR spectra were recorded on the same 
instruments at 100 MHz and 75 MHz, respectively. Residual solvent CHCl3 
was referenced at 7.26 ppm for 1H NMR spectra and the central signal of 
CDCl3 was referenced to 77.0 ppm for 13C NMR spectra. A range of NMR 
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techniques (DEPT-135, COSY, HMBC and HSQC) were used to aid the 
analysis of 1H and 13C spectra. For clarity in the NMR assignments, atoms are 
numbered in the experimental diagrams. This numbering does not correspond 
to IUPAC nomenclature.  
 
IR spectroscopy analysis was performed on an Agilent Technologies Cary 630 
FTIR spectrometer.  
 
Accurate mass spectrometry was recorded using electron spray ionisation on 
Shimadzu HRMS LCMS-IT-TOF mass spectrometer at Lancaster University, 
Lancaster UK, or the EPSRC Finnigan MAT 95 XP instrument at the UK 
EPSRC National Mass Spectrometry facility, Swansea, UK.  
 
Melting points were measured on a Gallenkamp melting point apparatus and 
are uncorrected.  
 
X-ray crystallography data was recorded using a Beamline I19 diffractometer 
AT the UK EPSRC National Crystallography Service at the University of 
Southampton or at Lancaster University, using an Agilent Supernova diffractor 
for single crystal X-ray diffraction. 
 
HPLC analysis was performed using a Shimdazu NexeraX2 instrument and 
this was used to determine enantiomeric excesses. 
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10.2. Experimental Procedures. 
10.2.1. Synthesis of 1,3-Dicarbonyl Compounds.  
 
3-Allylpentane-2,4-dione (301e): 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
                        
 
 
According to a literature procedure,122 to a solution of acetylacetone (1.50 mL, 
15.0 mmol) in acetone (20 mL) was added potassium carbonate (2.40 g, 18.0 
mmol) portionwise. The suspension was stirred at room temperature for 15 
minutes. Allyl bromide (1.55 mL, 18.0 mmol) was added dropwise. The 
mixture was heated to reflux at 80 °C for 18 hours. The mixture was filtered 
under reduced pressure and the filtrate was concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 99:1] afforded 301e (355 mg, 17%) as 
a pale liquid. RF 0.65 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2980, 1699 (C=O), 
1597, 1418; δH (400 MHz, CDCl3, 1.4:1 keto:enol tautomer, enol tautomer 
annotated by an asterisk) 16.68 (s, 1H*, H10), 5.86-5.75 (m, 1H*, H12), 5.72-
5.61 (m, 1H, H5), 5.09-4.93 (m, 2H and 2H*, H6 and H13), 3.70 (t, J = 7.5 Hz, 
1H, H3), 2.95 (dt, J = 5.1, 1.9 Hz, 2H*, H11), 2.55 (tt, J = 7.1, 1.3 Hz, 2H, H4), 
2.15 (s, 6H, H1), 2.06 (s, 6H*, H7); δC (100 MHz, CDCl3, 1.4:1 keto:enol 
tautomer, enol tautomer annotated by an asterisk) 203.6 (C2), 191.4 (C8*), 
135.6 (C12*), 134.0 (C5), 117.4 (C13*), 114.8 (C6), 107.0 (C9*), 67.9 (C3), 
32.1 (C4), 31.1 (C11*), 29.2 (C1), 22.8 (C7*). Synthesis of this compound has 















Ethyl 3-acetyl-4-oxopentanoate (301g): 




According to a literature procedure,117 to a solution of acetylacetone (2.05 mL, 
20.0 mmol) and ethyl bromoacetate (2.22 mL, 20.0 mmol) in dichloromethane 
(20 mL) was added solid potassium carbonate (2.76 g, 20.0 mmol). The 
mixture was stirred at room temperature for 72 hours. The reaction was 
quenched by addition of aq. HCl (1 N, 20 mL) and the aqueous layer was 
extracted with dichloromethane (3 x 20 mL). The combined organic phases 
were washed with brine (50 mL), dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 49:1-4:1] afforded 301g (1.82 g, 
48%) as a yellow oil. RF 0.68 [Petrol:EtOAc 1:1]; νmax (film)/cm−1 2983, 1723 
(C=O), 1701 (C=O), 1602; δH (400 MHz, CDCl3, 1.9:1 keto:enol tautomer, enol 
tautomer annotated by an asterisk) 16.76 (s, 1H*, H11), 4.17-4.06 (m, 3H and 
2H*, H3, H6 and H14), 3.22 (s, 2H*, H12), 2.85 (d, J = 6.7 Hz, 2H, H4), 2.24 
(s, 6H, H1), 2.13 (s, 6H*, H8), 1.27-1.19 (m, 3H and 3H*, H7 and H15); δC 
(100 MHz, CDCl3, 1.9:1 keto:enol tautomer, enol tautomer annotated by an 
asterisk) 202.4 (C2), 191.8 (C9*), 171.4 (C13*), 171.1 (C5), 104.3 (C10*), 63.2 
(C3), 61.1 (C6), 61.1 (C14*), 33.3 (C12*), 32.5 (C4), 29.5 (C1), 23.3 (C8*), 
14.1 (C7), 14.0 (C15*); HRMS (ESI) Found: [M+H]+, 187.0964. C9H14O4 





























According to a literature procedure,123 acetylacetone (3.08 mL, 30 mmol), 
iodobenzene (1.14 mL, 10 mmol), copper iodide (190 mg, 1 mmol), L-proline 
(230 mg, 2 mmol) and potassium carbonate (552 mg, 40 mmol) were 
dissolved in dimethylsulfoxide (40 mL) and the solution was heated to 90 °C 
for 18 hours. The reaction was quenched by the addition of aq. HCl (1 N, 50 
mL). The mixture was extracted with Et2O (3 x 50 mL). The combined organic 
layers were further washed with water (5 x 50 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 99:1] 
afforded 301i (500 mg, 28%) as a light brown solid. RF 0.55 [Petrol:EtOAc 
4:1]; m.p. 57–59 °C; δH (400 MHz, CDCl3) 16.6 (s, 1H, H4), 7.41-7.29 (m, 3H, 
H7 and H8), 7.19-7.15 (m, 2H, H6), 1.88 (s, 6H, H1); δC (100 MHz, CDCl3) 
190.6 (C2), 136.9 (C5), 131.1 (C6), 128.8 (C7), 127.4 (C8), 115.2 (C3), 24.1 
(C1); HRMS (ESI) Found: [M+H]+, 177.0906. C10H12O4 requires [M+H]+, 





















                            
 
According to a literature procedure,117 to a solution of acetylacetone (1.03 mL, 
10.0 mmol) in acetone (8 mL) was added solid potassium carbonate (1.38 g, 
10.0 mmol), followed by benzyl bromide (1.43 mL, 12.0 mmol). The mixture 
was heated to 65 °C for 18 hours. The solution was allowed to cool to room 
temperature and quenched with aq. HCl (1 N, 20 mL). The mixture was 
extracted with Et2O (3 x 25 mL) and the combined organic fractions were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:Et2O 19:1-9:1] afforded 301j (605 mg, 32%) 
as a colourless oil. RF 0.50 [Petrol:Et2O 4:1]; νmax (film)/cm−1 3062, 2948, 
2924, 1723 (C=O), 1697 (C=O), 1600, 1494; δH (400 MHz, CDCl3, 1:1 
enol:keto tautomer, keto tautomer annoted by an asterisk) 16.84 (s, 1H, H4), 
7.35-7.26 (m, 2H and 2H*, H8 and H16), 7.25-7.20 (m, 1H and 1H*, H9 and 
H17), 7.20-7.15 (m, 2H and 2H*, H7 and H15), 4.03 (t, J = 7.7 Hz, 1H*, H12), 
3.68 (s, 2H, H5), 3.17 (d, J = 7.6 Hz, 2H*, H13), 2.14 (s, 6H*, H10), 2.07 (s, 
6H, H1); δC (100 MHz, CDCl3, 1:1 enol:keto tautomer, keto tautomer annoted 
by an asterisk) 203.5 (C11*), 191.9 (C1), 139.6 (C6), 137.9 (C14*), 128.7 
(C16*), 128.6 (C8), 128.5 (C15*), 127.3 (C7), 126.7 (C17*), 126.2 (C9), 108.2 
(C3), 69.8 (C12*), 34.2 (C13*), 32.8 (C5), 29.7 (C10*), 23.2 (C1); HRMS (ESI) 





























                             
 
According to a literature procedure,117 to a stirred suspension of 1-phenyl-1,3-
butadione (1.62 g, 10.0 mmol) and potassium carbonate (3.04 g, 22.0 mmol) 
in acetone (40 mL) was added methyl iodide (623 μL, 10.0 mmol). The mixture 
was heated to reflux at 60 °C for 18 hours. After cooling to room temperature, 
the mixture was concentrated in vacuo to half the volume and quenched by 
addition of aq. HCl (1 N, 20 mL). The mixture was extracted with EtOAc (3 x 
20 mL). The combined organic phases were washed with water (30 mL), brine 
(30 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [Petrol:EtOAc 19:1] afforded 301k (1.00 g, 57%) as a yellow 
oil. RF 0.44 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2927, 1718 (C=O), 1675 (C=O), 
1597; δH (400 MHz, CDCl3) 7.99-7.94 (m, 2H, H7), 7.62-7.56 (m, 1H, H9), 
7.52-7.45 (m, 2H, H8), 4.48 (q, J = 7.4 Hz, 1H, H2), 2.15 (s, 3H, H4), 1.45 (dt, 
J = 7.0, 0.7 Hz, 3H, H5); δC (100 MHz, CDCl3) 205.0 (C3), 197.3 (C1), 135.9 
(C6), 133.7 (C9), 128.8 (C7), 128.6 (C8), 56.8 (C2), 27.8 (C4), 13.6 (C5); 
HRMS (ESI) Found: [M+H]+, 177.0905. C11H12O2 requires [M+H]+, 177.0910. 


















                            
According to a literature procedure,124 to a suspension of 1,3-diphenyl-1,3-
propanedione (1.12 g, 5.0 mmol) and potassium carbonate (1.03 g, 7.5 mmol) 
in dimethylformamide (5 mL) was added dropwise iodomethane (311 μL, 5 
mmol) dropwise. The reaction was stirred at 60 °C for 5 hours. The solution 
was allowed to cool to room temperature and quenched by the addition of 
water (50 mL). The mixture was extracted with EtOAc (4 x 50 mL). The 
combined organic phases were dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 19:1-9:1-5:1-3:1-1:1] afforded 
301l (281 mg, 24%) as a yellow solid. RF 0.55 [Petrol:EtOAc 5:1]; m.p. 71–73 
°C; νmax (film)/cm−1 2991, 2939, 1686 (C=O), 1664, 1593, 1578; δH (400 MHz, 
CDCl3) 7.87-7.84 (m, 4H, H5), 7.44 (td, J = 7.5, 1.5 Hz, 2H, H7), 7.36-7.30 (m, 
4H, H6), 5.20 (q, J = 7.1 Hz, 1H, H2), 1.49 (d, J = 6.9 Hz, 3H, H3); δC (100 
MHz, CDCl3) 197.1 (C1), 135.6 (C4), 133.4 (C7), 128.9 (C6), 128.4 (C5), 50.8 
(C2), 14.3 (C3); HRMS (ESI) Found: [M+Na]+, 239.1049. C14H16O2 requires 
[M+Na]+, 239.1043. Data matches literature values.124 



















Ethyl 4-oxochroman-3-carboxylate (301m): 
 
                    
 
According to a literature procedure,125 to a solution of 4-chromanone (1 g, 6.80 
mmol) in tetrahydrofuran (20 mL) cooled to −78 °C was added a solution of 
lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 7.4 mL, 7.40 mmol) 
dropwise and the mixture was stirred at −78 °C for 30 minutes. Ethyl 
cyanoformate (0.8 mL, 8.0 mmol) in tetrahydrofuran (6 mL) was added 
dropwise and the reaction was stirred at −78 °C for 1 hour. The mixture was 
allowed to warm to room temperature and was quenched by the addition of 
aq. NH4Cl (25 mL) and H2O (25 mL). The mixture was extracted with Et2O (3 x 
25 mL). The combined organic phases were washed with brine (30 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 19:1] afforded 301m (478 mg, 32%) as a white solid. RF 0.76 
[Petrol:EtOAc 5:1]; m.p 51–53 °C; νmax (film)/cm−1 2983, 2935, 1723 (C=O), 
1679 (C=O), 1604, 1578, 1468; δH (400 MHz, CDCl3, 2.1:1 keto:enol 
tautomer, enol tautomer annotated by an asterisk) 11.97 (s, 1H*, H22), 7.82 
(dd, J = 7.8, 1.5, 0.7 Hz, 1H, H6), 7.56 (dd, J = 7.9, 1.9 Hz, 1H*, H15), 7.39 
(ddd, J = 7.3, 1.8, 0.6 Hz, 1H, H1), 7.21 (ddd, J = 7.6, 1.8, 0.9 Hz, 1H*, H13), 
6.98-6.92 (m, 1H, H2), 6.91-6.85 (m, 1H and 1H*, H3 and H14), 6.77 (dd, J = 
8.2, 0.9 Hz, 1H*, H18), 4.86 (s, 2H*, H19), 4.69 (dd, J = 11.6, 8.5 Hz, 1H, 
H7a), 4.54 (dd, J = 11.6, 4.8 Hz, 1H, H7b) 4.22-4.11 (m, 2H and 2H*, H11 and 































J = 6.6 Hz, 3H*, H25); δC (100 MHz, CDCl3, 2.1:1 keto:enol tautomer, enol 
tautomer shown by an asterisk) 186.7 (C9), 169.4 (C23*), 166.9 (C10), 162.3 
(C16*), 161.0 (C4), 157.3 (C21*), 136.0 (C3), 132.7 (C15*), 127.2 (C6), 124.1 
(C13*), 121.4 (C2), 121.1 (C14*), 120.2 (C5), 117.9 (C17*), 117.5 (C1), 116.1 
(C18*), 91.6 (C20*), 67.9 (C7), 63.4 (C19*), 61.4 (C11), 60.4 (C24*), 52.2 
(C8), 13.9 (C12*), 13.7 (C25); HRMS (ESI) Found: [M+H]+, 221.0798. 
C12H12O4 requires [M+H]+, 221.0808. Synthesis of this compound has been 




                              
 
According to a literature procedure,117 to a stirred solution of γ-butyrolactone 
(384 μL, 5 mmol, 1.0 eq) in tetrahydrofuran (10 mL) cooled to −78 °C was 
added a solution of lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 
10.5 mL, 10.5 mmol, 2.1 eq) dropwise. The mixture was stirred at this 
temperature for 15 minutes. Acetic anhydride (471 μL, 5 mmol, 1.0 eq.) was 
added dropwise and the mixture was stirred at −78 °C for a further 1 hour. The 
reaction was quenched by addition of aq. HCl (1 N, 10 mL). The mixture was 
allowed to warm to room temperature and extracted with EtOAc (3 x 15 mL). 
The combined organic phases were washed with brine (30 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography 










[Petrol:EtOAc 3:1]; δH (400 MHz, CDCl3, 10:1 keto:enol tautomer, resonances 
due to keto tautomer quoted) 4.39-4.22 (m, 2H, H1), 3.69-3.60 (m, 1H, H3), 
2.74-2.62 (m, 1H, H2a), 2.39-2.35 (m, 3H, H6), 2.31-2.19 (m, 1H, H2b); δC 
(100 MHz, CDCl3) 200.0 (C5), 172.9 (C4), 67.2 (C1), 52.8 (C3), 29.5 (C6), 




                     
 
According to a literature procedure,117 to a stirred solution of N-Boc-2-
piperidone (995 mg, 5.0 mmol) in tetrahydrofuran (10 mL) cooled to −78 °C 
was added a solution of lithium bis(trimethylsilyl)amide (1 M in 
tetrahydrofuran, 10.5 mL, 10.5 mmol) dropwise. The mixture was stirred at this 
temperature for 15 minutes. Acetic anhydride (471 μL, 5.0 mmol) was added 
dropwise and the mixture was stirred at −78 °C for a further 1 hour. The 
reaction was quenched by addition of aq. NH4Cl (10 mL). The mixture was 
allowed to warm to room temperature and extracted with EtOAc (3 x 15 mL). 
The combined organic phases were washed with brine (30 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 19:1] afforded 301r (199 mg, 16%) as a yellow oil. RF 0.36 
[Petrol:EtOAc 1:1]; νmax (film)/cm−1 2978, 2931, 1716 (C=O), 1619; δH (400 
MHz, CDCl3, 1.9:1 enol:keto tautomer, keto tautomer annotated by an 


































= 6.7 Hz, 1H*, H15), 2.33 (t, J = 7.1 Hz, 2H, H3), 2.32 (s, 3H*, H18), 1.98 (s, 
3H, H8), 1.93-1.72 (m, 2H and 4H*, H2, H13 and H14), 1.51 (s, 9H, H11), 1.50 
(s, 9H*, H21); δC (100 MHz, CDCl3, 1.92:1 enol:keto tautomer annoted by an 
asterisk) 204.0 (C17*), 175.2 (C6), 171.8 (C5), 168.4 (C16*), 152.3 (C19*), 
152.1 (C9), 97.2 (C4), 83.3 (C20*), 82.8 (C10), 57.8 (C15*), 46.1 (C1), 45.9 
(C12*), 29.8 (C18*), 28.0 (C11), 27.9 (C21*), 23.8 (C3), 22.6 (C14*), 22.4 
(C2), 20.9 (C13*), 19.5 (C8); HRMS (ESI) Found: [M+H]+, 242.1391. 




                                
 
According to a literature procedure,126 to a solution of methane 
sulfonylacetone (1.0 g, 7.85 mmol) in acetone (30 mL) was added potassium 
carbonate (1.0 g, 7.85 mmol). Methyl iodide (458 μL, 7.85 mmol) was added 
dropwise and the mixture was stirred at room temperature for 2 hours. The 
reaction was quenched by addition of aq. HCl (1 N, 20 mL) and the mixture 
was extracted with EtOAc (3 x 20 mL). The combined organic phases were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 2:1] afforded 301s (268 mg, 23%) as a 
colourless oil. RF 0.20 [Petrol:EtOAc 1:1]; νmax (film)/cm−1 2935, 1716 (C=O), 
1295 (S=O); δH (400 MHz, CDCl3) 3.99 (q, J = 7.5 Hz, 1H, H3), 2.85 (d, J = 








CDCl3) 201.7 (C2), 69.1 (C3), 37.2 (C4), 30.8 (C1), 11.5 (C5). Synthesis of 
this compound has been reported in the literature.126 
 
1-tert-Butyl 3-methyl 2-oxopiperidine-1,3-dicarboxylate (301t): 
 
 
According to a literature procedure,127 to a solution of 1-Boc-2-piperidone (997 
mg, 5 mmol) in tetrahydrofuran (15 mL) cooled to −78 °C was added lithium 
bis(trimethylsilyl)amide (1 M in tetrahydrofuran solution, 6.5 mL, 6.5 mmol) 
and the reaction mixture was stirred at −78 °C for 1 hour. Methyl 
chloroformate (386 µL, 5 mmol) was added dropwise and the reaction mixture 
was stirred at −78 °C for 2 hours. The solution was allowed to warm to room 
temperature, poured into saturated aq. NH4Cl (15 mL) and extracted with 
EtOAc (3 x 15 mL). The combined extracts were dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 301t (980 mg, 76%) as a clear oil. RF 0.22 [Petrol:EtOAc 4:1]; δH 
(400 MHz, CDCl3) 3.77 (s, 3H, H10), 3.71-3.69 (m, 2H, H4), 3.52 (dd, J = 8.9, 
6.8 Hz, 1H, H7), 2.24-2.14 (m, 1H, H5a), 2.13-2.05 (m, 1H, H5b), 2.02-1.93 
(m, 1H, H6a), 1.87-1.77 (m, 1H, H6b), 1.52 (s, 9H, H1); δC (100 MHz, CDCl3) 
170.4 (C9), 167.3 (C8), 152.6 (C3), 83.5 (C2), 52.6 (C10), 51.3 (C7), 45.8 
(C4), 28.0 (C1), 24.2 (C5), 21.0 (C6); HRMS (ESI) Found: [M+Na]+, 280.1160. 
C12H19NO5 requires [M+Na]+, 280.1155. Synthesis of this compound has been 
























To a solution of δ-valerolactam (3.5 g, 35 mmol) in tetrahydrofuran (30 mL) 
and dimethylformamide (20 mL) at −50 °C was added sodium hydride (60 wt% 
in mineral oil, 1.55 g, 38.9 mmol) and the reaction was stirred at −50 °C for 45 
minutes. Benzyl chloroformate (5.50 mL, 36.3 mmol) was added dropwise and 
the reaction mixture was stirred at −50 °C for 6 hours, then at room 
temperature for 16 hours. The reaction was quenched by the addition of aq. 
NaHCO3 (30 mL) and the mixture was extracted with EtOAc (3 x 30 mL). The 
combined organic layers were washed with brine (30 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1-2:1] 
afforded 349 (2.0 g, 25%) as a pale yellow oil. RF 0.30 [Petrol:EtOAc 2:1]; δH 
(400 MHz, CDCl3)	   7.46-7.41 (m, 2H, H9), 7.39-7.29 (m, 3H, H10 and H11), 
5.28 (s, 2H, H7), 3.79-3.70 (m, 2H, H1), 2.59-2.48 (m, 1H, H4), 1.88-1.80 (m, 
4H, H2 and H3); δC (400 MHz, CDCl3) 171.2 (C5), 154.2 (C6), 135.4 (C8), 
128.6 (C10), 128.3 (C11), 128.1 (C9), 68.5 (C7), 46.6 (C1), 34.9 (C4), 22.7 
(C2), 20.4 (C3);	   HRMS (ESI) Found: [M+H]+, 234.1118. C13H15NO3 requires 
























To a solution of 349 (1.5 g, 6.9 mmol) in tetrahydrofuran (15 mL) cooled to 
−78 °C was added lithium bis(trimethylsilyl)amide  (1M in tetrahydofuran, 14.5 
mL, 14.5 mmol) and the reaction was stirred at −78 °C for 15 minutes. Acetic 
anhydride (0.650 mL, 6.9 mmol) was added dropwise and the reaction mixture 
was stirred at −78 °C for 2 hours. The reaction was quenched by the addition 
of NH4Cl (20 mL) and then allowed to warm to room temperature. The mixture 
was extracted with EtOAc (3 x 30 mL). The combined organic layers were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1] afforded 301u (500 mg, 27%) as a 
white solid. RF 0.50 [Petrol:EtOAc 2:1]; m.p. 37–39 °C; νmax (film)/cm−1 2931, 
1768, 1707 (C=O), 1679; δH (400 MHz, CDCl3)	  14.77 (s, 1H, H14), 7.46-7.40 
(m, 2H, H9), 7.40-7.30 (m, 3H, H10 and H11), 5.30-5.28 (m, 2H, H7), 3.73 (t, J 
= 5.8 Hz, 2H, H1), 2.40-2.34 (m, 2H, H3), 2.01 (s, 3H, H13), 1.90-1.81 (m, 2H, 
H2); δC (100 MHz, CDCl3) 176.1 (C12), 171.6 (C5), 153.7 (C6), 135.5 (C8), 
128.6 (C10), 128.3 (C11), 128.1 (C9), 97.3 (C4), 68.5 (C7), 46.3 (C1), 23.7 
(C3), 22.4 (C2), 19.6 (C13); HRMS (ESI) Found: [M+H]+, 276.1219. 
C15H17NO4 requires [M+H]+, 276.1230. 




















10.2.2 Synthesis of Propargyl Carbonates, Esters and Carbamates 
 
Methyl prop-2-ynyl carbonate (150): 
 
                             
According to a literature procedure,129 a solution of propargyl alcohol (1 mL, 
17 mmol) and pyridine (2.8 mL, 34 mmol) in diethyl ether (17 mL) was cooled 
to 0 °C. Methyl chloroformate (1.3 mL, 17 mmol) was added dropwise over 10 
min. The mixture was stirred at room temperature for 15 hours, then quenched 
with aq. HCl (1 N, 20 mL) and extracted with Et2O (3 x 20 mL). The organic 
phases were combined and washed with brine (30 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 3:1] 
afforded 150 (300 mg, 15%) as a clear oil. δH (400 MHz, CDCl3) 4.73 (d, J = 
2.5 Hz, 2H, H3), 3.82 (s, 3H, H1), 2.52 (t, J = 2.4 Hz, 1H, H5). Synthesis of 
this compound has been reported in the literature.129 
 
3-Methyl-4-oxopent-2-en-2-yl prop-2-ynyl carbonate (300a) and prop-2-
ynyl 2-acetyl-2-methyl-3-oxobutanoate (300b): 
 
 
                
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 76 mg, 1.90 mmol) in tetrahydrofuran (10 mL) was cooled 






























tetrahydrofuran (5 mL) was added dropwise and the mixture was stirred at 0 
°C for 10 minutes. Propargyl chloroformate (187 μL, 1.90 mmol) was added 
dropwise and the mixture was allowed to warm to room temperature and was 
stirred at room temperature for 1 hour. The reaction was quenched with aq. 
HCl (1 N, 50 mL) and extracted with EtOAc (3 x 30 mL). The combined 
organic fractions were washed with brine (30 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1] 
afforded an inseparable 5.3:1 mixture of carbonate 300a and ester 300b (250 
mg, 74%) as a clear oil. RF 0.21 [Petrol:EtOAc 4:1]; νmax (film)/cm–1 3281, 
2973, 2148 (C≡C), 1757 (C=O), 1653 (C=O), 1555; δH (400 MHz, CDCl3, 
resonances due to 310b annotated by an asterisk) 4.80 (s, 2H*, H16), 4.79 (d, 
J = 2.5 Hz, 2H, H8), 2.56 (t, J = 2.4 Hz, 1H, H10), 2.52 (t, J = 2.6 Hz, 1H*, 
H18), 2.30 (s, 3H, H1), 2.26 (s, 6H*, H11), 2.08 (d, J = 0.8 Hz, 3H, H6), 1.83 
(d, J = 1.0 Hz, 3H, H5), 1.61 (s, 3H*, H14); δC (100 MHz, CDCl3 5:1 
carbonate/ester, resonances due to 310b annotated by an asterisk) 201.5 
(C12*), 199.1 (C2), 168.2 (C15*), 151.7 (C7), 150.5 (C4), 125.0 (C3), 76.3 
(C9), 76.2 (C10), 75.8 (C18*), 75.3 (C17*), 72.7 (C13*), 56.0 (C8), 53.2 
(C16*), 30.9 (C1), 27.6 (C11*), 17.9 (C6), 17.3 (C14*), 14.0 (C5); HRMS (ESI) 







2-Acetylcyclohex-1-enyl prop-2-ynyl carbonate (266): 
 
                             
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 440 mg, 11.0 mmol) int tetrahydrofuran (60 mL) was cooled 
to 0 °C. A solution of 2-acetylcyclohexanone (1.32 mL, 10.0 mmol) in 
tetrahydrofuran (5 mL) was added dropwise and the mixture was stirred at 0 
°C for 10 minutes. Propargyl chloroformate (1.07 mL, 11.0 mmol) was added 
dropwise and the mixture was allowed to warm to room temperature and was 
stirred at room temperature for 1 hour. The reaction was quenched with aq. 
HCl (1 N, 30 mL) and extracted with EtOAc (3 x 30 mL). The combined 
organic fractions were washed with brine (30 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1] 
afforded 266 (1.96 g, 86%) as a clear oil. RF 0.46 [Petrol:EtOAc 4:1]; vmax 
(film)/cm–1 3283, 2940, 2864, 2128 (C≡C), 1757 (C=O), 1695 (C=O), 1649; δH 
(400 MHz, CDCl3) 4.80 (d, J = 2.4 Hz, 2H, H10), 2.56 (t, J = 2.4 Hz, 1H, H12), 
2.40-2.33 (m, 4H, H2 and H5), 2.30 (s, 3H, H8), 1.79-1.70 (m, 2H, H3), 1.68-
1.58 (m, 2H, H4); δC (100 MHz, CDCl3) 198.2 (C7), 154.2 (C1), 151.6 (C9), 
126.3 (C6), 76.4 (C11), 76.2 (C12), 56.0 (C10), 30.8 (C8), 28.2 (C2), 24.8 
(C5), 22.2 (C3), 21.5 (C4); HRMS (ESI) Found: [M+H]+, 223.0964. C12H14O4 



















2-Acetyl-3,4-dihydronaphthalen-1-yl prop-2-ynyl carbonate (303ba) and 




              
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 220 mg, 5.50 mmol) in tetrahydrofuran (40 mL) was cooled 
to 0 °C. A solution of 2-acetyltetralone (940 mg, 5.0 mmol) in tetrahydrofuran 
(2 mL) was added dropwise and the mixture was stirred at 0 °C for 10 
minutes. Propargyl chloroformate (540 μL, 5.50 mmol) was added dropwise 
and the mixture was allowed to warm to room temperature and was stirred at 
room temperature for 1 hour.  The reaction was quenched by the addition of 
aq. HCl (1 N, 25 mL) and the mixture was extracted with EtOAc (3 x 25 mL). 
The combined organic phases were washed with brine (50 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 9:1-4:1] afforded an inseparable 7.7:1 mixture of carbonate 
303ba and ester 303bb (1.18 g, 87%) as a pale solid. RF 0.27 [Petrol:EtOAc 
4:1]; m.p. 53–55 °C; vmax (film) cm−1 3278, 2940, 2840, 2569, 2137 (C≡C), 
1755 (C=O), 1654, 1617, 1569; δH (400 MHz, CDCl3, resonances due to 
303bb annotated by an asterisk) 8.08 (dd, J = 7.9, 1.3 Hz, 1H*, H23), 7.52 (td, 
J = 7.6, 1.5 Hz, 1H*, H26), 7.39 (d, J = 7.8 Hz, 1H, H7), 7.37-7.20 (m, 3H and 







































2.6 Hz, 2H*, H30), 2.99 (t, J = 6.4 Hz, 2H*, H19), 2.89 (t, J = 6.8 Hz, 2H, H3), 
2.76-2.69 (m, 2H and 2H*, H2 and H18), 2.62 (t, J = 2.5 Hz, 1H, H16), 2.51 (t, 
J = 2.5 Hz, 1H*, H32), 2.45 (s, 3H, H12), 2.37 (s, 3H*, H28); δC (100 MHz, 
CDCl3, resonances due to 303bb annotated by an asterisk) 200.3 (C27*), 
197.2 (C11), 191.5 (C22*), 167.7 (C29*), 151.7 (C13), 149.9 (C6), 142.8 
(C21*), 138.6 (C5), 134.2 (C26*), 131.3 (C20*), 130.4 (C8), 129.5 (C4), 128.8 
(C25*), 128.0 (C23*), 127.6 (C10), 127.0 (C24*), 126.8 (C9), 124.9 (C1), 
123.1 (C7), 77.3 (C31*), 76.4 (C16), 76.2 (C15), 75.7 (C32*), 71.4 (C17*), 
56.3 (C14), 53.2 (C30*), 30.5 (C12), 28.9 (C18*), 28.6 (C28*), 27.1 (C3), 25.5 
(C19*), 23.4 (C2); HRMS (ESI) Found: [M+H]+, 271.0961. C16H14O4 requires 
[M+H]+, 271.0965. Synthesis of this compound has been reported in the 
literature.117 
 
 2-iso-Butyrylcyclohex-1-enyl prop-2-ynyl carbonate (303c): 
 
                         
 
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 110 mg, 2.75 mmol) in tetrahydrofuran (20 mL) was cooled 
to 0 °C. A solution of 2-isobutyrylcyclohexanone (410 μL, 2.5 mmol) in 
tetrahydrofuran (4 mL) was added dropwise and the mixture was stirred at 0 
°C for 15 minutes. Propargyl chloroformate (268 μL, 2.75 mmol) was added 




















stirred at room temperature for 1 hour. The reaction was quenched by the 
addition of aq. HCl (1 N, 25 mL) and the mixture was extracted with EtOAc (3 
x 25 mL). The combined organic phases were washed with brine (30 mL), 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 49:1-19:1] afforded carbonate 303c (384 mg, 61%) as a clear 
oil. RF 0.56 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3242, 2939, 2868, 2122 (C≡C), 
1757 (C=O), 1638; δH (400 MHz, CDCl3) 4.66 (d, J = 2.6 Hz, 2H, H11), 2.83 
(sept, J = 6.8 Hz, 1H, H8), 2.51 (t, J = 2.5 Hz, 1H, H13), 2.26-2.20 (m, 4H, H2 
and H5), 1.68-1.51 (m, 4H, H3 and H4), 0.94 (d, J = 6.8 Hz, 6H, H9); δC (100 
MHz, CDCl3) 206.0 (C7), 151.4 (C10), 150.3 (C1), 125.7 (C6), 76.3 (C13), 
75.9 (C12), 55.5 (C11), 38.8 (C8), 27.3 (C2), 25.4 (C5), 21.9 (C4), 21.3 (C3), 
17.9 (C9); HRMS (ESI) Found: [M+H]+, 251.1273. C14H18O4 requires [M+H]+, 
251.1278. Data matches literature values.117 
 
 3-Oxo-2-phenylcyclopent-1-enyl prop-2-ynyl carbonate (303d): 
 
                          
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 132 mg, 3.30 mmol) in tetrahydrofuran (20 mL) was cooled 
to 0 °C. A solution of 2-phenyl-1,3-indandione (666 mg, 3.0 mmol) in 
tetrahydrofuran (5 mL) was added dropwise and the mixture was stirred at 0 
°C for 10 minutes. Propargyl chloroformate (323 μL, 3.30 mmol) was added 
























stirred at room temperature for 1 hour. The reaction was quenched with aq. 
HCl (1 N, 50 mL) and extracted with with EtOAc (3 x 50 mL). The combined 
organic fractions were washed with brine (50 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1] 
afforded 303d (784 mg, 86%) as a bright orange solid. RF 0.28 [Petrol:EtOAc 
4:1]; m.p. 90–92 °C; νmax (film)/cm−1 3244, 2134 (C≡C), 1764 (C=O), 1716 
(C=O); δH (400 MHz, CDCl3) 7.60-7.52 (m, 2H, H3), 7.41 (d, J = 7.2 Hz, 1H, 
H8), 7.34-7.12 (m, 5H, H1, H2, H9 and H10), 6.97 (d, J = 1.0 Hz, 1H, H11), 
4.68 (d, J = 2.5 Hz, 2H, H15), 2.50 (t, J = 2.5 Hz, 1H, H17); δC (100 MHz, 
CDCl3) 192.7 (C6), 162.8 (C13), 149.7 (C14), 138.7 (C7), 133.4 (C9), 130.0 
(C12), 129.7 (C10), 128.6 (C3), 128.4 (C2), 128.4 (C4), 128.4 (C1), 122.6 
(C8), 121.2 (C5), 119.0 (C11), 76.9 (C16), 75.7 (C17), 56.8 (C15). Data 
matches literature values.117 	  
2-Methyl-3-oxocyclohex-1-enyl prop-2-ynyl carbonate (303e): 
 
                               
 
According to a literature procedure,117 to a suspension of 2-methyl-1,3-
cyclohexadione (0.38 g, 3.0 mmol) in acetone (5 mL) was added potassium 
carbonate (0.83 g, 6.0 mmol). The mixture was cooled to 0 °C and stirred at 
this temperature for 15 minutes. Propargyl chloroformate (320 μL, 3.3 mmol) 
was added dropwise, the ice bath was removed and the mixture was stirred at 
















aq. HCl (1 N, 40 mL) and the mixture was extracted with EtOAc (3 x 40 mL). 
The combined organic phases were washed with aq. HCl (1 N, 2 x 50 mL), 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 19:1] afforded 303e (487 mg, 78%) as a yellow solid. RF 0.70 
[Petrol:EtOAc 4:1]; m.p. 43–45 °C; δH (400 MHz, CDCl3) 4.69 (d, J = 2.5 Hz, 
2H, H9), 2.56 (t, J = 2.8 Hz, 1H, H11), 2.52-2.46 (m, 2H, H3), 2.32 (t, J = 6.4 
Hz, 2H, H1), 1.97-1.87 (m, 2H, H2), 1.57 (t, J = 1.8 Hz, 3H, H7); δC (100 MHz, 
CDCl3) 198.7 (C6), 163.1 (C4), 150.1 (C8), 124.6 (C5), 76.3 (C11), 76.0 
(C10), 56.0 (C9), 36.5 (C1), 27.9 (C3), 20.5 (C2), 8.0 (C7); HRMS (ESI) 
Found: [M+H]+, 209.0817. C11H12O4 requires [M+H]+, 209.0808. Data matches 
literature values.117 
 
2-Methyl-3-oxo-1-phenylbut-1-enyl prop-2-ynyl carbonate (303fa) and 3-
methyl-4-oxo-4-phenylbut-2-en-2-yl prop-2-ynyl carbonate (303fb): 
 
 
             
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 240 mg, 6.0 mmol) in tetrahydrofuran (40 mL) was cooled 
to 0 °C. A solution of diketone 301k (880 mg, 5.0 mmol) in tetrahydrofuran (3 
mL) was added dropwise and the mixture was stirred at 0 °C for 10 minutes. 
Propargyl chloroformate (590 μL, 6.0 mmol) was added dropwise and the 




















temperature for 1 hour. The reaction was quenched by the addition of aq. HCl 
(1 N, 20 mL) and the mixture was extracted with EtOAc (3 x 25 mL). The 
combined organic phases were washed with brine (50 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 19:1-
15:1] afforded an inseparable 4.9:1 mixture of carbonates 303fa and 303fb 
(1.17 g, 90%) as a clear solid. RF 0.20 [Petrol:EtOAc 9:1]; m.p. 54–56 °C; νmax 
(film)/cm−1 3255, 2126 (C≡C), 1759 (C=O), 1690 (C=O), 1595; δH (400 MHz, 
CDCl3, resonances due to 303fa quoted) 7.85-7.80 (m, 2H, H7), 7.55 (tt, J = 
7.3, 2.0 Hz, 1H, H9), 7.47-7.38 (m, 2H, H8), 4.48 (d, J = 2.5 Hz, 2H, H11), 
2.43 (t, J = 2.4 Hz, 1H, H13), 2.12 (q, J = 1.2 Hz, 3H, H1), 1.96 (q, J = 1.3 Hz, 
3H, H4); δC (100 MHz, CDCl3, resonances due to 303fa quoted) 196.9 (C2), 
151.6 (C10), 145.6 (C5), 136.8 (C6), 133.1 (C9), 128.8 (C7), 128.5 (C8), 
123.9 (C3), 76.3 (C12), 75.9 (C13), 55.5 (C11), 16.1 (C1), 15.2 (C4); HRMS 
(ESI) Found: [M+H]+, 259.0955. C15H14O4 requires [M+H]+, 259.0965. 
Synthesis of this compound has been reported in the literature.117 
 
3-Acetylhexa-2,5-dien-2-yl prop-2-ynyl carbonate (303g): 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   
 
 
A suspension of sodium hydride (60 wt% in mineral oil, 48.4 mg, 1.21 mmol) 
in tetrahydrofuran (7 mL) was cooled to 0 °C. A solution of diketone 301e (154 
















mixture was stirred at 0 °C for 15 minutes. Propargyl chloroformate (118 μL, 
1.21 mmol) was added dropwise and the mixture was allowed to warm to 
room temperature and was stirred at room temperature for 1 hour. The 
reaction was quenched by the addition of aq. HCl (1 N, 10 mL) and the 
mixture was extracted with EtOAc (3 x 15 mL). The combined organic phases 
were washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 99:1] afforded 303g (100 mg, 
41%) as a light green oil. RF 0.64 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3285, 
2926, 2130 (C≡C), 1757 (C=O), 1649; δH (400 MHz, CDCl3) 5.81-5.70 (m, 1H, 
H2), 5.09-5.01 (m, 2H, H1), 4.79 (d, J = 2.3 Hz, 2H, H10), 3.01 (d, J = 5.9 Hz, 
2H, H3), 2.57 (t, J = 2.6 Hz, 1H, H12), 2.29 (s, 3H, H8), 2.08 (s, 3H, H5); δC 
(100 MHz, CDCl3) 198.5 (C7), 152.1 (C6), 151.6 (C9), 133.8 (C2), 127.0 (C4), 
115.9 (C1), 76.3 (C12), 75.8 (C11), 56.0 (C10), 32.0 (C3), 31.0 (C8), 17.7 











Ethyl-3-acetyl-4-((prop-2-ynyloxy)carbonyloxy)pent-3-enoate (303ha) and 
4-ethyl 1-prop-2-ynyl 2,2-diacetylsuccinate  (303hb): 
 
                                                
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 130 mg, 3.26 mmol) in tetrahydrofuran (50 mL) was cooled 
to 0 °C. A solution of 301g (550 mg, 2.96 mmol) in tetrahydrofuran (10 mL) 
was added dropwise and the mixture was stirred at 0 °C for 10 minutes. 
Propargyl chloroformate (320 μL, 3.26 mmol) was added dropwise and the 
mixture was allowed to warm to room temperature and was stirred at room 
temperature for 1 hour. The reaction was quenched by the addition of aq. HCl 
(1 N, 20 mL) and the mixture was extracted with EtOAc (3 x 20 mL). The 
combined organic phases were washed with brine (30 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-3:1] 
afforded an inseparable 4.3:1 mixture of carbonate 303ha and ester 303hb 
(681 mg, 86%) as a grey oil. RF 0.77 [Petrol:EtOAc 1:1]; δH (400 MHz, CDCl3, 
resonances due to 303ha quoted CDCl3) 4.78 (d, J = 2.5 Hz, 2H, H11), 4.09 
(q, J = 7.2 Hz, 2H, H2), 3.29 (s, 2H, H4), 2.57 (t, J = 2.7 Hz, 1H, H13), 2.35 (s, 
3H, H9), 2.11 (s, 3H, H5), 1.21 (t, J = 7.4 Hz, 3H, H1); δC (100 MHz, CDCl3, 
resonances due to 303ha quoted) 197.8 (C8), 170.1 (C3), 153.8 (C6), 151.2 
(C10), 124.0 (C7), 76.5 (C13), 76.1 (C12), 61.0 (C2), 56.1 (C11), 34.0 (C4), 
31.1 (C9), 18.2 (C5), 14.1 (C1); HRMS (ESI) Found: [M+H]+, 269.1013. 
C13H16O6 requires [M+H]+, 269.1020. Data matches literature values.117 





















3-Benzyl-4-oxopent-2-en-2-yl prop-2-ynyl carbonate (303i): 
 
                 
 
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% mineral oil, 116 mg, 2.90 mmol) in tetrahydrofuran (20 mL) was cooled to 
0 °C. A solution of 301j (500 mg, 2.64 mmol) in tetrahydrofuran (5 mL) was 
added dropwise and the mixture was stirred at 0 °C for 10 minutes. Propargyl 
chloroformate (282 μL, 2.90 mmol) was added dropwise and the mixture was 
allowed to warm to room temperature and was stirred at room temperature for 
1.5 hours. The reaction was quenched by the addition of aq. HCl (1 N, 30 mL) 
and the mixture was extracted with EtOAc (3 x 25 mL). The combined organic 
phases were washed with brine (30 mL), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 9:1] afforded 303i (401 
mg, 50%) as a clear oil. RF 0.21 [Petrol:EtOAc 4:1]; δH (400 MHz, CDCl3) 
7.34-7.28 (m, 2H, H2), 7.25-7.19 (m, 3H, H1 and H3), 4.85 (d, J = 2.5 Hz, 2H, 
H12), 3.70 (s, 2H, H5), 2.61 (t, J = 2.4 Hz, 1H, H14), 2.28 (s, 3H, H10), 2.18 
(s, 3H, H6); δC (100 MHz, CDCl3) 198.9 (C9), 152.0 (C7), 151.7 (C11), 138.0 
(C4), 128.6 (C2), 128.5 (C8), 128.0 (C3), 126.4 (C1), 77.2 (C13), 76.3 (C14), 
56.1 (C12), 33.8 (C5), 31.3 (C10), 18.0 (C6); HRMS (ESI) Found: [M+H]+, 


















 4-Oxo-3-phenylpent-2-en-2-yl prop-2-ynyl carbonate (303j): 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
 
A suspension of sodium hydride (60 wt% in mineral oil, 74.8 mg, 1.87 mmol) 
in tetrahydrofuran (15 mL) was cooled to 0 °C. A solution of 301i (300 mg, 
1.70 mmol) in tetrahydrofuran (5 mL) was added dropwise and the mixture 
was stirred at 0 °C for 10 minutes. Propargyl chloroformate (182 μL, 1.87 
mmol) was added dropwise and the mixture was allowed to warm to room 
temperature and was stirred at room temperature for 1.5 hours. The reaction 
was quenched by the addition of aq. HCl (1 N, 10 mL) and the mixture was 
extracted with EtOAc (3 x 25 mL). The combined organic phases were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 4:1] afforded 303j (279 mg, 57%) as a 
green solid. RF 0.16 [Petrol:EtOAc 2:1]; m.p. 46–48 °C; νmax (film)/cm−1 3270, 
2989, 2126 (C≡C), 1763 (C=O), 1686 (C=O), 1612; δH (400 MHz, CDCl3) 
7.41-7.30 (m, 4H, H2 and H3), 7.25-7.21 (m, 2H, H1), 4.81 (d, J = 2.8 Hz, 2H, 
H11), 2.58 (t, J = 2.1 Hz, 1H, H13), 2.11 (s, 3H, H9), 1.91 (s, 3H, H5); δC (100 
MHz, CDCl3) 198.2 (C8), 151.1 (C10), 150.7 (C6), 134.8 (C4), 131.1 (C7), 
129.3 (C3), 128.8 (C2), 128.0 (C1), 76.4 (C12), 76.1 (C13), 55.9 (C11), 30.6 



















4-oxopent-2-en-2-yl prop-2-ynyl carbonate (303k): 
 
 
                           
A suspension of sodium hydride (60 wt% in mineral oil, 98.0 mg, 2.45 mmol) 
in tetrahydrofuran (30 mL) was cooled to 0 °C. A solution of acetylacetone 
(222 μL, 2.22 mmol) in tetrahydrofuran (5 mL) was added dropwise and the 
mixture was stirred at 0 °C for 10 minutes. Propargyl chloroformate (239 μL, 
2.45 mmol) was added dropwise and the mixture was allowed to warm to 
room temperature and was stirred at room temperature for 1 hour. The 
reaction was quenched by the addition of aq. HCl (1 N, 15 mL) and the 
mixture was extracted with EtOAc (3 x 15 mL). The combined organic phases 
were washed with brine (20 mL), dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 1:1] afforded 303k (334 mg, 
84%) as a clear oil. RF 0.23 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3278, 2130 
(C≡C), 1761, 1701 (C=O), 1668 (C=O), 1630; δH (400 MHz, CDCl3) 5.73 (s, 
1H, H3), 4.67 (d, J = 2.5 Hz, 2H, H7), 2.54 (t, J = 2.5 Hz, 1H, H9), 2.05 (s, 3H, 
H5), 1.92 (s, 3H, H1); δC (100 MHz, CDCl3) 194.8 (C4), 156.4 (C2), 150.2 
(C6), 115.9 (C3), 76.2 (C9), 76.2 (C8), 55.7 (C7), 30.6 (C5), 20.5 (C1); HRMS 













1-(2-Oxocyclopentylidene) ethyl prop-2-ynyl carbonate (303m): 
 
                          
 
 
A suspension of sodium hydride (60 wt% in mineral oil, 660 mg, 16.50 mmol) 
in tetrahydrofuran (40 mL) was cooled to 0 °C. A solution of 2-
acetylcyclopentanone (2.20 mL, 15.0 mmol) in tetrahydrofuran (2 mL) was 
added dropwise and the mixture was stirred at 0 °C for 10 minutes. Propargyl 
chloroformate (1.61 mL, 16.50 mmol) was added dropwise and the mixture 
was allowed to warm to room temperature and was stirred for 1 hour. The 
reaction was quenched by the addition of aq. HCl (1 N, 30 mL) and the 
mixture was extracted with EtOAc (3 x 30 mL). The combined organic phases 
were washed with brine (40 mL), dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1] afforded 303m (2.61 g, 
73%) as a pale solid. RF 0.30 [Petrol:EtOAc 4:1]; m.p. 37–39 °C; νmax 
(film)/cm−1 3255, 2983, 2133 (C≡C), 1766 (C=O), 1697 (C=O), 1653; δH (400 
MHz, CDCl3) 4.78 (d, J = 2.4 Hz, 2H, H10), 4.15 (q, J = 7.2 Hz, 2H, H7), 2.68-
2.60 (m, 4H, H2 and H4), 2.55 (t, J = 2.5 Hz, 1H, H12), 1.94 (quint, J = 7.7 Hz, 
2H, H3), 1.24 (t, J = 6.9 Hz, 3H, H8); δC (100 MHz, CDCl3) 163.3 (C6), 158.1 
(C1), 150.8 (C9), 118.8 (C5), 76.3 (C12), 76.1 (C11), 60.2 (C7), 56.0 (C10), 
32.9 (C2), 29.3 (C4), 18.8 (C3), 14.0 (C8); HRMS (ESI) Found: [M+H]+, 















Ethyl 2-methyl-3-((prop-2-ynyloxy)carbonyloxy)but-2-enoate (303n): 
 
                         
 
A suspension of sodium hydride (60 wt% in mineral oil, 92.3 mg, 2.31 mmol) 
in tetrahydrofuran (10 mL) was cooled to 0 °C. A solution of 2-methyl ethyl 
acetoacetate (300 μL, 2.1 mmol) in tetrahydrofuran (5 mL) was added 
dropwise and the mixture was stirred at 0 °C for 10 minutes. Propargyl 
chloroformate (225 μL, 2.31 mmol) was added dropwise and the mixture was 
allowed to warm to room temperature and was stirred at room temperature for 
1.5 hours. The reaction was quenched by the addition of aq. HCl (1 N, 20 mL) 
and the mixture was extracted with EtOAc (3 x 15 mL). The combined organic 
phases were washed with brine (20 mL), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 19:1] afforded 303n (200 
mg, 45%) as a clear oil. RF 0.65 [Petrol:EtOAc 7:1]; νmax (film)/cm−1 3368, 
2939, 2122 (C≡C), 1723 (C=O), 1686 (C=O), 1638; δH (400 MHz, CDCl3) 4.79 
(d, J = 2.4 Hz, 2H, H9), 4.18 (q, J = 7.3 Hz, 2H, H6), 2.55 (t, J = 2.4 Hz, 1H, 
H11), 2.05 (q, J = 1.2 Hz, 3H, H1), 1.90 (q, J = 1.2 Hz, 3H, H4), 1.27 (t, J = 6.8 
Hz, 3H, H7); δC (100 MHz, CDCl3) 166.2 (C5), 152.1 (C8), 151.3 (C2), 117.0 
(C3), 76.6 (C10), 76.0 (C11), 60.9 (C6), 55.8 (C9), 18.1 (C1), 14.5 (C4), 14.0 















Ethyl 2-fluoro-3-((prop-2-ynyloxy)carbonyloxy) but-2-enoate (303o): 
 
                         
 
A suspension of sodium hydride (60 wt% in mineral oil, 352 mg, 8.80 mmol) in 
tetrahydrofuran (30 mL) was cooled to 0 °C. A solution of 2-ethyl fluoroacetate 
(1.00 mL, 8.0 mmol) in tetrahydrofuran (5 mL) was added dropwise and the 
mixture was stirred at 0 °C for 10 minutes. Propargyl chloroformate (857 μL, 
8.80 mmol) was added dropwise and the mixture was allowed to warm to 
temperature and was stirred at room temperature for 1.5 hours. The reaction 
was quenched by the addition of aq. HCl (1 N, 20 mL) and the mixture was 
extracted with EtOAc (3 x 25 mL). The combined organic phases were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 19:1] afforded 303o (1.2 g, 65%) as a 
clear oil. RF 0.70 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3289, 2987, 2133 (C≡C), 
1768, 1727 (C=O), 1686 (C=O); δH (400 MHz, CDCl3) 4.79 (d, J = 2.4, 2H, 
H8), 4.26 (q, J = 7.2 Hz, 2H, H5), 2.57 (t, J = 2.2 Hz, 1H, H10), 2.10 (d, J = 5.9 
Hz, 3H, H1), 1.29 (t, J = 7.3 Hz, 3H, H6); δC (100 MHz, CDCl3) 158.9 (d, J = 
31.5 Hz, C4), 151.4 (d, J = 3.9 Hz, C7), 145.1 (d, J = 30.8 Hz, C2), 143.7 (d, J 
= 235.1 Hz, C3), 76.3 (C10), 76.1 (C9), 61.7 (C5), 56.4 (C8), 15.3 (C1), 13.9 


















(E)-1-(2-Oxodihydrofuran-3(2H)-ylidene) ethyl prop-2-ynyl carbonate 
(303p): 
 
                           
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 103 mg, 2.58 mmol) in tetrahydrofuran (20 mL) was cooled 
to 0 °C. A solution of 301q (220 mg, 1.72 mmol) in tetrahydrofuran (5 mL) was 
added dropwise and the mixture was stirred at 0 °C for 10 minutes. Propargyl 
chloroformate (185 μL, 1.89 mmol) was added dropwise and the mixture was 
allowed to warm to room temperature and was stirred at room temperature for 
1.5 hours. The reaction was quenched by the addition of aq. HCl (1 N, 20 mL) 
and the mixture was extracted with EtOAc (3 x 25 mL). The combined organic 
phases were washed with brine (50 mL), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 3:1] afforded carbonate 
303p (201 mg, 55%) as a green oil. RF 0.20 [Petrol:EtOAc 3:1]; δH (300 MHz, 
CDCl3) 4.79 (d, J = 2.4 Hz, 2H, H8), 4.33 (t, J = 7.4 Hz, 2H, H2), 2.98 (tq, J = 
7.6, 1.7 Hz, 2H, H3), 2.56 (t, J = 2.6 Hz, 1H, H10), 2.06 (t, J = 1.8 Hz, 3H, H6); 
δH (75 MHz, CDCl3) 167.1 (C1), 153.0 (C5), 151.1 (C7), 113.3 (C4), 76.4 (C9), 
76.1 (C10), 64.6 (C2), 56.1 (C8), 26.0 (C3), 19.5 (C6); HRMS (ESI) Found: 






















    
According to a literature procedure,117 a suspension of sodium hydride (60 
wt% in mineral oil, 26 mg, 0.65 mmol) in tetrahydrofuran (7 mL) was cooled to 
0 °C. A solution of 301r (130 mg, 0.54 mmol) in tetrahydrofuran (3 mL) was 
added dropwise and the mixture was stirred at 0 °C for 15 minutes. Propargyl 
chloroformate (59.0 μL, 0.60 mmol) was added dropwise and the mixture was 
allowed to warm to room temperature and was stirred at room temperature for 
1 hour. The reaction was quenched by the addition of aq. HCl (1 N, 10 mL) 
and the mixture was extracted with EtOAc (3 x 15 mL). The combined organic 
phases were washed with brine (30 mL), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 9:1-5:1] afforded 303q 
(121 mg, 69%) as a clear oil. RF 0.40 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3268, 
2980, 2128 (C≡C), 1759 (C=O), 1707 (C=O), 1638; δH (400 MHz, CDCl3) 4.78 
(d, J = 2.6 Hz, 2H, H12), 3.69-3.63 (m, 2H, H4), 2.57 (t, J = 2.4 Hz, 1H, H14), 
2.46 (tq, J = 7.0, 2.0 Hz, 2H, H6), 2.36 (t, J = 1.8 Hz, 3H, H10), 1.85-1.77 (m, 
2H, H5), 1.53 (s, 9H, H1); δC (100 MHz, CDCl3) 165.2 (C3), 156.4 (C9), 152.4 
(C8), 151.1 (C11), 120.7 (C7), 83.0 (C2), 76.3 (C14), 76.3 (C13), 56.0 (C12), 
45.4 (C4), 28.0 (C1), 23.4 (C6), 21.7 (C5), 18.9 (C10); HRMS (ESI) Found: 





















3-(Methylsulfonyl)but-2-en-2-yl prop-2-ynyl carbonate (303r): 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
A suspension of sodium hydride (60 wt% in mineral oil, 30.4 mg, 0.76 mmol) 
in tetrahydrofuran (30 mL) was cooled to 0 °C. A solution of 301s (104 mg, 
0.69 mmol) in tetrahydrofuran (5 mL) was added dropwise and the mixture 
was stirred at 0 °C for 10 minutes. Propargyl chloroformate (74 μL, 0.76 
mmol) was added dropwise and the mixture allowed to warm to room 
temperature and was stirred at room temperature for 1.5 hours. The reaction 
was quenched by the addition of aq. HCl (1 N, 10 mL) and the mixture was 
extracted with EtOAc (3 x 10 mL). The combined organic phases were 
washed with brine (10 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 4:1-1:1] afforded 303r (101 mg, 64%) 
as a white solid. RF 0.10 [Petrol:EtOAc 1:1]; m.p. 75–77 °C; νmax (film)/cm−1 
3293, 2929, 2137 (C≡C), 1763, 1668 (C=O); δH (300 MHz, CDCl3) 4.78 (d, J = 
2.7 Hz, 2H, H7), 2.99 (s, 3H, H5), 2.58 (t, J = 2.3 Hz, 1H, H9), 2.13 (q, J = 1.2 
Hz, 3H, H1), 2.03 (q, J = 1.7 Hz, 3H, H4); δC (75 MHz, CDCl3) 152.7 (C2), 
150.8 (C6), 127.7 (C3), 76.4 (C8), 76.0 (C9), 56.3 (C7), 42.6 (C5), 18.3 (C1), 


















3-Ethyl 3-prop-2-ynyl 4-oxochroman-3,3-dicarboxylate (303sa) and (Z)-





To a suspension of sodium hydride (60 wt% in mineral oil, 48 mg, 1.20 mmol) 
in tetrahydrofuran (15 mL) was cooled to 0 °C. A solution of 301m (240 mg, 
1.09 mmol) in tetrahydrofuran (5 mL) was added dropwise and the reaction 
mixture was stirred at 0 °C 15 minutes. Propargyl chloroformate (117 μL, 1.20 
mmol) was added dropwise and the mixture was allowed to warm to room 
temperature and was stirred at room temperature for 1 hour. The reaction was 
quenched by the addition of aq. HCl (1 N, 20 mL) and extracted with EtOAc (3 
x 20 mL). The combined organic layers were washed with brine (30 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 4:1] afforded an inseparable mixture of 303sa and 303sb in a 
3.6:1 ratio (231 mg, 70%) as a colourless oil. Rf 0.38 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 3281, 2883, 2130, 1735 (C=O), 1695 (C=O); δH (400 MHz, CDCl3, 
resonances due to 303sa quoted) 7.96 (dd, J = 8.0, 1.7 Hz, 1H, H3), 7.51 
(ddd, J = 9.0, 7.3, 1.9 Hz, 1H, H4), 7.08 (ddd, J = 8.1, 7.3, 1.1 Hz, 1H, H5), 
6.98 (dd, J	   =	  8.6, 0.8 Hz, 1H, H6), 4.93 (s, 2H, H8), 4.81 (d, J = 2.5 Hz, 2H, 
H14), 4.30 (q, J = 7.1 Hz, 1H, H11a), 4.30 (q, J = 7.2 Hz, 1H, H11b), 2.49 (t, J 
= 2.4 Hz, 1H, H16), 1.27 (t, J = 7.2 Hz, 3H, H12);	   δC (100 MHz, CDCl3, 
resonances due to 313sa quoted) 183.7 (C1), 164.7 (C10), 164.5 (C13), 160.7 































75.8 (C15), 65.1 (C9), 63.0 (C11), 53.8 (C14), 13.9 (C12); HRMS (ESI) Found: 
[M+H]+, 303.0860. C16H14O6 requires [M+H]+, 303.0863. 
 




To a solution of diethyl methyl malonate (425 µL, 2.5 mmol) in tetrahydrofuran 
(20 mL) was added potassium tert-butoxide (313 mg, 3.13 mmol) and the 
mixture was stirred at room temperature for 10 minutes. Propargyl 
chloroformate (270 µL, 3.12 mmol) was added dropwise and the solution was 
stirred at room temperature for 90 minutes. The reaction was quenched with 
aq. HCl (1 N, 20 mL) and extracted with EtOAc (3 x 20 mL). The combined 
organic fractions were washed with brine (20 mL), dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 19:1] 
afforded 303t (300 mg, 47%) as a clear oil. RF 0.66 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 3280, 2963, 1731 (C=O);  δH (400 MHz, CDCl3) 4.73 (d, J = 2.5 Hz, 
2H, H7), 4.22 (q, J = 7.1 Hz, 4H, H2), 2.47 (t, J = 2.5 Hz, 1H, H9), 1.69 (s, 3H, 
H5), 1.24 (t, J = 7.2 Hz, 6H, H1); δC (100 MHz, CDCl3) 167.2 (C3), 166.9 (C6), 
76.5 (C9), 75.4 (C8), 62.3 (C2), 61.7 (C7), 53.3 (C4), 18.6 (C5), 13.7 (C1); 
HRMS (ESI) Found: [M+Na]+, 279.0818. C12H16O6 requires [M+Na]+, 
279.0839. 
 


















A suspension of sodium hydride (60 wt in mineral oil%, 48.5 mg, 1.21 mmol) 
in tetrahydrofuran 10 mL) was cooled to 0 °C. A solution of 301t (300 mg, 1.1 
mmol) in tetrahydrofuran (5 mL) was added dropwise and the mixture was 
stirred at 0 °C for 10 minutes. Propargyl chloroformate (117 µL, 1.21 mmol) 
was added dropwise and the mixture was allowed to warm to room 
temperature and was stirred at room temperature for 1 hour. The reaction was 
quenched with the addition of aq. HCl (1 N, 20 mL) and extracted with EtOAc 
(3 x 25 mL). The combined organic fractions were washed with brine (25 mL), 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 4:1-3:1] afforded 303u (211 mg, 57%) as a yellow oil. RF 0.17 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 3270, 2980, 1716 (C=O); δH (400 MHz, 
CDCl3) 4.74 (dd, J = 4.9, 2.5 Hz, 2H, H12), 3.76 (s, 3H, H10), 3.50 (t, J = 6.9 
Hz, 2H, H4), 2.48 (t, J = 2.3 Hz, 1H, H14), 2.47-2.44 (m, 2H, H6), 1.83-1.74 
(m, 2H, H5), 1.45 (s, 9H, H1); δC (100 MHz, CDCl3) 167.2 (C9), 166.5 (C11), 
165.0 (C8), 152.4 (C3), 83.4 (C2), 76.4 (C14), 75.6 (C13), 65.6 (C7), 53.6 
(C12), 53.3 (C10), 45.2 (C4), 28.1 (C6), 27.7 (C1), 19.2 (C5); HRMS (ESI) 






















Prop-2-ynyl 1H-indole-1-carboxylate (315): 
 
 
A suspension of sodium hydride (60 wt% in mineral oil, 110 mg, 2.75 mmol) in 
tetrahydrofuran 15 mL) was cooled to 0 °C. A solution of indole 301a (296 mg, 
2.5 mmol) in tetrahydrofuran (5 mL) was added dropwise and the mixture was 
stirred at 0 °C for 10 minutes. Propargyl chloroformate (268 µL, 2.75 mmol) 
was added dropwise and the mixture was warmed to room temperature and 
stirred for 1 hour. The reaction was quenched with the addition of aq. HCl (1 
N, 20 mL) and extracted with EtOAc (3 x 20 mL). The combined organic 
fractions were washed with brine (20 mL), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 9:1] afforded 315 (130 
mg, 26%) as a red/brown solid. RF 0.35 [Petrol:EtOAc 4:1]; m.p. 48–51 °C; 
νmax (film)/cm−1 3281, 2137 (C≡C), 1712 (C=O), 1604; δH (400 MHz, CDCl3) 
8.10 (d, J = 7.9 Hz, 1H, H1), 7.49 (d, J = 3.8 Hz, 1H, H4), 7.45 (dt, J = 7.9, 1.1 
Hz, 1H, H7), 7.26-7.21 (m, 1H, H5), 7.17-7.12 (m, 1H, H6), 6.50 (dd, J = 3.8, 
0.7 Hz, 1H, H2), 4.89 (d, J = 2.5 Hz, 2H, H10), 2.49 (t, J = 2.5 Hz, 1H, H12); 
δC (100 MHz, CDCl3) 150.0 (C9), 135.2 (C3), 130.3 (C8), 125.1 (C4), 124.6 
(C5), 123.1 (C6), 121.0 (C7), 115.1 (C1), 108.6 (C2), 76.9 (C12), 76.0 (C11), 















10.2.3. Palladium-Catalysed Alkenylation Reactions for the Coupling of 





                             
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 2-acetylcyclohexanone (30 μL, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 
the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of 302a and 302h in an 8.8:1 ratio (66 mg, 
corresponding to 60 mg of 302a, 85%, r.r. > 19:1) as a red solid. RF 0.40 
[Petrol:EtOAc 4:1]; m.p. 68–71 °C; νmax (film)/cm−1 3419, 2911, 2870, 1693 
(C=O), 1644 (C=O), 1421; δH (400 MHz, CDCl3) 5.02 (q, J = 1.4 Hz, 1H, H8a), 
4.91 (q, J = 1.4 Hz, 1H, H8b), 2.59-2.37 (m, 6H, H9, H12 and H15), 2.18 (s, 
9H, H1, H5 and H17), 1.75-1.62 (m, 4H, H13 and H14), 1.55 (s, 3H, H6); δC 
(100 MHz, CDCl3) 209.7 (C2), 208.3 (C4), 207.5 (C11), 207.5 (C16), 141.1 
(C7), 116.8 (C8), 71.9 (C3), 67.1 (C10), 41.2 (C12), 36.2 (C15), 35.7 (C9), 
27.2 (C13), 27.2 (C1), 27.0 (C5), 26.3 (C17), 21.8 (C14), 18.9 (C6); HRMS 






















                          
 
Carbonate 300 (23.5 mg, 0.12 mmol), Pd2(dba)3 (5.5 mg, 0.006 mmol), 
DPEphos (6.5 mg, 0.012 mmol) and 2-acetyl-1-tetralone (26.7 mg, 0.12 mmol) 
were added to a dried tube under argon. The tube was fitted with a septum 
and purged further with argon. 1,4-Dioxane (1.5 mL) was added and the 
sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of 302b and 302h in a 14:1 ratio (34.8 mg, 
corresponding to 32.3 mg of 302b, 79%, r.r. > 19:1) as a red solid. RF 0.33 
[Petrol:EtOAc 4:1]; m.p. 82–84 °C; νmax (film)/cm−1 2976, 2931, 1702 (C=O), 
1674 (C=O); δH (400 MHz, CDCl3) 8.01 (dd, J = 7.9, 1.12 Hz, 1H, H13), 7.47 
(td, J = 7.5, 1.4 Hz, 1H, H14), 7.30 (t, J = 8.2 Hz, 1H, H15), 7.20 (d, J = 7.8 
Hz, 1H, H16), 5.04 (q, J = 1.2 Hz, 1H, H8a), 4.98 (q, J = 1.2 Hz, 1H, H8b), 
3.12-3.01 (m, 1H, H18a), 2.92 (dt, J = 17.4, 5.0 Hz, 1H, H18b), 2.75 (dt, J = 
17.1, 1.4 Hz, 1H, H9a), 2.56 (dt, J = 14.0, 5.0 Hz, 1H, H19a), 2.47 (dt, J = 
17.2, 1.2 Hz, 1H, H9b), 2.38-2.26 (m, 1H, H19b), 2.20 (s, 3H, H21), 2.16 (s, 
3H, H1), 2.16 (s, 3H, H5), 1.54 (s, 3H, H6); δC (100 MHz, CDCl3) 207.2 (C2), 
207.1 (C4), 206.8 (C20), 197.1 (C11), 143.3 (C17), 141.3 (C7), 134.0 (C14), 
























63.5 (C10), 36.0 (C9), 28.9 (C19), 27.2 (C21), 27.2 (C1), 27.1 (C5), 25.7 
(C18), 18.7 (C6); HRMS (ESI) Found: [M+Na]+, 363.1551. C21H24O4 requires 
[M+Na]+, 363.1554.   
 
The formation of 302b was also carried out under enantioselective conditions: 
Carbonate 300 (31.3 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), (R)-
Tol-BINAP L12 (6.5 mg, 0.0096 mmol) and 2-acetyltetralone (30 mg, 0.16 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1 mL) was added and the 
sealed tube was stirred at room temperature for 16 hours, then concentrated 
in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 302b 
(37 mg, 68% yield, r.r. > 19:1). Chiral HPLC: OD-H column, 1 mL/min, 9:1 
Hexane:IPA, tA (major) = 11.2 min, tB (minor) = 12.9 min, 27% ee; [α]D25 +1.4 




                    
                              
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and ethyl 2-methyl acetoacetate (34 ųL, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 





















the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 4 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1] 
afforded 302c (36 mg, 47%, r.r. > 19:1) a yellow solid. RF 0.25 [Petrol:EtOAc 
4:1]; m.p. 40–42 °C; νmax (film)/cm−1 2972, 2931, 2875, 1694 (C=O), 1641 
(C=O); δH (400 MHz, CDCl3) 5.02 (q, J = 1.2 Hz, 1H, H8a), 4.87 (q, J = 1.4 Hz, 
H8b), 3.01 (sept, J = 6.6 Hz, 1H, H17), 2.54-2.39 (m, 5H, H9, H12 and H15a), 
2.18 (s, 3H, H1), 2.17 (s, 3H, H5), 1.79-1.60 (m, 5H, H13, H14 and H15b), 
1.55 (s, 3H, H6), 1.10 (d, J = 7.1 Hz, 3H, H18), 0.98 (d, J = 6.2 Hz, 3H, H19); 
δC (100 MHz, CDCl3) 214.8 (C16), 209.9 (C11), 207.6 (C2), 207.4 (C4), 141.4 
(C7), 116.9 (C8), 71.9 (C3) 67.6 (C10), 41.5 (C12), 36.0 (C17), 35.7 (C9), 34.3 
(C15), 27.2 (C1), 27.1 (C5), 27.1 (C14), 22.0 (C13), 21.0 (C18), 20.6 (C19), 





                               
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol), and 2-methyl-1,3-cyclohexadione (30.2 mg, 
0.24 mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 






















stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1] 
afforded an inseparable mixture of homo-coupled 301d (302db), regioisomer 
302, minor isomer 304d and 302h in a 9:4:1.2:1 ratio (39 mg, corresponding 
to 20 mg of 302db, 27%) as an orange solid. RF 0.29 [Petrol:EtOAc 9-1:4:1]; 
m.p. 63–65 °C; νmax (film)/cm−1 3368, 2939, 1723 (C=O), 1686 (C=O), 1638; 
δH (400 MHz, CDCl3, resonances due to 302db quoted) 4.67 (q, J = 1.5 Hz, 
1H, H7a), 4.11 (q, J = 1. 5 Hz, 1H, H7b), 2.96-2.87 (m, 2H, H12a), 2.84-2.75 
(m, 2H, H12b), 2.72-2.57 (m, 3H, H2a, Hb and H2c), 2.54-2.50 (m, 1H, H2d), 
2.48 (t, J = 1.5 Hz, 2H, H8), 2.18-2.13 (m, 2H, H13), 1.60-1.58 (m, 2H H1), 
1.33-1.31 (m, 6H, H5 and H10); δC (100 MHz, CDCl3, resonances due to 
302db quoted) 209.1 (C3), 208.1 (C11), 144.9 (C6), 113.0 (C7), 73.5 (C4), 
63.2 (C9), 38.7 (C2), 37.5 (C12), 36.0 (C8), 26.7 (C5), 17.5 (C1), 17.5 (C10), 
17.4 (C13); For homo-coupled 302db: HRMS (ESI) Found: [M+H]+, 291.1580. 
C17H22O4 requires [M+H]+, 291.1591. For 302d: HRMS (ESI) Found: [M+H]+, 
279.1580. C16H22O4 requires [M+H]+, 279.1591. 
 
3,6-Diacetyl-6-allyl-3-methyl-4-methyleneoctane-2,7-dione (302e):  
  
                             
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301e (33.6 mg, 0.24 mmol) were added 




















further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 4:1] afforded an inseparable mixture of 
302e and 302h in a 9.3:1 ratio (55 mg, corresponding to 49.4 mg of 302e, 
70%, r.r. > 19:1) as a pale yellow solid. RF 0.33 [Petrol:EtOAc 9:1-4:1]; m.p. 
64–66 °C; νmax (film)/cm−1 2981, 2926, 1694 (C=O), 1638 (C=O); δH (400 
MHz, CDCl3) 5.50-5.38 (m, 1H, H12), 5.11-5.04 (m, 2H, H13), 4.97 (q, J = 1.6 
Hz, 1H, H6a), 4.87 (q, J = 1.8 Hz, 1H, H6b), 2.82 (dt, J = 7.3, 1.3 Hz, 2H, 
H11), 2.57 (t, J = 1.8 Hz, 2H, H7), 2.16 (s, 6H, H1), 2.14 (s, 6H, H10), 1.56 (s, 
3H, H4); δC (100 MHz, CDCl3) 207.0 (C2), 206.2 (C9), 141.9 (C5), 132.0 
(C12), 119.4 (C13), 115.3 (C6), 71.9 (C3), 69.2 (C8), 35.5 (C11), 32.5 (C7), 
27.1 (C1), 26.8 (C10), 18.9 (C4); HRMS (ESI) Found: [M+H]+, 293.1736. 





                             
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and acetylacetone (25 μL, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 


















tube was added to an oil bath preheated to 80 °C. The mixture was stirred at 
80 °C for 2 hours, then cooled to room temperature and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 4:1] afforded an 
inseparable mixture of 302f and 302h in a 10:1 ratio (37 mg, corresponding to 
33.6 mg 302f, 56%, r.r. not determined) as a yellow solid. RF 0.27 
[Petrol:EtOAc 9:1-4:1]; m.p. 63–65 °C; νmax (film)/cm−1 2983, 2926, 1704 
(C=O), 1639 (C=O), 1562; δH (400 MHz, CDCl3) 16.88 (s, 1H, H11), 5.08 (t, J 
= 2.2 Hz, 1H, H6a), 5.01 (t, J = 1.9 Hz, 1H, H6b), 2.83 (t, J = 2.0 Hz, 2H, H7), 
2.21 (s, 6H, H1), 2.06 (s, 6H, H10), 1.64 (s, 3H, H4); δC (100 MHz, CDCl3) 
207.1 (C2), 192.3 (C9), 144.5 (C5), 114.5 (C6), 106.0 (C8), 71.0 (C3), 30.7 
(C7), 26.9 (C1), 22.7 (C10), 18.9 (C4); HRMS (ESI) Found: [M+H]+, 253.1442. 
C14H20O4 requires [M+H]+, 253.1456. 
 
Ethyl 3,3,6-triacetyl-6-methyl-5-methylene-7-oxooctanoate (302g): 
 
 
                       
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301g (44.6 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 























column chromatography [Petrol:EtOAc 9:1-4:1] afforded an inseparable 
mixture of 302g, homo-coupled 301g and 302h in a 11:1.2:1 ratio (59 mg, 
corresponding to 48.4 mg of 302g, 60%, r.r. > 19:1) as an orange oil. RF 0.38 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 2992, 2967, 1700 (C=O), 1678 (C=O); δH 
(400 MHz, CDCl3) 4.97 (q, J = 1.5 Hz, 1H, H6a), 4.77 (q, J = 1.7 Hz, 1H, H6b), 
4.11 (q, J = 6.9 Hz, 2H, H13), 3.26 (s, 2H, H11), 2.82 (t, J = 1.7 Hz, 2H, H7), 
2.16 (s, 6H, H10), 2.15 (s, 6H, H1), 1.57 (s, 3H, H4), 1.23 (t, J = 7.2 Hz, 3H, 
H14); δC (100 MHz, CDCl3) 206.7 (C2), 204.9 (C9), 171.2 (C12), 142.4 (C5), 
115.3 (C6), 71.9 (C3), 68.5 (C8), 61.0 (C13), 35.6 (C11), 33.2 (C7), 27.0 (C1), 
26.0 (C10), 18.8 (C4), 14.0 (C14); HRMS (ESI) Found: [M+H]+, 339.1789. 




                              
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11.0 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.020 mmol) and 3-methyl-2,4-pentanedione (28 μL, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 
the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 


















m.p. 72–74 °C; νmax (film)/cm−1 3386, 2909, 1698 (C=O), 1652, 1426; δH (400 
MHz, CDCl3) 4.99 (q, J = 1.4 Hz, 1H, H6a), 4.83 (q, J = 1.3 Hz, 1H, H6b), 2.56 
(t, J = 2.5 Hz, 2H, H7), 2.15 (s, 6H, H1), 2.13 (s, 6H, H10), 1.55 (s, 3H, H4), 
1.42 (s, 3H, H11); δC (100 MHz, CDCl3) 207.0 (C2), 207.0 (C9), 141.9 (C5), 
115.7 (C6), 72.0 (C3) 66.0 (C8), 36.0 (C7), 27.1 (C1), 26.3 (C10), 18.8 (C4), 




                            
 
Carbonate 300 (65.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301i (42 mg, 0.24 mmol) were added to 
a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1-4:1] afforded an inseparable 
mixture of 302i and 302h in a 4.8:1 ratio (35 mg, corresponding to 28.2 mg of 
302i, 36%, r.r. > 19:1) as a red oil. RF 0.22 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 
3058, 2983, 2926, 1692 (C=O), 1641 (C=O), 1500; δH (400 MHz, CDCl3) 7.36-
7.27 (m, 5H, H12, H13 and H14), 5.08 (q, J = 1.7 Hz, 1H, H6a), 4.89 (q, J = 
























H1), 1.61 (s, 3H, H4); δC (100 MHz, CDCl3) 207.5 (C2), 205.8 (C9), 141.1 
(C5), 136.1 (C11), 129.0 (C12), 128.2 (C14), 128.0 (C13), 117.1 (C6), 72.8 
(C8), 71.8 (C3), 35.2 (C7), 28.1 (C1), 27.0 (C10), 19.0 (C4); HRMS (ESI) 




                            
 
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301j (44.6 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1-4:1] afforded 302j (60 mg, 73%, r.r. 
> 19:1) as a yellow oil. RF 0.38 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3386, 2924, 
2338, 1695 (C=O), 1638; δH (400 MHz, CDCl3) 7.25-7.19 (m, 3H, H14 and 
H15), 6.97-6.91 (m, 2H, H13), 5.02 (q, J = 1.8 Hz, 1H, H6a), 4.98 (q, J = 1.5 
Hz, 1H, H6b), 3.40 (s, 2H, H11), 2.44 (t, J = 1.7 Hz, 2H, H7), 2.20 (s, 6H, 
H10), 2.10 (s, 6H, H1), 1.40 (s, 3H, H4); δC (100 MHz, CDCl3) 206.9 (C2), 
206.4 (C9), 142.1 (C5), 135.9 (C12), 129.5 (C13), 128.4 (C15), 127.2 (C14), 
































                           
 
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301k (42.3 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1-4:1] afforded an inseparable 
mixture of 302k and 302h in a 13:1 ratio (45 mg, corresponding to 42.7 mg of 
302k, 54%, r.r. > 19:1) as a red oil. RF 0.31 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 
2987, 2928, 1762 (C=O), 1674 (C=O); δH (400 MHz, CDCl3) 7.68-7.64 (m, 2H, 
H16), 7.50 (tt, J = 7.4, 2.0 Hz, 1H, H18), 7.41-7.35 (m, 2H, H17), 5.02 (q, J = 
1.3 Hz, 1H, H8a), 4.93 (q, J = 1.2 Hz, 1H, H8b), 2.80 (dt, J = 18.3, 1.6 Hz, 1H, 
H9a), 2.70 (dt J = 18.3, 1.1 Hz, 1H, H9b), 2.13 (s, 3H, H12), 2.04 (s, 3H, H1), 
1.88 (s, 3H, H5), 1.58 (s, 3H, H14), 1.40 (s, 3H, H6); δC (100 MHz, CDCl3) 
207.1 (C11), 206.9 (C2), 206.9 (C4), 200.1 (C13), 141.6 (C7), 136.4 (C15), 





















36.8 (C9), 26.8 (C1 and C5), 26.4 (C12), 19.7 (C14), 18.5 (C6); HRMS (ESI) 




       
                         
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301m (53 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1-5:1-4:1] afforded 302m (55 mg, 
62%, r.r. > 19:1) as a brown oil. RF 0.42 [Petrol:EtOAc 5:1]; νmax (film)/cm−1 
2982, 2117, 1695 (C=O), 1607, 1480; δH (400 MHz, CDCl3) 7.88 (ddd, J = 7.9, 
1.8, 0.4 Hz, 1H, H16), 7.47 (ddd, J = 8.4, 1.8, 0.5 Hz, 1H, H15), 7.05-7.00 (m, 
1H, H14), 6.95 (dd, J = 8.4, 0.6 Hz, 1H, H13), 5.21 (q, J = 1.2 Hz, 1H, H8a), 
5.09 (q, J = 0.5 Hz, 1H, H8b), 4.78 (d, J = 11.7 Hz, 1H, H18a), 4.67 (d, J = 
12.1 Hz, 1H, H18b), 4.17 (qd, J = 7.2, 1.2 Hz, 2H, H20), 2.69 (d, J = 17.0 Hz, 
1H, H9a), 2.49 (d, J = 16.8 Hz, 1H, H9b), 2.16 (s, 3H, H1), 2.15 (s, 3H, H5), 
1.57 (s, 3H, H6), 1.18 (t, J = 6.9 Hz, 3H, H21); δC (100 MHz, CDCl3) 207.2 


























(C14), 127.9 (C16), 121.8 (C15), 119.8 (C12), 118.5 (C8), 117.7 (C13), 71.9 
(C3), 70.9 (C18), 62.0 (C20), 56.7 (C10), 31.8 (C9), 27.1 (C1), 27.0 (C5), 18.6 
(C6), 13.8 (C21); HRMS (ESI) Found: [M+H]+, 373.1629. C21H24O6 requires 
[M+H]+, 373.1646.  
 
The formation of 302m was also carried out under enantioselective conditions: 
Carbonate 300 (31.3 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol) (R)-
Tol-BINAP L12 (7.3 mg, 0.0096 mmol) and 301m (35.2 mg, 0.16 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. 1,4-Dioxane (1 mL) was added and the sealed tube 
was stirred at room temperature for 16 hours, then concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 302m (21 mg, 
35% yield, r.r. > 19:1). Chiral HPLC: OD-H column, 1 mL/min, 9:1 Hexane:IPA, 






                           
 
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.0120 mmol), 


















(35 μL, 0.24 mmol) were added to a dried tube under argon. The tube was 
fitted with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 80 °C. The 
mixture was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 302n (43 mg, 58%, r.r. > 19:1) as a yellow oil. RF 0.35 [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 2982, 2110, 1752 (C=O), 1702 (C=O); δH (400 MHz, 
CDCl3) 4.99 (q, J = 1.3 Hz, 1H, H8a), 4.98 (q, J = 1.4 Hz, 1H, H8b), 4.14 (q, J 
= 7.2 Hz, 1H, H16a), 4.14 (q, J = 7.2 Hz, 1H, H16b), 2.78-2.69 (m, 2H, H9a 
and H14a), 2.44-2.24 (m, 2H, H12), 2.16 (s, 3H, H1), 2.14 (s, 3H, H5), 2.10-
1.88 (m, 4H, H9b, H13 and H14b), 1.51 (s, 3H, H6), 1.21 (t, J = 7.0 Hz, 3H, 
H17); δC (100 MHz, CDCl3) 213.5 (C11), 207.2 (C2), 207.2 (C4), 170.0 (C15), 
142.6 (C7), 115.5 (C8), 71.5 (C3), 61.7 (C16), 59.6 (C10), 37.4 (C12), 36.3 
(C9), 32.3 (C14), 27.3 (C1), 26.9 (C5), 19.6 (C13), 18.6 (C6), 13.9 (C17); 













                           
 
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and ethyl-2-fluoroacetoacetate (30 μL, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 
the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 302o (40 mg, 55%, r.r. > 19:1) as a yellow oil. RF 0.39 [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 2987, 2933, 2341, 1762, 1736 (C=O), 1717 (C=O); δH 
(400 MHz, CDCl3) 5.37 (s, 1H, H6a), 5.07 (s, 1H, H6b), 4.29-4.20 (m, 2H, 
H12), 2.97-2.74 (m, 2H, H7), 2.30 (d, J = 5.0 Hz, 3H, H10), 2.15 (s, 6H, H1), 
1.52 (s, 3H, H4), 1.28 (t, J = 7.0 Hz, 3H, H13); δC (100 MHz, CDCl3) 206.6 
(C2), 201.0 (d, J = 27.5 Hz, C9), 165.6 (d, J = 25.4 Hz, C11), 139.8 (C5), 
118.8 (C6), 99.8 (d, J = 197.1 Hz, C8), 71.7 (C3), 62.9 (C12), 35.1 (d, J = 21.8 
Hz, C7), 27.0 (C1a), 26.9 (C1b), 25.5 (C10), 18.7 (C4), 13.9 (C13); HRMS 



















Ethyl 2,5-diacetyl-2,5-dimethyl-4-methylene-6-oxoheptanoate (302p):  
 
                           
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and ethyl 2-methyl acetoacetate (34 µL, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 
the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 302p (27 mg, 38%, r.r. > 19:1) as a black oil. RF 0.29 [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 2983, 2931, 1701 (C=O), 1653 (C=O); δH (400 MHz, 
CDCl3) 5.01-4.99 (m, 2H, H8a and H8b), 4.18 (q, J = 7.1 Hz, 1H, H15a), 4.18 
(q, J = 7.1 Hz, 1H, H15b), 2.69 (dt, J = 18.1, 1.8 Hz, H9a), 2.49 (dt, J = 17.7, 
1.5 Hz, H9b), 2.19 (s, 3H, H12), 2.11 (s, 3H, H1), 2.10 (s, 3H, H5), 1.43 (s, 
3H, H6), 1.39 (s, 3H, H14), 1.19 (t, J = 7.2 Hz, 3H, H16); δC (100 MHz, CDCl3) 
207.2 (C2), 207.1 (C4), 205.0 (C11), 172.7 (C13), 142.4 (C7), 116.0 (C8), 
72.0 (C3), 61.8 (C15), 58.7 (C10), 36.2 (C9), 27.3 (C1), 27.0 (C5), 26.0 (C12), 
19.0 (C14), 18.6 (C6), 13.9 (C16); HRMS (ESI) Found: [M+H]+, 297.1684. 





















                             
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol), and 301q (30.8 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1-4:1] afforded an inseparable 
mixture of 302q, 302h and homo-coupled 301q in a 6.8:2.2:1 ratio (35 mg, 
corresponding to 23.0 mg of 302q, 34%, r.r. > 19:1) as a yellow oil. RF 0.15 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 2981, 2924, 2855, 1759 (C=O), 1701 
(C=O); δH (300 MHz, CDCl3) 5.02 (q, J = 1.4 Hz, 1H, H8a), 4.89 (q, J = 1.8 Hz, 
1H, H8b), 4.38-4.24 (m, 2H, H12), 3.13-3.00 (m, 2H, H13), 3.01 (dt, J = 18.2, 
1.6 Hz, 1H, H9a), 2.43-2.33 (m, 1H, H9b), 2.36 (s, 3H, H15), 2.17 (s, 3H, H1), 
2.16 (s, 3H, H5), 1.59 (s, 3H, H6); δC (75 MHz, CDCl3) 206.6 (C2), 206.4 (C4), 
203.3 (C14), 174.7 (C11), 142.1 (C7), 115.6 (C8), 66.9 (C12), 60.5 (C10), 
37.7 (C9), 29.7 (C13), 27.0 (C1), 27.0 (C5), 25.7 (C15), 18.9 (C6); HRMS 





















                      
 
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301r (58 mg, 0.24 mmol) were added to 
a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 9:1-4:1] afforded an inseparable 
mixture of 302r and homo-coupled 301r in a 17:1 ratio (81 mg, corresponding 
to 76 mg of 302r, 81%, r.r. > 19:1) as a red oil. RF 0.30 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2980, 2933, 1768 (C=O), 1714 (C=O); δH (400 MHz, CDCl3) 
4.98 (q, J = 0.7 Hz, 1H, H8a), 4.95 (d, J = 1.0 Hz, 1H, H8b), 3.65-3.53 (m, 2H, 
H12), 2.78 (dt, J = 16.8, 1.6 Hz, 1H, H9a), 2.39-2.30 (m, 1H, H9b), 2.28-2.22 
(m, 2H, H14), 2.24 (s, 3H, H16), 2.13 (s, 3H, H1), 2.11 (s, 3H, H5), 2.00-1.91 
(m, 1H, H13a), 1.80-1.70 (m, 1H, H13b), 1.56 (s, 3H, H6), 1.47 (s, 9H, H19); 
δC (100 MHz, CDCl3) 207.3 (C2), 207.1 (C4), 206.1 (C15), 171.6 (C11), 152.6 
(C17), 141.3 (C7), 117.4 (C8), 83.1 (C18), 71.8 (C3), 62.5 (C10), 46.5 (C12), 






























                           
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 301s (36.0 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 
hours, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 4:1] afforded 302s (39 mg, 54%, r.r. > 
19:1) as a dark yellow solid. RF 0.15 [Petrol:EtOAc 4:1]; m.p. 89–92 °C; νmax 
(film)/cm−1 3006, 2931, 1701 (C=O), 1641; δH (400 MHz, CDCl3) 5.05 (t, J = 
1.2 Hz, 1 H, H8a), 4.83 (q, J = 1.6 Hz, 1H, H8b), 3.20 (d, J = 15.8 Hz, 1H, 
H9a), 2.80 (s, 3H, H11), 2.45 (s, 3H, H13), 2.45 (dd, J = 16.4, 1.1 Hz, 1H, 
H9b), 2.17 (s, 3H, H1), 2.13 (s, 3H, H5), 1.75 (s, 3H, H14), 1.60 (s, 3H, H6); 
δC (100 MHz, CDCl3) 206.6 (C2), 206.5 (C4), 206.0 (C12), 140.5 (C7), 118.0 
(C8), 74.6 (C10), 71.8 (C3), 35.4 (C11), 33.6 (C9), 28.8 (C13), 27.1 (C1), 27.0 
(C5), 18.9 (C14), 14.5 (C6); HRMS (ESI) Found: [M+H]+, 303.1250. C14H22O5S 

























Carbonate 300 (31.4 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), 
DPEphos (8.6 mg, 0.0160 mmol) and 301u (44.3 mg, 0.16 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Dioxane (1 mL) was added and the sealed tube was added 
to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 hours, 
then cooled to room temperature and concentrated in vacuo. Flash column 
chromatography [Petrol:EtOAc 4:1-1:1] afforded 302u (28 mg, 41%, r.r. not 
determined) as a colourless oil. RF 0.10 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 
2950, 2109, 1770, 1697 (C=O); δH (400 MHz, CDCl3) 7.42-7.30 (m, 5H, H20, 
H21 and H22), 5.26 (s, 2H, H18), 5.02 (q, J = 0.8 Hz, 1H, H8a), 4.97 (q, J = 
1.2 Hz, 1H, H8b), 3.73 (dd, J = 7.1, 5.1 Hz, 2H, H14), 2.84 (dt, J = 16.4, 1.1 
Hz, 1H, H9a), 2.42-2.35 (m, 2H, H9b and H13a), 2.26 (s, 3H, H16), 2.16 (s, 
3H, H1), 2.10 (s, 3H, H5), 2.04 (ddd, J = 15.5, 10.2, 5.3 Hz, 1H, H13b), 1.84-
1.73 (m, 2H, H14), 1.62 (s, 3H, H6); δC (100 MHz, CDCl3) 207.4 (C2), 207.2 
(C5), 205.9 (C15), 171.6 (C11), 153.9 (C17), 141.2 (C7), 135.2 (C19), 128.5 
(C21), 128.3 (C22), 128.0 (C20), 118.0 (C8), 71.7 (C3), 68.6 (C18), 62.8 































20.6 (C13), 18.7 (C6); HRMS (ESI) Found: [M+H]+, 428.2071. C24H29NO6 




                           
 
Carbonate 266 (53.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 304a (49 mg, 70%, r.r. > 19:1) as a yellow solid. RF 0.38 
[Petrol:EtOAc 4:1]; m.p. 55–58 °C; νmax (film)/cm−1 3389, 2933, 1699 (C=O); 
δH (400 MHz, CDCl3) 4.97 (q, J = 1.3 Hz, 1H, H10a), 4.84 (q, J = 1.4 Hz, 1H, 
H10b), 2.54 (t, J = 1.5 Hz, 2H, H11), 2.49 (t, J = 7.0 Hz, 2H, H2), 2.31-2.21 
(m, 1H, H5a), 2.14 (s, 6H, H15 and H16), 2.13 (s, 3H, H8), 1.93-1.52 (m, 5H, 
H3, H4 and H5b), 1.43 (s, 3H, H17); δC (100 MHz, CDCl3) 209.3 (C1), 207.3 
(C13), 207.3 (C14), 207.1 (C7), 141.2 (C9), 116.4 (C10), 73.9 (C6), 65.8 
(C12), 41.0 (C2), 36.5 (C11), 32.9 (C5), 27.1 (C3), 26.7 (C8), 26.3 (C15), 26.3 
(C16), 21.8 (C4), 18.3 (C17); HRMS (ESI) Found: [M+H]+, 293.1749. C17H24O4 
























                        
 
Carbonate 303b (64.8 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 304b (58 mg, 71%, r.r. > 19:1) as a yellow oil. RF 0.34  [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 2929, 1698 (C=O), 1676 (C=O), 1599; δH (400 MHz, 
CDCl3) 8.03 (dd, J = 8.0, 1.2 Hz, 1H, H3), 7.47 (td, J = 7.4, 1.5 Hz, 1H, H4), 
7.31 (t, J = 8.0 Hz, 1H, H5), 7.20 (d, J = 7.9 Hz, 1H, H6), 4.88 (q, J = 1.2 Hz, 
1H, H14a), 4.79 (q, J = 1.7 Hz, 1H, H14b), 3.01-2.88 (m, 2H, H8), 2.81 (dt, J = 
18.4, 2.0 Hz, 1H, H15a), 2.63-2.44 (m, 3H, H9 and H15b), 2.28 (s, 3H, H12), 
2.15 (s, 3H, H19), 2.14 (s, 3H, H20), 1.47 (s, 3H, H21); δC (100 MHz, CDCl3) 
206.9 (C17), 206.8 (C18), 206.0 (C11), 196.4 (C1), 142.9 (C2), 140.5 (C13), 
133.8 (C4), 132.1 (C7), 128.6 (C6), 127.8 (C3), 127.0 (C5), 116.9 (C14), 70.4 
(C10), 66.1 (C16), 36.5 (C15), 29.3 (C9), 28.3 (C12), 26.3 (C19 and C20), 
25.8 (C8), 18.0 (C21); HRMS (ESI) Found: [M+Na]+, 363.1568. C21H24O4 


























The formation of 304b was also carried out under enantioselective conditions: 
Carbonate 303b (43.2 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol) (R)-
Xylyl-P-PHOS L19 (7.3 mg, 0.0096 mmol) and 3-methyl-2,4-pentanedione 
301h (0.019 μL, 0.16 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Tetrahydrofuran (1 
mL) was added and the sealed tube was stirred at 60 °C for 2 hours, then 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 304b (30 mg, 57% yield, r.r. > 19:1). Chiral HPLC: AD-H column, 1 
mL/min, 9:1 Hexane:IPA, tA (minor) = 10.7 min, tB (major) = 12.6 min, 21% ee; 





                      
 
Carbonate 303c (60.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 4 hours, then cooled to room temperature and 
























afforded product 304c (47 mg, 61%, r.r. > 19:1) as a yellow solid. RF 0.35 [4:1 
Pet:EtOAc]; m.p. 82–84 °C; νmax (film)/cm−1 2968, 2935, 1694 (C=O), 1636; δH 
(400 MHz, CDCl3) 4.93 (q, J = 1.5 Hz, 1H, H12a), 4.87 (q, J = 1.5 Hz, 1H, 
H12b), 2.92 (sept, J = 7.0 Hz, 1H, H8), 2.64 (dt, J = 18.5, 1.6 Hz, 1H, H13a), 
2.56-2.43 (m, 3H, H2 and H13b), 2.33-2.22 (m, 2H, H5), 2.17 (s, 3H, H17), 
2.17 (s, 3H, H18), 1.92-1.81 (m, 2H, H3), 1.77-1.67 (m, 2H, H4), 1.48 (s, 3H, 
H19), 1.10 (d, J = 6.6 Hz, 3H, H9), 1.06 (d, J = 6.7 Hz, 3H, H10); δC (100 
MHz, CDCl3) 213.7 (C7), 209.9 (C1), 207.4 (C15), 207.3 (C16), 140.6 (C11), 
116.2 (C12), 74.5 (C6), 66.0 (C14), 41.1 (C2), 37.2 (C8), 36.5 (C13), 32.4 
(C5), 26.9 (C3), 26.4 (C17), 26.4 (C18), 21.8 (C4), 20.9 (C9), 20.5 (C10), 18.3 






                            
 
Carbonate 303d (73.0 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 311h (28 
μL, 0.240 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 





























concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 304d (66 mg, 74%) as an orange oil. RF 0.33 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 2102, 1740 (C=O), 1699 (C=O), 1591; δH (400 MHz, CDCl3) 8.08-
8.02 (m, 2H, H2), 7.91-7.84 (m, 2H, H1), 7.45-7.39 (m, 2H, H7), 7.36-7.27 (m, 
3H, H8 and H9), 4.96 (q, J = 1.4 Hz, 1H, H11a), 4.92 (q, J = 1.2 Hz, 1H, 
H11b), 2.74 (t, J = 1.5 Hz, 2H, H12), 2.08 (s, 6H, H15), 1.42 (s, 3H, H16); δC 
(100 MHz, CDCl3) 207.0 (C14), 199.0 (C4), 141.6 (C10), 141.2 (C3), 136.1 
(C1), 134.6 (C6), 128.8 (C8), 128.4 (C7), 128.1 (C9), 123.9 (C2), 118.7 (C11), 
69.8 (C5), 66.3 (C13), 36.3 (C12), 26.1 (C15), 17.8 (C16); HRMS (ESI) Found: 






                              
Carbonate 303e (50 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 





















afforded product 304e (29 mg, 43%, r.r. 4.0:1) as a yellow solid. RF 0.31 
[Petrol:EtOAc 4:1]; m.p. 42–44 °C; νmax (film)/cm−1 3382, 2994, 2950, 2942, 
1722 (C=O), 1692 (C=O), 1634; δH (400 MHz, CDCl3) 4.89 (q, J = 1.7 Hz, 1H, 
H7a), 4.73 (q, J = 1.7 Hz, H7b), 2.85-2.74 (m, 2H, H2a), 2.62-2.53 (m, 2H, 
H2b), 2.47 (t, J = 1.2 Hz, 2H, H8), 2.15-2.12 (m, 1H, H1), 2.10 (s, 6H, H11), 
1.42 (s, 3H, H12), 1.31 (s, 3H, H5); δC (100 MHz, CDCl3) 208.0 (C3), 206.6 
(C10), 142.8 (C6), 114.8 (C7), 73.2 (C4), 65.9 (C9), 38.5 (C2), 36.2 (C8), 26.2 
(C11), 18.9 (C1), 18.2 (C12), 17.4 (C5); HRMS (ESI) Found: [M+H]+, 




                           
 
Carbonate 303f (61.9 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of 304f and homocoupled 303f in a 5.1:1 ratio 
(60 mg, corresponding to 49.5 mg of 304f, 63%, r.r. > 19:1) as a red solid. RF 

























1698 (C=O), 1667 (C=O); δH (400 MHz, CDCl3) 7.83-7.79 (m, 2H, H3), 7.50 
(tt, J = 7.3, 1.9 Hz, 1H, H1), 7.41-7.35 (m, 2H, H2), 5.13 (q, J = 1.3 Hz, 1H, 
H11a), 4.87 (q, J = 1.6 Hz, 1H, H11b), 2.80 (dt, J = 18.3, 1.9 Hz, 1H, H12a), 
2.61 (dt, J = 18.3, 1.6 Hz, 1H, H12b), 2.18 (s, 3H, H8), 2.14 (s, 3H, H16), 2.12 
(s, 3H, H17), 1.68 (s, 3H, H9), 1.43 (s, 3H, H18); δC (100 MHz, CDCl3) 207.2 
(C14), 207.2 (C15), 206.2 (C7), 200.7 (C5), 143.0 (C10), 135.7 (C4), 132.9 
(C1), 129.3 (C3), 128.3 (C2), 115.8 (C11), 70.3 (C6), 65.9 (C13), 36.7 (C12), 
27.6 (C8), 26.3 (C16), 26.2 (C17), 20.9 (C9), 18.2 (C18); HRMS (ESI) Found: 
[M+H]+, 329.1759. C20H24O4 requires [M+H]+, 329.1747.  
 
The formation of 304f was also carried out under enantioselective conditions: 
Carbonate 303f (45,8 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol) (R)-
Xylyl-P-PHOS L12 (7.3 mg, 0.0096 mmol) and 3-methyl-2,4-pentanedione 
301h (0.019 μL, 0.16 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Tetrahydrofuran (1 
mL) was added and the sealed tube was stirred at 60 °C for 2 hours, then 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 304f (18 mg, 34% yield, r.r. > 19:1). Chiral HPLC: OD-H column, 1 
mL/min, 9:1 Hexane:IPA, tA (major) = 7.7 min, tB (minor) = 8.5 min, 19% ee; 








                               
Carbonate 303g (53.2 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded product 304g (32 mg, 46%, r.r. 10:1) as a brown oil. RF 0.34 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 3386, 2924, 2835, 1694 (C=O); δH (400 
MHz, CDCl3) 5.67-5.55 (m, 1H, H5), 5.16-5.04 (m, 3H, H6 and H8a), 4.90 (q, J 
= 1.8 Hz, 1H, H8b), 2.80 (dt, J = 7.0, 1.5 Hz, 2H, H4), 2.57 (t, J = 1.5 Hz, 2H, 
H9), 2.17 (s, 6H, H1), 2.13 (s, 6H, H12), 1.42 (s, 3H, H13); δC (100 MHz, 
CDCl3) 206.8 (C11), 205.8 (C2), 140.6 (C7), 132.9 (C5), 118.8 (C6), 117.2 
(C8), 76.8 (C3), 65.9 (C10), 36.0 (C4), 35.7 (C9), 27.8 (C1), 26.2 (C12), 18.2 


























Ethyl 3,3,6-triacetyl-6-methyl-4-methylene-7-oxooctanoate (304h): 
 
                               
 
 
Carbonate 303h (50 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol), and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1] 
afforded an inseparable 16:1.2:1 mixture of 304h, 302h and 302g (38 mg, 
corresponding to 33.5 mg of 304h, 41%, r.r. 3.5:1) as a green oil. RF 0.31 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 2983, 2935, 1697 (C=O), 1638; δH (400 
MHz, CDCl3) 5.09 (q, J = 1.8 Hz, 1H, H9a), 4.87 (q, J = 1.9 Hz, 1H, H9b), 4.13 
(q, J = 4.1 Hz, 2H, H6), 3.05 (s, 2H, H4), 2.54 (t, J = 1.6 Hz, 2H, H10), 2.25 (s, 
6H, H1), 2.11 (s, 6H, H13), 1.40 (s, 3H, H14), 1.25 (t, J = 7.2 Hz, 3H, H7); δC 
(100 MHz, CDCl3) 206.4 (C12), 204.8 (C2), 170.6 (C5), 140.2 (C8), 117.2 
(C9), 73.5 (C3), 65.3 (C11), 61.2 (C6), 37.7 (C4), 36.0 (C10), 28.1 (C1), 26.2 
(C13), 18.0 (C14), 14.0 (C7); HRMS (ESI) Found: [M+Na]+, 361.1606. 


























3,6-Diacetyl-3-benzyl-6-methyl-4-methyleneoctane-2,7-dione (304i):       
              
                            
 
Carbonate 303i (65.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol), and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of 304i and homocoupled 303i in a 6.5:1 ratio 
(21 mg, corresponding to 17.5 mg of 304i, 21%, r.r. > 19:1) as a yellow solid. 
RF 0.37 [Petrol:EtOAc 4:1]; m.p. 70–72 °C; νmax (film)/cm−1 3384, 2993, 2927, 
1692 (C=O), 1641, 1500; δH (400 MHz, CDCl3) 7.24-7.17 (m, 3H, H1 and H2), 
7.06 (dd, J = 7.7, 1.5 Hz, 2H, H3), 5.18 (q, J = 1.4 Hz, 1H, H10a), 4.91 (q, J = 
1.9 Hz, 1H, H10b), 3.47 (s, 2H, H5), 2.64 (t, J = 1.7 Hz, 2H, H11), 2.15 (s, 6H, 
H8), 2.11 (s, 6H, H14), 1.41 (s, 3H, H15); δC (100 MHz, CDCl3) 206.9 (C13), 
205.8 (C7), 141.2 (C9), 136.1 (C4), 129.7 (C3), 128.4 (C2), 127.0 (C1), 117.5 
(C10), 78.0 (C6), 66.0 (C12), 37.8 (C5), 35.6 (C11), 28.4 (C8), 26.2 (C14), 































Carbonate 266 (35.5 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), 
DPEphos (8.6 mg, 0.0160 mmol) and 301j (30.4 mg, 0.16 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Tetrahydrofuran (1 mL) was added and the sealed tube 
was added to an oil bath preheated to 60 °C. The mixture was stirred at 60 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 304l (21 mg, 
36%, r.r. not determined) as a colourless oil. RF 0.44 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 2942, 2206, 1694 (C=O); δH (400 MHz, CDCl3) 7.25-7.19 (m, 3H, 
H20 and H21), 6.99-6.93 (m, 2H, H19), 5.04 (q, J = 1.7 Hz, 1H, H10a), 4.97 
(q, J	  = 1.5 Hz, 1H, H10b), 3.40 (dd, J = 19.3, 15.0 Hz, 2H, H17), 2.56 (dt, J = 
19.1, 1.6 Hz, 1H, H11a), 2.52-2.36 (m, 3H, H1 and H11b), 2.24 (s, 3H, H14), 
2.22 (s, 3H, H16), 2.17-2.13 (m, 2H, H4a), 2.07 (s, 3H, H8), 2.07-2.00 (m, 1H, 
H4b), 1.90-1.80 (m, 1H, H2a), 1.77-1.66 (m, 1H, H2b), 1.57-1.46 (m, 2H, H3); 
δC (100 MHz, CDCl3) 209.1 (C6), 207.4 (C7), 206.9 (C13), 206.6 (C15), 141.2 
(C9), 135.9 (C18), 129.6 (C19), 128.4 (C20), 127.2 (C12), 115.8 (C10), 73.4 
(C5), 70.2 (C12), 41.0 (C11), 38.0 (C17), 33.6 (C1), 33.0 (C4), 27.7 (C14), 
27.4 (C16), 27.1 (C2), 26.7 (C8), 21.7 (C3); HRMS (ESI) Found: [M+H]+, 


























The formation of 304l was also carried out under enantioselective conditions: 
Carbonate 266 (35.5 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), (R)-
Xylyl-P-PHOS L19 (7.3 mg, 0.0096 mmol) and 301j (30.4 mg, 0.16 mmol) 
were added to a dried tube under argon. The tube was fitted with a septum 
and purged further with argon. Tetrahydrofuran (1 mL) was added and the 
sealed tube was stirred at 60 °C for 2 hours, then concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 304l (17 mg, 
29% yield, r.r. not determined). Chiral HPLC: AD-H column, 1 mL/min, 9:1 
Hexane:IPA, tA (minor) = 8.4 min, tB (major) = 9.5 min, 19% ee; [α]D25 +1.0 (c 








Carbonate 303m (57.2 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 























concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of 304m and 302h in a 17:1 ratio (45 mg, 
corresponding to 42.6 mg of 304m, 58%, r.r. > 19:1) as a red oil. RF 0.36 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 3015, 2935, 1719 (C=O), 1698 (C=O); δH 
(400 MHz, CDCl3) 4.99 (q, J = 1.2 Hz, 1H, H10a), 4.72 (q, J = 1.5 Hz, 1H, 
H10b), 4.17 (q, J = 7.2 Hz, 1H, H7a), 4.17 (q, J = 7.2 Hz, 1H, H7b), 2.81 (dt, J 
= 18.2, 1.4 Hz, 1H, H11a), 2.66 (dt, J = 17.9, 1.6 Hz, 1H, H11b), 2.57-2.49 (m, 
1H, H4a), 2.37-2.24 (m, 3H, H2 and H4b), 2.11 (s, 3H, H15), 2.10 (s, 3H, 
H16), 1.98-1.80 (m, 2H, H3), 1.41 (s, 3H, H17), 1.23 (t, J = 6.2 Hz, 3H, H8); δC 
(100 MHz, CDCl3) 212.0 (C1), 207.1 (C13), 207.0 (C14), 170.2 (C6), 139.3 
(C9), 114.7 (C10), 67.4 (C5), 66.2 (C12), 61.8 (C7), 37.7 (C2), 35.9 (C11), 
33.2 (C4), 26.3 (C15), 26.1 (C16), 19.2 (C3), 17.8 (C17), 14.0 (C8); HRMS 
(ESI) Found: [M+H]+, 309.1699. C17H24O5 requires [M+H]+, 309.1697. 
 
Ethyl 2,5-diacetyl-2,5-dimethyl-3-methylene-6-oxoheptanoate (304n): 
                             
                         
 
Carbonate 303n (54.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 



















concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of 304n, homocoupled 302h and 
homocoupled 303n in a 16:1.3:1 ratio (34 mg, corresponding to 30 mg of 
304n, 42%, r.r. > 19:1) as a yellow oil. RF 0.35 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 2935, 2873, 1694 (C=O), 1641, 1556; δH (400 MHz, CDCl3) 5.00 
(q, J = 1.2 Hz, 1H, H9a), 4.76 (q, J = 1.4 Hz, 1H, H9b), 4.21 (q, J = 7.1 Hz, 
2H, H6), 2.70 (d, J = 6.2 Hz, 2H, H10), 2.21 (s, 3H, H1), 2.13 (s, 3H, H14), 
2.12 (s, 3H, H15), 1.55 (s, 3H, H4), 1.43 (s, 3H, H16), 1.27 (t, J = 7.1 Hz, 3H, 
H7); δC (100 MHz, CDCl3) 207.1 (C12), 206.9 (C13), 204.8 (C2), 171.4 (C5), 
142.0 (C8), 114.7 (C9), 66.4 (C3), 66.3 (C11), 61.6 (C6), 36.1 (C10), 27.0 
(C1), 26.3 (C14), 26.2 (C15), 19.9 (C4), 17.8 (C16), 14.0 (C7); HRMS (ESI) 





                             
  
Carbonate 303o (55.2 mg, 0.240 mmol), Pd2(dba)3 (11 mg, 0.0120 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 




















concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 8:1-5:1] 
afforded product 304o (25 mg, 35%, r.r. > 19:1) as a clear oil. RF 0.35 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 2987, 2937, 1753, 1727 (C=O), 1697 
(C=O); δH (400 MHz, CDCl3) 5.33 (q, J = 0.7 Hz, 1H, H8a), 5.09 (sext, J = 1.6 
Hz, 1H, H8b), 4.30 (q, J = 7.1 Hz, 2H, H5), 2.78 (s, 2H, H9), 2.30 (d, J = 4.8 
Hz, 3H, H1), 2.12 (s, 6H, H13 and H14), 1.38 (s, 3H, H15), 1.31 (t, J = 6.9 Hz, 
3H, H6); δC (100 MHz, CDCl3) 206.6 (C11), 206.5 (C12), 199.9 (d, J = 29.3 
Hz, C2), 165.1 (d, J = 25.6 Hz, C4), 136.7 (d, J = 21.3 Hz, C7), 119.1 (d, J = 
8.4 Hz, C8), 100.0 (d, J = 198.5 Hz, C3), 66.2 (C10), 62.9 (C5), 34.4 (d, J = 
3.6 Hz, C9), 26.4 (C13), 26.4 (C14), 25.7 (C1), 17.9 (C15), 13.9 (C6); HRMS 





                           
 
Carbonate 303q (77.6 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 



























afforded 304q (50 mg, 53%, r.r. > 19:1) as a red oil. RF 0.31 (4:1 
Petrol:EtOAc); νmax (film)/cm−1 2978, 2933, 1764, 1714 (C=O), 1695 (C=O), 
1457; δH (400 MHz, CDCl3) 4.98 (q, J = 1.2 Hz, 1H, H12a), 4.78 (q, J = 1.7 
Hz, 1H, H12b), 3.67-3.53 (m, 2H, H4), 2.82 (dt, J = 18.2, 1.8 Hz, 1H, H13a), 
2.49 (dt, J = 18.4, 1.9 Hz, 1H, H13b), 2.39-2.29 (m, 1H, H5a), 2.27 (s, 3H, 
H10), 2.15 (s, 3H, H17), 2.13 (s, 3H, H18), 2.07-1.99 (m, 1H, H5b), 1.83-1.74 
(m, 2H, H6), 1.49 (s, 9H, H1), 1.46 (s, 3H, H19); δC (100 MHz, CDCl3) 207.1 
(C15), 206.8 (C16), 204.4 (C9), 170.6 (C8), 153.0 (C3), 142.0 (C11), 116.2 
(C12), 83.3 (C2), 69.5 (C7), 66.2 (C14), 46.5 (C4), 36.1 (C13), 28.1 (C5), 28.1 
(C10), 27.9 (C1), 26.4 (C17), 26.1 (C18), 19.6 (C6), 18.1 (C19); HRMS (ESI) 




                             
Carbonate 303r (55.7 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and 3-methyl-2,4-pentanedione 301h (28 
μL, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 80 °C. The mixture 
was stirred at 80 °C for 2 hours, then cooled to room temperature and 




















afforded 304r (15 mg, 21%, r.r. > 19:1) as a green oil. RF 0.10 [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 2927, 2855, 1712 (C=O), 1695 (C=O), 1634; δH (400 
MHz, CDCl3) 5.23 (q, J = 1.6 Hz, 1H, H7a), 5.07 (q, J = 1.9 Hz, 1H, H7b), 3.07 
(s, 3H, H1), 2.96-2.94 (m, 1H, H8a), 2.93-2.91 (m, 1H, H8b), 2.25 (s, 3H, H4), 
2.18 (s, 3H, H12), 2.17 (s, 3H, H13), 1.86 (s, 3H, H5), 1.48 (s, 3H, H14); δC 
(100 MHz, CDCl3) 207.1 (C10), 207.0 (C11), 202.7 (C3), 137.2 (C6), 121.1 
(C7), 80.2 (C2), 65.7 (C9), 37.8 (C1), 35.7 (C8), 27.2 (C4), 26.7 (C12), 26.2 
(C13), 18.9 (C5), 15.6 (C14); HRMS (ESI) Found: [M+H]+, 303.0790. 
C14H22SO5 requires [M+H]+, 303.1261. 
 
3-Ethyl 3-prop-2-ynyl 4-oxochroman-3,3-dicarboxylate (304s): 
 
 
Carbonate 303s (48 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), 
DPEphos (8.6 mg, 0.0160 mmol) and 3-methyl-2,4-pentanedione 301h (19 µL, 
0.16 mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. Tetrahydrofuran (1 mL) was added and 
the sealed tube was added to an oil bath preheated to 60 °C. The mixture was 
stirred at 60 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded 304s (19 mg, 32%, r.r. 2.3:1) as a clear oil. RF 0.25 [Petrol:EtOAc 



























J = 8.1, 1.8 Hz, 1H, H3), 7.47 (ddd, J = 9, 7.4, 2.0 Hz, 1H, H4), 7.04 (ddd, J = 
8.1, 7.3, 1.0 Hz, 1H, H5), 6.93 (dd, J = 8.4, 0.8 Hz, 1H, H6), 4.94 (q, J = 1.2 
Hz, 1H, H14a), 4.87 (q, J = 1.8 Hz, 1H, H14b), 4.88 (q, J = 17.6, Hz, 2H, H11), 
2.86 (t, J = 1.8 Hz, 2H, H15), 2.13 (s, 6H, H18 and H21), 1.47 (s, 3H, H19), 
1.26 (t, J = 7.2 Hz, 3H, H12); δC (100 MHz, CDCl3) 207.1 (C17), 206.9 (C20), 
189.0 (C1), 168.1 (C10), 160.8 (C13), 137.1 (C2), 136.1 (C4), 127.9 (C3), 
121.9 (C5), 120.2 (C7), 118.0 (C14), 117.5 (C6), 70.2 (C8), 66.5 (C16), 63.9 
(C9), 62.2 (C11), 36.4 (C15), 26.3 (C18), 26.1 (C21), 17.7 (C19), 14.0 (C12); 
HRMS (ESI) Found: [M+H]+, 373.1638. C21H24O6 requires [M+H]+, 373.1646.  
 
The formation of 304s was also carried out under enantioselective conditions: 
Carbonate 303s (48 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), (R)-
Xylyl-P-PHOS L19 (7.3 mg, 0.0096 mmol) and 3-methyl-2,4-pentanedione 
(0.019 μL, 0.16 mmol) were added to a dried tube under argon. The tube was 
fitted with a septum and purged further with argon. Tetrahydrofuran (1 mL) 
was added and the sealed tube was stirred at 60 °C for 2 hours, then 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded chiral 304s (14 mg, 24% yield, r.r. 3.2:1). Chiral HPLC: AD-H column, 
1 mL/min, 9:1 Hexane:IPA, tA (major) = 7.6 min, tB (minor) = 10.0 min, 9% ee; 











Carbonate 303d (48.7 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), 
DPEphos (8.6 mg, 0.0160 mmol) and 2-acetylcyclohexanone (22 µL, 0.16 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-dioxane (1 mL) was added and the 
sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 19:1-9:1] 
afforded 304t (21 mg, 33% r.r. not determined) as a colourless oil. RF 0.35 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 2939, 1697 (C=O); δH (400 MHz, CDCl3) 
8.05-7.98 (m, 2H, H3 and H6), 7.89-7.82 (m, 2H, H4 and H5), 7.42-7.37 (m, 
2H, H12), 7.35-7.27 (m, 3H, H11	  and H13), 4.98 (q, J = 1.1 Hz, 1H, H15a), 
4.96 (q, J = 1.0 Hz, 1H, H15b), 2.75 (dt, J = 18.1, 1.6 Hz, 1H, H16a), 2.57 (dt, 
J =	  18.0, 1.4 Hz, 1H, H16b), 2.44-2.34 (m, 3H, H20a and H21), 2.06 (s, 3H, 
H24), 1.95-1.86 (m, 1H, H19a), 1.74-1.56 (m, 4H, H18, H19b and H20b); δC 
(100 MHz, CDCl3) 209.7 (C22), 208.1 (C23), 199.2 (C1), 199.0 (C8), 141.2 
(C2), 141.1 (C7), 140.7 (C14), 136.1 (C3 and C6), 134.8 (C10), 128.7 (C11), 
128.5 (C12), 128.0 (C13), 123.9 (C4), 123.9 (C5), 119.8 (C15), 69.7 (C9), 
67.4 (C17), 41.1 (C21), 36.2 (C16), 34.5 (C20), 26.9 (C19), 26.2 (C24), 21.9 

































Ethyl 2-acetyl-4-(1-acetyl-2-oxocyclohexyl)-2-fluoropent-4-enoate (304u): 
 
                               
  
 
Carbonate 266 (53.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
DPEphos (13.1 mg, 0.024 mmol) and ethyl 2-fluoroacetoacetate (30 μL, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 
the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] 
afforded an inseparable mixture of diastereoisomers of 304u in a 1:1 ratio (49 
mg, 63%, r.r. > 19:1) as a yellow oil. RF 0.37 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 2944, 2870, 1751, 1699 (C=O), 1640; δH (400 MHz, CDCl3, 
resonances due to diastereoisomer 304ub annotated by an asterisk) 5.37 (s, 
1H and 1H*, H10a and H10a), 5.02 (d, J = 6.3 Hz, 1H and 1H*, H10b and 
H10b), 4.23 (q, J = 7.0 Hz, 2H and 2H*, H16 and H16), 2.96-2.68 (m, 2H and 
2H*, H11 and H11), 2.58-2.35 (m, 2H and 2H*, H2 and H2), 2.32-2.26 (m, 3H 
and 3H*, H14 and H14), 2.27-2.21 (m, 1H and 1H*, H5a and H5a), 2.13 (s, 3H 
and 3H*, H8 and H8), 2.11-2.01 (m, 1H and 1H*, H5b and H5b), 1.85-1.52 (m, 
4H and 4H*, H3, H4, H3 and H4), 1.26 (t, J = 7.2, Hz, 3H, H17) 1.25 (t, J = 7.2 
























304ub annotated by an asterisk) 208.9 (C1), 208.7 (C1*), 206.7 (C7), 206.5 
(C7*), 201.2 (d, J = 28.8 Hz, C13), 200.9 (d, J = 28.8 Hz, C13*), 165.7 (d, J = 
25.5 Hz, C15), 165.7 (d, J = 25.5 Hz, C15*), 139.2 (d, J = 22.7 Hz, C9), 139.2 
(d, J = 22.7 Hz, C9*), 119.5 (d, J = 3.8 Hz, C10), 118.8 (d, J = 4.0 Hz, C10*), 
99.8 (d, J = 201.5 Hz, C12), 99.7 (d, J = 201.1 Hz, C12*), 73.8 (C6*), 73.4 
(C6), 62.8 (C16), 62.8 (C16*), 40.8 (C2*), 40.8 (C2), 35.4 (d, J = 20.2 Hz, 
C11), 35.3 (d, J = 19.5 Hz, C11*), 32.2 (C5), 32.2 (C5*), 27.0 (C3), 26.9 (C3*), 
26.9 (C8*), 26.7 (C8), 25.6 (C14), 25.4 (C14*), 21.7* (C4*), 21.7 (C4), 13.9 
(C17), 13.8 (C17*); HRMS (ESI) Found: [M+H]+, 327.1604. C17H23FO5 requires 
[M+H]+, 327.1602. 
 
10.2.4. Mechanistic Studies for the Coupling of 1,3-Dicarbonyl 
Compounds 	  
d3-3-Methyl 2,4-petanedione (D3]-301h):  
 
                        
 
To a solution of acetylacetone (1.02 mL, 10.0 mmol) in acetone (30 mL) was 
added potassium carbonate (1.38 g, 10.0 mmol). The mixture was stirred at 
room temperature for 15 minutes. d3-Iodomethane (0.747 mL, 12.0 mmol) was 
added dropwise and the reaction was heated to reflux at 65 °C for 18 hours. 
The reaction was quenched with aq. HCl (1 N, 30 mL). The mixture was 
extracted with EtOAc (3 x 30 mL). The combined organic phases were 















column chromatography [Petrol:EtOAc 19:1] afforded [D3]-301h (200 mg, 
17%) as a green liquid. Analysis by 1H NMR spectroscopy indicated 98% 
deuterium incorportation. RF 0.55 [Petrol:EtOAc 4:1]; vmax (film)/cm−1 2240, 
1721, 1700 (C=O), 1611; δH (400 MHz, CDCl3, 1.4:1 keto:enol tautomer, enol 
tautomer is annotated by an asterisk) 16.39 (s, 1H, H9*), 3.62 (s, 1H, H3), 
2.16 (s, 6H, H1), 2.08 (s, 6H, H5*); δC (100 MHz, CDCl3, 1.4:1 keto:enol 
tautomer, enol tautomer annotated by an asterisk) 205.1 (C2), 190.4 (C6*), 
104.6 (C7*), 61.8 (C3), 28.6, (C1), 23.3 (C5*), 12.7-11.5 (m, C4 and C8*). 
Synthesis of this compound has been reported in the literature.131 
 
d3-3-Methyl-4-oxopent-2-en-2-yl prop-2-ynyl carbonate ([D3]-300a) and d3-
prop-2-ynyl 2-acetyl-2-methyl-3-oxobutanoate ([D3]-300b): 
 
 
                   
 
A suspension of sodium hydride (60 wt% in mineral oil, 56 mg, 1.40 mmol) in 
tetrahydrofuran (15 mL) was cooled to 0 °C. A solution of [D3]-301h (150 mg, 
1.28 mmol) in tetrahydrofuran (3 mL) was added dropwise and was stirred at 0 
°C for 10 minutes. Propargyl chloroformate (136 μL, 1.40 mmol) was added 
dropwise and the reaction mixture was allowed to warm to room temperature 
and was stirred at room temperature for 1 hour. The reaction was quenched 
by the addition of aq. HCl (1 N, 10 mL) and the mixture was extracted with 
















mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 4:1] afforded an inseparable mixture of carbonate [D3]-300a and 
ester [D3]-300b in a 5:1 ratio (120 mg, 47%) as a clear oil. RF 0.21 
[Petrol:EtOAc 4:1]; νmax (film)/cm–1 3285, 2130 (C≡C), 1991 (C-D), 1757 
(C=O), 1668 (C=O), 1647; δH (400 MHz, CDCl3, resonances due to [D3]-300a 
quoted) 4.80 (d, J = 2.4 Hz, 2H, H8), 2.57 (t, J = 2.4 Hz, 1H, H10), 2.31 (s, 3H, 
H1), 2.09 (s, 3H, H5), resonance to due H4 not observed; δC (100 MHz, 
CDCl3, resonances due to [D3]-300a quoted) 199.1 (C2), 151.7 (C7), 150.6 
(C6), 124.9 (C3), 76.4 (C9), 76.2 (C10), 56.0 (C8), 30.9 (C1), 18.0 (C5), 
resonance due to C4 not observed; HRMS (ESI) Found: [M+H]+, 200.1004. 
C10H9D3O4 requires [M+H]+, 200.0997. 
 
d4-3-Methyl-4-oxopent-2-en-2-yl prop-2-ynyl carbonate ([D4]-300a) and d4-
prop-2-ynyl 2-acetyl-2-methyl-3-oxobutanoate ([D4]-300b): 
 
                     
 
According to a literature procedure,132 to a solution of [D3]-300 (45.7 mg, 0.23 
mmol) in MeCN (4 mL) was added potassium carbonate (95.5 mg, 0.69 mmol) 
at room temperature and the suspension was stirred for 30 minutes. 
Deuterium oxide (0.61 mL) was added and the mixture was stirred at room 
temperature for 18 hours. The mixture was extracted with CH2Cl2 (10 mL), 
dried (MgSO4) and concentrated in vacuo to afford an inseparable mixture of 


















clear oil. Analysis by 1H NMR spectroscopy indicated 96% deuterium 
incorporation. RF 0.21 [Petrol:EtOAc 4:1]; νmax (film)/cm–1 3285, 2924, 2585, 
2131 (C≡C), 1991 (C-D), 1760 (C=O), 1648; δH (400 MHz, CDCl3, resonances 
due to [D4]-300a quoted) 4.79 (s, 2H, H8), 2.30 (s, 3H, H1), 2.08 (s, 3H, H5); 
δC (100 MHz, CDCl3, resonances due to [D4]-300a quoted) 199.0 (C2), 151.7 
(C7), 150.5 (C6), 124.9 (C3), 76.3 (t, J = 12.6 Hz, C9), 75.9 (t, J = 8.3 Hz, 
C10), 56.0 (C8), 30.9 (C1), 17.9 (C5), resonance due to C4 was not observed; 
HRMS (ESI) Found: [M+H]+ 201.1064. C10H8D4O4 requires [M+H]+, 201.1059. 
 
d1-3-Methyl-4-oxopent-2-en-2-yl prop-2-ynyl carbonate ([D]-300a) and d4-
prop-2-ynyl 2-acetyl-2-methyl-3-oxobutanoate ([D]-300b): 
 
                   
 
According to a literature procedure,132 to a solution of propargyl carbonate 300 
(144 mg, 0.730 mmol) in MeCN (8 mL) was added solid potassium carbonate 
(311 mg, 2.25 mmol). The suspension was stirred at room temperature for 30 
min. Deuterium oxide (2 mL) was added via syringe and the solution was 
stirred at room temperature for 1 hour. The mixture was extracted with CH2Cl2 
(10 mL), dried (MgSO4) and concentrated in vacuo to afford an inseparable 
mixture of deuterated alkyne [D]-300a and ester [D]-300b in a 5.3:1 ratio (140 
mg, 97%) as a pale yellow oil. Analysis by 1H NMR spectroscopy indicated 
97% deuterium incorporation. RF 0.21 [Petrol:EtOAc 4:1]; νmax (film)/cm–1 
















resonances due to [D]-300a quoted) 4.74 (s, 2H, H8), 2.24 (s, 3H, H1), 2.03 
(s, 3H, H5), 1.77 (s, 3H, H4); δC (100 MHz, CDCl3, resonances due to [D]-
300a quoted) 199.1 (C2), 151.7 (C7), 150.5 (C6), 125.0 (C3), 76.4 (t, J = 6.9 
Hz, C9), 75.9 (t, J = 8.3 Hz, C10), 56.0 (C8), 30.9 (C1), 17.9 (C5), 14.0 (C4); 






                               
 
[D]-300 (47.3 mg, 0.24), Pd2(dba)3 (11 mg, 0.012 mmol), DPEphos (13.1 mg, 
0.024 mmol) and 2-acetyl-1-tetralone (53.2 mg, 0.24 mmol) were added to a 
dried tube under argon. The tube was fitted with a septum and purged further 
with argon. 1,4-Dioxane (1.5 mL) was added and the sealed tube was added 
to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 hours, 
then cooled to room temperature and concentrated in vacuo. Flash column 
chromatography [Petrol:EtOAc 9:1-4:1] afforded an inseparable mixture of [D]-
302b and the homocoupled product of 2-acetyl-1-tetralone (301b) in a 10:1 
ratio (60 mg, corresponding to 54 mg of [D]-302b, 66%, r.r. > 19:1) as a red 
oil. 1H NMR analysis indicated 46% deuterium incorporation at the vinylic 









[Petrol:EtOAc 4:1]; νmax (film)/cm–1 2935, 1699 (C=O), 1671 (C=O), 1599; 
HRMS (ESI) Found: [M+H]+, 342.1805. C21H23DO4 requires [M+H]+, 342.1810. 
 
d4-3-(3-(2-Acetyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)prop- 




                   
 
 
Carbonate 300 (23.5mg, 0.12 mmol), carbonate [D4]-300 (24.0 mg, 0.12 
mmol), Pd2(dba)3 (11 mg, 0.012 mmol), DPEphos (13.1 mg, 0.024 mmol) and 
2-acetyl-1-tetralone (53.2 mg, 0.24 mmol) were added to a dried tube under 
argon. The tube was fitted with a septum and purged further with argon. 1,4-
Dioxane (1.5 mL) was added and the sealed tube was added to an oil bath 
preheated to 80 °C. The mixture was stirred at 80 °C for 2 hours, then cooled 
to room temperature and concentrated in vacuo. Flash column 
chromatography [Petrol:EtOAc 9:1-4:1] afforded a mixture of 302b and [D4]-
302b (57 mg, 69 %, r.r. > 19:1) as a red oil. RF 0.41 [Petrol:EtOAc 4:1]; νmax 
(film)/cm–1 2927, 1699 (C=O), 1671 (C=O), 1599; HRMS analysis indicated the 
presence 302b and [D4]-302bb only. HRMS (ESI) 302b: Found: [M+Na]+ 
363.1559. C21H24O4 requires [M+Na]+, 363.1567; [D4]-302b: Found: [M+Na]+, 














10.2.5. The Synthesis of Pyrroles  
 
Methyl 1H-pyrrole-3-carboxylate (313c): 
 
 
According to a literature procedure,133 to a suspension of potassium tert-
butoxide (2.1 g, 18.7 mmol) in tetrahydrofuran (24 mL) was added dropwise a 
solution of p-toluenesulfonylmethyl isocyanide (3 g, 15.3 mmol) and methyl 
acrylate (1.25 mL, 14 mmol) in tetrahydrofuran (10 mL) over 30 minutes. The 
resulting mixture was stirred at room temperature for 2 hours. The reaction 
was quenched with water (30 mL) and extracted with ethyl acetate (3 x 30 
mL). The organic phase was dried (MgSO4), and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 4:1] afforded 313c  (443 mg, 25%) as 
a brown solid. RF 0.46 [Petrol:EtOAc 3:1]; m.p. 88–92 °C; νmax (film)/cm−1 3263 
(N–H), 1664 (C=O), 1502; δH (400 MHz, CDCl3) 9.27 (br s, 1H, H2) 7.43-7.39 
(m, 1H, H1), 6.75-6.72 (m, 1H, H4), 6.65-6.61 (m, 1H, H3), 3.81 (s, 3H, H7); 
δC (100 MHz, CDCl3) 165.9 (C6), 123.7 (C1), 119.0 (C4), 115.8 (C5), 109.5 
(C3), 51.1 (C7); HRMS (ESI) Found: [M+H]+, 126.0550. C6H7NO2 requires 
[M+H]+, 126.0550. Synthesis of this compound has been reported in the 
literature.133 














tert-Butyl 1H-pyrrole-1-carboxylate  (350): 
 
 
According to a literature procedure,134 to a solution of pyrrole (1 g, 15 mmol) in 
acetonitrile (20 mL) was added di-tert butyl dicarbonate (3.9 g, 18 mmol) and 
4-dimethylaminopyridine(0.25 g, 4.5 mmol) at room temperature. The mixture 
was stirred at room temperature for 2.5 hours. The solvent was removed in 
vacuo and the residue was purified by flash column chromatography 
[Petrol:EtOAc 4:1], to give 350 (1.7 g, 70%) as a yellow oil. RF 0.82 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1  2980, 1738 (C=O); δH (400 MHz, CDCl3) 
7.14 (t, J = 2.3 Hz, 2H, H2), 6.12 (t, J = 2.4 Hz, 2H, H1), 1.50 (s, 9H, H5); δC 
(100 MHz, CDCl3) 148.8 (C3), 119.9 (C2), 117.7 (C1), 83.4 (C4), 27.8 (C5). 
Synthesis of this compound has been reported in the literature.134 
 
tert-Butyl 2,5-dimethyl 1H-pyrrole-1,2,5-tricarboxylate (351): 
 
 
According to a literature procedure,135 to a solution of 2,2,6,6-tetramethyl-
piperidine (1.35 mL, 0.08 mol) in tetrahydrofuran (20 mL) under an 
atmosphere of argon at −78 °C was added n-butyllithium (1.6 M in hexanes, 5 
mL, 8 mmol) dropwise via cannula. A solution of 350 (535 mg, 3.2 mmol) in 
































mixture was stirred at −78 °C for 3 hours before being transferred dropwise via 
cannula into a stirred solution of methyl chloroformate (0.740 mL, 3.2 mmol) 
cooled to −78 °C. After 30 minutes the reaction was quenched by the addition 
of aq. NH4Cl (10 mL) and allowed warmed to room temperature. Water (10 
mL) was added and the mixture was extracted with Et2O (4 x 20 mL). The 
combined organic layers were washed with aq. HCl (1 N, 20 mL) and brine (20 
mL), then dried (MgSO4) and concentrated in vauo. Flash column 
chromatography [EtOAc:Petrol 1:4] afforded 351 (300 mg, 33%) as a pink 
solid. RF 0.55 [Petrol:EtOAc 4:1]; m.p. 172–174 °C; νmax (film)/cm−1 2959, 
1774 (C=O), 1705 (C=O), 1537; δH (400 MHz, CDCl3) 6.83 (s, 2H, H1), 3.78 
(s, 6H, H7), 1.66 (s, 9H, H5); δC (100 MHz, CDCl3) 160.0 (C6), 148.8 (C3), 
126.7 (C2), 115.9 (C1), 86.3 (C4), 52.0 (C7), 27.3 (C5); HRMS (ESI) Found: 
[M+Na]+, 306.0946. C13H17NO6 requires [M+Na]+, 306.0948. Synthesis of this 
compound has been reported in the literature.135 
 
Dimethyl 1H-pyrrole-2,5-dicarboxylate (313e): 
 
 
According to a literature procedure,134 to a solution of 351 (140 mg, 0.494 
mmol) in dichloromethane (1.5 mL) cooled to 0 ᵒC  was added 
trifluoroaceticacid (0.5 mL) and the resulting mixture was stirred at room 
temperature for 2 hours. The mixture was diluted with EtOAc (5 mL) and 















(MgSO4) and concentrated in vacuo to afford 313e (85 mg, 95%) as a white 
solid. RF 0.55 [Petrol:EtOAc 4:1];  m.p. 128–130 °C; νmax (film)/cm−1 3289 (N–
H), 1709 (C=O), 1554;  δH (400 MHz, CDCl3) 9.77 (br s, 1H, H3), 6.87 (d, J = 
2.6 Hz, 1H, H1), 3.89 (s, 3H, H5); δC (100 MHz, CDCl3) 160.7 (C4), 126.0 
(C2), 115.6 (C1), 52.0 (C5). Synthesis of this compound has been reported in 
the literature.134 
 




According to a literature procedure,136 to a solution of methyl-2-pyrrole 
carboxylate (300 mg, 2.4 mmol) and isovaleryl chloride (380 µL, 3.1 mmol) in 
dichloromethane (10 mL) cooled to 0 ᵒC was added aluminium chloride (959 
mg, 7.2 mmol). The mixture was stirred at room temperature for 18 hours. The 
solution was poured into ice-cold water (20 mL), then extracted with CH2Cl2 (2 
x 20 mL). The organic layer was dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 4:1] afforded 313f (405 mg, 
81%) as a yellow solid. RF 0.12 [Petrol:EtOAc 4:1]; m.p. 111–114 °C; νmax 
(film)/cm−1 3192, 2953, 1697 (C=O), 1636 (C=O); δH (400 MHz, CDCl3) 9.48 
(br s, 1H, H7), 7.45 (dd, J = 3.2, 1.5 Hz, 1H, H6), 7.28 (dd, J = 2.4, 1.5 Hz, 1H, 
H4), 3.88 (s, 3H, H1), 2.62 (d, J = 7.1 Hz, 2H, H9), 2.26 (sept, J = 7.7 Hz, 1H, 




















(C2), 127.7 (C5), 126.0 (C6), 123.8 (C3), 114.8 (C4), 51.9 (C1), 48.8 (C9), 
25.5 (C10), 22.8 (C11); HRMS (ESI) Found: [M+H]+, 210.1097. C11H15NO3 
requires [M+H]+, 210.1125. Synthesis of this compound has been reported in 
the literature.136 
 




According to a literature procedure,136 to a solution of methyl-2-pyrrole 
carboxylate (300 mg, 2.4 mmol) and benzoyl chloride (361 µL, 3.1 mmol) in 
dichloromethane (10 mL) cooled to 0 °C was added aluminium chloride (959 
mg, 7.2 mmol). The mixture was stirred at room temperature for 18 hours. The 
solution was poured into ice-cold water (20 mL), then extracted with 
dichloromethane (2 x 20 mL). The organic layer was dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1-1:1] 
afforded 313g (398 mg, 72%) as a pink solid. RF 0.16 [Petrol:EtOAc 3:1]; m.p. 
147–149 °C; νmax (film)/cm−1 3352, 2950, 1716 (C=O), 1617, 1595; δH (400 
MHz, CDCl3) 10.57 (br s, 1H, H7), 7.87-7.81 (m, 2H, H10), 7.60-7.54 (m, 2H, 
H6 and H12), 7.50-7.44 (m, 2H, H11) 7.37 (dd, J = 2.4, 1.7 Hz, 1H, H4), 3.88 
(s, 3H, H1); δC (100 MHz, CDCl3) 195.7 (C8), 161.4 (C2), 138.9 (C9), 128.9 
(C10), 128.7 (C12), 128.3 (C11), 126.0 (C6), 125.6 (C5), 123.8 (C3), 114.8 





















[M−H]−, 228.0666. Synthesis of this compound has been reported in the 
literature.136 
 




According to a literature procedure,137 a solution of phosphorus(III) oxychloride 
(1 mL) in dimethylformamide (0.862 mL) added at 0 °C, was warmed to room 
temperature and stirred for 30 minutes. Then a solution of methyl 1H-pyrrole-
2-carboxylate (700 mg, 5.6 mmol) in dimethylformamide (1.6 mL) was added 
and reaction mixture was allowed to warm to room temperature and was 
stirred at room temperature for 16 hours. The mixture was cooled to 0 ᵒC and 
NaOH (4 N, 5 mL) was added slowly with stirring until pH 7 had been reached. 
The mixture was filtered and extracted with EtOAc (3 x 20 mL). The organic 
phases were combined and washed with water (20 mL), and brine (20 mL) 
then concentrated in vacuo. Flash column chromatography [Petrol:EtOAC 4:1] 
afforded 313h (200 mg, 26%) as a light red liquid. RF 0.48 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2983, 1731 (C=O); δH (400 MHz, CDCl3) 10.13 (br s, 1H, H7), 
9.67 (s, 1H, H9), 6.95-6.91 (m, 2H, H4 and H6), 3.91 (s, 3H, H1); δC (100 


















115.7 (C4), 52.2 (C1). Synthesis of this compound has been reported in the 
literature.137                                                                                                                                                       
 




According to a literature procedure,136 to a solution of methyl-2-pyrrole 
carboxylate (300 mg, 2.4 mmol) and butyryl chloride (324 µL, 3.1 mmol) in 
dichloromethane (10 mL) stirred at 0 °C was added aluminium chloride (959 
mg, 7.2 mmol) and the solution was stirred at room temperature for 18 hours. 
The solution was poured into ice-cold water (20 mL), then extracted with 
dichloromethane (2 x 20 mL). The organic layer was dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1] 
afforded 352 (140 mg, 30%) as a beige solid. RF 0.15 [Petrol:EtOAc 3:1]; m.p. 
88–90 °C; νmax (film)/cm−1 3278 (N–H), 2955, 1697 (C=O), 1664 (C=O), 1559; 
δH (400 MHz, CDCl3) 9.87 (br s, 1H, H7), 7.55 (dd, J = 3.1, 1.6 Hz, 1H, H6), 
7.29 (dd, J = 2.5, 1.6 Hz, 1H, H4), 3.88 (s, 3H, H1), 2.74 (t, J = 7.3 Hz, 2H, 
H9), 1.73 (sext, J = 7.2 Hz, 2H, H10), 0.97 (t, J = 7.6 Hz, 3H, H11); δC (100 
MHz, CDCl3) 196.1 (C8), 161.4 (C2), 127.2 (C5), 126.2 (C6), 123.7 (C3), 



















[M−H]−, 194.0824. C10H13NO3 requires [M−H]−, 194.0823. Synthesis of this 
compound has been reported in the literature.136 
 




According to a literature procedure,136 to a solution of 352 (400 mg, 2.05 
mmol) in trifluoroacetic acid (1.57 mL, 20.5 mmol) was added triethylsilane 
(0.654 mL, 4.1 mmol) and the reaction mixture was stirred at room 
temperature for 24 hours. The reaction mixture was quenched with aq. 
NaHCO3 (15 mL) and the mixture was extracted with Et2O (3 x 20 mL). The 
combined extracts were dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [Petrol:EtOAc 4:1] afforded 313i (149 mg, 40%) as a 
white solid. RF 0.56 [Petrol:EtOAc 1:1]; m.p. 69–70 °C; νmax (film)/cm−1 3289 
(N–H), 2924, 1677 (C=O); δH (400 MHz, CDCl3) 9.16 (br s, 1H, H7), 6.77-6.73 
(m, 2H, H4 and H6), 3.83 (s, 3H, H1), 2.46 (t, J = 7.9 Hz, 2H, H8), 1.59-1.49 
(m, 2H, H9), 1.35 (sext, J = 7.4 Hz, 2H, H10), 0.91 (t, J = 7.2 Hz, 3H, H11); δC 
(100 MHz, CDCl3) 161.2 (C2), 126.7 (C5), 122.0 (C3), 120.8 (C6), 115.0 (C4), 
51.3 (C1), 33.1 (C9), 26.3 (C8), 22.3 (C10), 13.9 (C11). Synthesis of this 


















(Z)-Ethyl 2-(hydroxyimino)-3-oxobutanoate (353): 
 
According to a literature procedure,138 to a solution of ethyl acetoacetate (3.4 
mL, 26.9 mmol) in glacial acetic acid cooled to 0 °C was added a solution of 
sodium nitrite (1.84 g, 26.7 mmol) in water (7 mL). The reaction was allowed 
to warm to room temperature and stirred at this temperature for 30 minutes. 
The reaction was quenched with water (30 mL) and extracted with EtOAc (2 x 
25 mL). The organic layers were combined and washed with H2O (20 mL) and 
aq. NaHCO3 (20 mL). The organic layer was dried (MgSO4) and concentrated 
in vacuo, giving 353 (1.72 g, 40 %) as a pale yellow oil. RF 0.10 [Petrol:EtOAc 
4:1]; δH (400 MHz, CDCl3) 8.81 (br s, 1H, H7), 4.39 (q, J = 7.4 Hz, 2H, H5), 
2.41 (s, 3H, H1), 1.36 (t, J = 7.2 Hz, 3H, H6); δC (100 MHz, CDCl3) 193.2 (C2), 
161.2 (C4), 151.3 (C3), 62.4 (C5), 25.5 (C1), 14.0 (C6). Synthesis of this 








According to a literature procedure,139 a solution of 353 (0.840 g, 5 mmol), 
ethyl acetoacetate (0.840 mL, 7 mmol) and sodium acetate (1.18 g, 14.4 
























powder (0.90 g, 13.8 mmol) was added portionwise over a period of 5 minutes 
and the reaction mixture was heated from 60 °C to 90 °C  and stirred for 2 
hours. The reaction mixture was allowed to cool slightly and poured into ice-
cold water (50 mL). The precipitate was collected by vacuum filtration and 
solid washed with water (50 mL) and re-dissolved in hot methanol (50 mL).  
The product was then precipitated with water (50 mL), collected by filtration, 
and dried in vacuo to give 313j (508 mg, 42 %) as a white solid. RF 0.30 
[Petrol:EtOAc 4:1]; m.p. 91–94 °C; δH (400 MHz, CDCl3) 9.08 (br s, 1H, H7), 
4.36-4.26 (m, 4H, H2 and H12), 2.56 (s, 3H, H7), 2.51 (s, 3H, H10), 1.37 (t, J 
= 7.1 Hz, 1H, H1), 1.36 (t, J = 7.1 Hz, 1H, H13); δC (100 MHz, CDCl3) 165.5 
(C3), 161.7 (C11), 138.8 (C4), 130.9 (C8), 117.9 (C6), 113.6 (C9), 60.3 (C2), 
59.5 (C12), 14.4 (C7), 14.4 (C10), 14.3 (C1), 12.0 (C13); HRMS (ESI) Found: 
[M+H]+, 238.1075. C12H17NO4 requires [M+H]+, 238.1085.  
 




According to a literature procedure,140 to a solution of 313h (95 mg, 0.63 
mmol) in methanol (1 mL) was added sodium borohydride (24 mg, 0.63 mmol) 
and the solution was stirred at room temperature for 3 hours. The reaction 
mixture was quenched with water (2 mL) and extracted with Et2O (2 x 5 mL). 

















and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 1:1] 
afforded 313k (60 mg, 97%) as a pink oil. RF 0.05 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 3296 (O-H), 1671 (C=O), 1571; δH (400 MHz, CDCl3) 10.09 (br s, 
1H, H7), 6.83 (dd, J = 3.7, 2.5 Hz, 1H, H4), 6.12-6.09 (m, 1H, H6), 4.67 (s, 2H, 
H8), 3.84 (s, 3H, H1), 2.84 (br s, 1H, H9); δC (100 MHz, CDCl3) 162.2 (C2), 
137.1 (C5), 122.2 (C3), 116.0 (C4), 108.4 (C6), 57.8 (C8), 51.6 (C1); HRMS 
(ESI) Found: [M−H]−, 154.0517. C7H9NO3 requires [M−H]−, 154.0510. 
Synthesis of this compound has been reported in the literature.141 
 
10.2.6. Palladium Catalysed Alkenylation Reactions with N-Heterocycles 	  
2-(3-(1H-Indol-1-yl)prop-1-en-2-yl)-2-acetylcyclohexanone (312a): 
 
                                                          
 
 
Carbonate 266 (53.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and indole 311a (28 mg, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 80 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 19:1-9:1] afforded 312a (39 mg, 
55%) as a yellow solid. RF 0.52 [Petrol:EtOAc 4:1]; m.p. 94–96 °C; νmax 





















1511; δH (400 MHz, CDCl3) 7.63 (dt, J = 8.1, 1.1 Hz, 1H, H15), 7.36 (dq, J = 
8.1, 0.8 Hz, 1H, H18), 7.23-7.17 (m, 1H, H16), 7.13-7.07 (m, 1H, H17), 7.06 
(d, J = 3.2 Hz, 1H, H12), 6.54 (dd, J = 3.1, 0.9 Hz, 1H, H13), 4.99-4.98 (m, 1H, 
H10a), 4.85-4.79 (m, 1H, H11a), 4.63-4.57 (m, 2H, H10b and H11b), 2.55 (dd, 
J = 8.0, 5.9 Hz, 2H, H1), 2.48-2.41 (m, 1H, H3a), 2.22 (s, 3H, H8), 2.12-2.03 
(m, 2H, H3b), 2.01-1.93 (m, 1H, H2a), 1.90-1.66 (m, 3H, H2b and H4); δC 
(100 MHz, CDCl3) 208.8 (C6), 206.8 (C7), 142.3 (C9), 136.3 (C14), 128.6 
(C18), 128.3 (C19), 121.8 (C16), 120.8 (C15), 119.5 (C17), 115.8 (C10), 
109.7 (C12), 101.8 (C13), 72.2 (C5), 48.3 (C11), 41.1 (C1), 33.3 (C3), 27.0 
(C2), 26.3 (C8), 22.0 (C4); HRMS (ESI) Found: [M+H]+, 296.1650. C19H21NO2 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and methyl-indole-3-carboxylate 311b (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 























4:1] afforded 312b (59 mg, 70%) as a pale yellow solid. RF 0.20 [Petrol:EtOAc 
4:1]; m.p. 108–110 °C; νmax (film)/cm−1 2950, 1692 (C=O), 1528; δH (400 MHz, 
CDCl3) 8.12-8.08 (m, 1H, H17), 7.71 (s, 1H, H12), 7.37-7.34 (m, 1H, H15), 
7.23-7.17 (m, 2H, H16 and H18), 4.95 (q, J = 0.6 Hz, 1H, H10a), 4.84-4.77 (m, 
1H, H11a), 4.52-4.46 (m, 2H, H10b and H11b), 3.83 (s, 3H, H21), 2.56-2.45 
(m, 2H, H1), 2.45-2.37 (m, 1H, H4a), 2.15 (s, 3H, H8), 2.02-1.88 (m, 2H, H2a 
and H4b), 1.84-1.55 (m, 3H, H2b and H3); δC (100 MHz, CDCl3) 208.6 (C6), 
206.8 (C7), 165.3 (C20), 141.5 (C9), 136.8 (C19), 135.0 (C12), 126.4 (C14), 
123.1 (C17), 122.0 (C16), 121.6 (C18), 115.8 (C10), 110.5 (C15), 107.7 
(C13), 72.2 (C5), 51.0 (C21), 48.9 (C11), 41.1 (C1), 33.5 (C4), 27.0 (C2), 26.2 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-cyanoindole (34.1 mg, 0.24 mmol) 
were added to a dried tube under argon. The tube was fitted with a septum 
and purged further with argon. Toluene (1.5 mL) was added and the sealed 
tube was added to an oil bath preheated to 120 °C. The mixture was stirred at 
120 °C for 2 hours, then cooled to room temperature and concentrated in 
























(43 mg, 55%) as a yellow solid. RF 0.20 [Petrol:EtOAc 4:1]; m.p. 96–99 °C; 
νmax (film)/cm−1 3121, 2942, 2214 (C≡N), 1697 (C=O), 1645; δH (400 MHz, 
CDCl3) 7.76-7.73 (m, 1H, H15), 7.60 (s, 1H, H12), 7.49 (dt, J = 8.1, 0.9 Hz, 
1H, H16), 7.36-7.31 (m, 1H, H18), 7.30-7.26 (m, 1H, H17), 5.06 (q, J = 1.1 Hz, 
1H, H10a), 4.90 (dt, J = 17.7, 1.3 Hz, 1H, H11a), 4.59-4.54 (m, 2H, H10b and 
H11b), 2.64-2.47 (m, 3H, H1 and H4a), 2.22 (s, 3H, H8), 2.07-1.97 (m, 2H, 
H2a and H4b), 1.94-1.85 (m, 1H, H3a), 1.82-1.72 (m, 1H, H2b), 1.72-1.62 (m, 
1H, H3b); δC (100 MHz, CDCl3) 208.6 (C6), 206.8 (C7), 141.3 (C9), 135.7 
(C19), 135.6 (C12), 127.6 (C14), 124.2 (C18), 122.3 (C17), 119.8 (C15), 
115.9 (C10), 115.7 (C13), 111.1 (C16), 86.4 (C20), 72.2 (C5), 49.0 (C11), 
41.1 (C1), 33.6 (C4), 26.8 (C2), 26.2 (C8), 22.1 (C3); HRMS (ESI) Found: 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and ethyl-1H-2-indole carboxylate (45.4 mg, 
0.24 mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. Toluene (1.5 mL) was added and the 
sealed tube was added to an oil bath preheated to 120 °C. The mixture was 



























concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 29:1-
19:1-9:1-4:1] afforded 312d (52 mg, 59%) as a pale yellow solid. RF 0.45 
[Petrol:EtOAc 4:1]; m.p. 102–104 °C; νmax (film)/cm−1 2957, 1697 (C=O), 1649; 
δH (400 MHz, CDCl3) 7.70-7.64 (m, 2H, H15 and H16), 7.40-7.34 (m, 2H, H13 
and H18), 7.19-7.15 (m, 1H, H17), 5.19 (d, J = 18.1 Hz, 1H, H11a), 5.13 (d, J 
= 18.1 Hz, 1H, H11b), 4.32 (qd, J = 7.2, 1.0 Hz, 2H, H10), 4.20 (q, J = 1.2 Hz, 
2H, H21), 2.61-2.56 (m, 2H, H1), 2.52-2.43 (m, 1H, H3a), 2.36 (s, 3H, H8), 
2.27-2.18 (m, 1H, H3b), 2.02-1.91 (m, 2H, H4), 1.91-1.80 (m, 1H, H2a), 1.77-
1.64 (m, 1H, H2b), 1.38 (t, J = 7.1 Hz, 3H, H22); δC (100 MHz, CDCl3) 208.9 
(C6), 207.3 (C7), 161.9 (C20), 140.5 (C9), 140.1 (C19), 127.2 (C12), 125.7 
(C14), 125.5 (C13), 122.3 (C15), 120.9 (C17), 113.4 (C10), 111.4 (C16), 
108.8 (C18), 72.0 (C5), 60.4 (C21), 46.7 (C11), 41.0 (C1), 33.4 (C3), 27.3 
(C4), 26.2 (C8), 22.0 (C2), 14.3 (C22); HRMS (ESI) Found: [M+H]+, 368.1847. 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 5-chloro-1H-indole (36.3 mg, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 























sealed tube was added to an oil bath preheated to 120 °C. The mixture was 
stirred at 120 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 19:1-9:1] 
afforded 312e (41 mg, 52%) as a brown solid. RF 0.45 [Petrol:EtOAc 4:1]; m.p. 
113–115 °C; νmax (film)/cm−1 2948, 1701 (C=O), 1643; δH (400 MHz, CDCl3) 
7.57 (dd, J = 2.1, 0.6 Hz, 1H, H15), 7.30 (dt, J = 8.8, 0.8 Hz, 1H, H17), 7.15 
(dd, J = 8.7, 2.0 Hz, 1H, H18), 7.06 (d, J = 3.4 Hz, 1H, H12), 6.46 (dd, J = 3.2, 
0.9 Hz, 1H, H13), 5.00-4.97 (m, 1H, H10a), 4.84-4.77 (m, 1H, H11a), 4.58-
4.51 (m, 2H, H10b and H11b), 2.62-2.51 (m, 2H, H1), 2.49-2.41 (dddd, J = 
14.4, 8.3, 5.5, 2.2 Hz, 1H, H2a), 2.20 (s, 3H, H8), 2.08-2.00 (m, 1H, H2b), 
2.00-1.93 (m, 1H, H4a) 1.91-1.81 (m, 1H, H4b), 1.81-1.72 (m, 1H, H3a), 1.72-
1.63 (m, 1H, H3b); δC (100 MHz, CDCl3) 208.7 (C6), 206.8 (C7), 142.2 (C9), 
134.7 (C19), 129.9 (C12), 129.4 (C16), 125.3 (C14), 122.1 (C18), 120.2 
(C15), 115.7 (C10), 110.9 (C17), 101.5 (C13), 72.2 (C5), 48.7 (C11), 41.1 
(C1), 33.5 (C2), 27.0 (C4), 26.3 (C8), 22.1 (C3); HRMS (ESI) Found: [M+H]+, 





Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 7-nitro-1H-indole (38.9 mg, 0.24 mmol) 























and purged further with argon. Toluene (1.5 mL) was added and the sealed 
tube was added to an oil bath preheated to 120 °C. The mixture was stirred at 
120 °C for 2 hours, then cooled to room temperature and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 19:1-9:1-4:1] afforded 
312f (51 mg, 62%) as a brown/green solid. RF 0.63 [Petrol:EtOAc 4:1]; m.p. 
125–128 °C; νmax (film)/cm−1 2948, 1714 (C=O), 1694 (C=O), 1504; δH (400 
MHz, CDCl3) 7.88 (dd, J = 7.8, 1.0 Hz, 1H, H15), 7.81 (dd, J = 7.9, 1.1 Hz, 1H, 
H17), 7.27 (d, J = 3.4 Hz, 1H, H12), 7.14 (t, J = 7.9 Hz, 1H, H16), 6.70 (d, J = 
3.4 Hz, 1H, H13), 4.97-4.91 (m, 1H, H11a), 4.87-4.81 (m, 2H, H10a and 
H11b), 4.31-4.29 (m, 1H, H10b), 2.55 (dd, J = 8.0, 5.9 Hz, 2H, H1), 2.50-2.42 
(m, 1H, H2a), 2.23 (s, 3H, H8), 2.10-2.00 (m, 1H, H2b), 1.99-1.84 (m, 2H, H4), 
1.82-1.73 (m, 1H, H3a),1.70-1.60 (m, 1H, H3b); δC (100 MHz, CDCl3) 208.7 
(C6), 207.3 (C7), 142.6 (C9), 136.7 (C18), 133.8 (C19), 133.6 (C12), 127.4 
(C15), 127.0 (C14), 120.2 (C17), 118.7 (C16), 114.7 (C10), 103.7 (C13), 72.1 
(C5), 51.8 (C11), 41.0 (C1), 33.3 (C2), 27.1 (C4), 26.5 (C8), 22.0 (C3); HRMS 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 






















added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 19:1-9:1-4:1] afforded 312g (51 
mg, 62%) as an orange solid. RF 0.22 [Petrol:EtOAc 4:1]; m.p. 120–122 °C; 
νmax (film)/cm−1 2927, 2111, 1709 (C=O), 1694 (C=O), 1511 (N-O); δH (400 
MHz, CDCl3) 8.57 (d, J = 2.1 Hz, 1H, H15), 8.11 (dd, J = 8.1, 2.1 Hz, 1H, 
H17), 7.46 (d, J = 9.0 Hz, 1H, H18), 7.21 (d, J = 3.2 Hz, 1H, H12), 6.71 (d, J = 
3.2 Hz, 1H, H13), 5.04 (s, 1H, H10a), 4.90 (dt, J = 17.4, 1.5 Hz, 1H, H11a), 
4.58 (dt, J = 17.5, 1.6 Hz, 1H, H11b), 4.54 (s, 1H, H10b), 2.64-2.47 (m, 3H, 
H1 and H4a), 2.22 (s, 3H, H8), 2.09-1.98 (m, 2H, H2a and H4b), 1.95-1.86 (m, 
1H, H2b), 1.83-1.63 (m, 2H, H3); δC (100 MHz, CDCl3) 208.6 (C6), 205.8 
(C7), 141.8 (C9), 141.8 (C16), 139.2 (C19), 131.9 (C12), 127.6 (C14), 118.1 
(C15), 117.6 (C17), 115.6 (C10), 110.0 (C18), 104.5 (C13), 72.1 (C5), 49.0 
(C11), 41.1 (C1), 33.6 (C4), 27.0 (C2), 26.2 (C8), 22.1 (C3); HRMS (ESI) 











Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 5-methoxy-1H-indole (35.2 mg, 0.24 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. Toluene (1.5 mL) was added and the 
sealed tube was added to an oil bath preheated to 120 °C. The mixture was 
stirred at 120 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 29:1-
19:1-9:1-4:1] afforded 312h (21 mg, 27%) as a red oil. RF 0.25 [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 3121, 2942, 2214 (C≡N), 1697 (C=O), 1645; δH (400 
MHz, CDCl3) 7.26-7.23 (m, 1H, H18), 7.08 (d, J = 2.4 Hz, 1H, H15), 7.01 (d, J 
= 3.0 Hz, 1H, H12), 6.87 (dd, J = 8.9, 2.5 Hz, 1H, H17), 6.44 (dd, J = 3.1, 0.8 
Hz, 1H, H13), 4.98 (t, J = 1.3 Hz, 1H, H10a), 4.78 (dt, J = 17.6, 1.6 Hz, 1H, 
H11a), 4.62 (t, J = 1.6 Hz, 1H, H10b), 4.55 (dt, J = 17.6, 1.6 Hz, 1H, H11b), 
3.84 (s, 3H, H20), 2.55 (dd, J = 8.1, 6.4 Hz, 2H, H1), 2.47-2.39 (m, 1H, H3a), 
2.20 (s, 3H, H8), 2.10-2.03 (m, 1H, H3b), 2.01-1.90 (m, 1H, H4a), 1.89-1.74 
(m, 2H, H2a and H4b), 1.73-1.64 (m, 1H, H2b); δC (100 MHz, CDCl3) 208.8 
(C6), 206.8 (C7), 154.1 (C16), 142.5 (C9), 131.6 (C19), 129.1 (C12), 128.8 
(C14), 115.8 (C10), 112.1 (C17), 110.6 (C18), 102.5 (C15), 101.4 (C13), 72.2 































Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 2-methyl indole (31.4 mg, 0.24 mmol) 
were added to a dried tube under argon. The tube was fitted with a septum 
and purged further with argon. Toluene (1.5 mL) was added and the sealed 
tube was added to an oil bath preheated to 120 °C. The mixture was stirred at 
120 °C for 2 hours, then cooled to room temperature and concentrated in 
vacuo. Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 312i (14 
mg, 19%) as a red oil. RF 0.30 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2927, 1697 
(C=O); δH (400 MHz, CDCl3) 7.52 (d, J = 7.7 Hz, 1H, H15), 7.23 (d, J = 8.6 Hz, 
1H, H18), 7.15-7.10 (m, 1H, H17), 7.08-7.04 (m, 1H, H16), 6.29 (s, 1H, H13), 
4.92 (t, J = 1.5 Hz, 1H, H10a), 4.73 (dt, J = 19.0, 2.4 Hz, 1H, H11a), 4.47 (dt, J 
= 17.8, 1.7 Hz, 1H, H11b), 4.27 (t, J = 2.1 Hz, 1H, H10b), 2.62-2.55 (m, 2H, 
H1), 2.50-2.43 (m, 1H, H2a), 2.38 (s, 3H, H20), 2.30 (s, 3H, H8), 1.94-1.79 (m, 
2H, H2b and H4a), 1.78-1.55 (m, 3H, H3 and H4b); δC (100 MHz, CDCl3) 























120.7 (C17), 119.7 (C15), 119.5 (C16), 114.8 (C10), 109.1 (C18), 100.4 
(C13), 72.1 (C5), 44.9 (C11), 41.1 (C1), 33.4 (C2), 27.1 (C4), 26.4 (C8), 22.2 







Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and azaindole (28.4 mg, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 312j (52 mg, 
73%) as a brown solid. RF 0.20 [Petrol:EtOAc 4:1]; m.p. 60–62 °C; νmax 
(film)/cm−1 2931, 1709 (C=O), 1695 (C=O), 1511; δH (400 MHz, CDCl3) 8.27 
(d, J = 4.8 Hz, 1.6 Hz, H17), 7.88 (dd, J = 7.9, 1.6 Hz, 1H, H16), 7.27 (d, J = 
3.6 Hz, 1H, H12), 7.03 (dd, J = 7.8, 4.6 Hz, 1H, H15), 6.48 (d, J = 3.6 Hz, 
H13), 4.97 (t, J = 1.3 Hz, 1H, H10a), 4.84 (t, J = 1.4 Hz, 2H, H11), 4.68 (t, J = 






















3H, H8), 2.21-2.15 (m, 1H, H4b), 1.95-1.75 (m, 4H, H2 and H3); δC (100 MHz, 
CDCl3) 209.1 (C6), 207.2 (C7), 147.7 (C18), 143.1 (C9), 142.9 (C17), 128.7 
(C16), 128.7 (C12), 120.2 (C14), 116.1 (C10), 115.8 (C15), 100.0 (C13), 72.4 
(C5), 45.9 (C11), 41.0 (C1), 32.9 (C4), 27.1 (C2), 26.8 (C8), 21.8 (C3); HRMS 
(ESI) Found: [M+H]+, 297.1588. C18H20N2O2 requires [M+H]+, 297.1598.  
 
2-(3-(9H-Carbazol-9-yl)prop-1-en-2-yl)-2-acetylcyclohexanone (312k): 
                                              
 
 
Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and carbazole (40.1 mg, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Column chromatography [Petrol:EtOAc 9:1-4:1] afforded 312k (44 mg, 53%) 
as an orange solid. RF 0.30 [Petrol:EtOAc 4:1]; m.p. 105–107 °C; νmax 
(film)/cm−1 2942, 1701 (C=O), 1645; δH (400 MHz, CDCl3) 8.11 (dt, J = 7.8, 
0.9 Hz, 2H, H13), 7.46 (dd, J = 7.0, 1.1 Hz, 2H, H16), 7.40 (dt, J = 8.2, 0.8 Hz, 
2H, H14), 7.25 (dd, J = 7.2, 1.2 Hz, 2H, H15), 4.98 (dt, J = 18.3, 1.7 Hz, 1H, 
H11a), 4.92 (t, J = 1.4 Hz, 1H, H10a), 4.70 (dt, J = 18.3, 1.9 Hz, 1H, H11b), 
























2.35 (s, 3H, H8), 2.25-2.16 (m, 1H, H3b), 2.06-1.90 (m, 2H, H4), 1.89-1.81 (m, 
1H, H2a), 1.80-1.69 (m, 1H, H2b); δC (100 MHz, CDCl3)  208.9 (C6), 207.3 
(C7), 140.5 (C12), 140.1 (C9), 125.9 (C16), 122.9 (C17), 120.3 (C13), 119.2 
(C14), 114.8 (C10), 108.8 (C15), 72.1 (C5), 45.0 (C11), 41.1 (C1), 33.5 (C3), 
27.2 (C4), 26.5 (C8), 22.2 (C2); HRMS (ESI) Found: [M+H]+, 346.1795. 
C23H23NO2 requires [M+H]+, 346.1802. 
2-(3-(1H-Pyrrol-1-yl)prop-1-en-2-yl)-2-acetylcyclohexanone (314a): 
 
                                         
 
 
Carbonate 266 (53.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and pyrrole (16.7 μL , 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 19:1] afforded 314a (12 mg, 
21%) as a black solid. RF 0.56 [Petrol:EtOAc 4:1]; m.p. 114–116 °C; νmax 
(film)/cm−1 3386, 3099, 3056, 2944, 2858, 1695 (C=O), 1511; δH (400 MHz, 
CDCl3) 6.59 (t, J = 2.1 Hz, 2H, H12), 6.14 (t, J = 2.3 Hz, 2H, H13), 5.07 (t, J = 
1.0 Hz, 1H, H10a), 4.92 (t, J = 1.5 Hz, 1H, H10b), 4.55 (dt, J = 16.5, 1.2 Hz, 
H11a), 4.36 (dt, J = 16.5, 1.2 Hz, 1H, H11b), 2.50 (dd, J = 8.0, 6.2 Hz, 2H, 
H1), 2.42-2.35 (m, 1H, H3a), 2.11 (s, 3H, H8), 2.03-1.88 (m, 2H, H2a and 



















CDCl3) 208.8 (C6), 206.8 (C7), 144.0 (C9), 121.5 (C12), 116.9 (C10), 108.4 
(C13), 72.4 (C5), 51.7 (C11), 41.0 (C1), 33.1 (C3), 26.9 (C2), 26.7 (C8), 21.9 







Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and methyl-1H-pyrrole-2-carboxylate (313b) 
(30 mg, 0.24 mmol) were added to a dried tube under argon. The tube was 
fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 314b (59 mg, 81%) as a yellow solid. RF 0.43 [Petrol:EtOAc 4:1]; 
m.p. 104–106 °C; νmax (film)/cm−1 2946, 1716 (C=O), 1692 (C=O), 1643; δH 
(400 MHz, CDCl3) 6.95 (dd, J = 4.1, 1.9 Hz, 1H, H12), 6.88 (dd, J = 2.5, 1.8 
Hz, 1H, H13), 6.17 (dd, J = 3.9, 2.6 Hz, 1H, H14), 4.98-4.92 (m, 2H, H10a and 
H11a), 4.85 (dt, J = 16.7, 1.5 Hz, 1H, H11b), 4.39 (t, J = 1.7 Hz, 1H, H10b), 
3.75 (s, 3H, H17), 2.63-2.47 (m, 2H, H1), 2.44-2.35 (m, 1H, H2a), 2.25 (s, 3H, 






















1H, H3b); δC (100 MHz, CDCl3) 209.0 (C6), 207.3 (C7), 161.2 (C16), 143.9 
(C9), 129.7 (C13), 121.8 (C15), 118.1 (C12), 114.2 (C10), 108.6 (C14), 72.1 
(C5), 51.0 (C17), 50.2 (C11), 40.9 (C1), 33.0 (C2), 27.1 (C4), 26.6 (C8), 21.7 
(C3); HRMS (ESI) Found: [M+Na]+, 326.1348. C17H21NO4 requires [M+Na]+, 
326.1363.  
 
The formation of 314b was also carried out under enantioselective conditions: 
Carbonate 266 (35.5 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), (R)-
Xylyl-P-PHOS L19 (7.3 mg, 0.0096 mmol) and methyl-1H-pyrrole-2-
carboxylate 313b (20 mg, 0.16 mmol) were added to a dried tube under argon. 
The tube was fitted with a septum and purged further with argon. 
Tetrahydrofuran (1 mL) was added and the sealed tube was stirred at 60 °C 
for 2 hours, then concentrated in vacuo. Flash column chromatography 
[Petrol:EtOAc 9:1-4:1] afforded 314b (39 mg, 80% yield, r.r. > 19:1). Chiral 
HPLC: OD-H column, 1 mL/min, 19:1 Hexane:IPA, tA (minor) = 8.7 min, tB 
(major) = 9.1 min, 19% ee; [α]D25 −0.5 (c 0.1, CHCl3, 19% ee).  
 




Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 























a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Toluene (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 120 °C. The mixture was stirred at 120 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 314c (30.5 mg, 
42%) as a dark yellow solid. RF 0.09 [Petrol:EtOAc 4:1]; m.p. 74–76 °C; νmax 
(film)/cm−1 2952, 1712 (C=O), 1694 (C=O); δH (400 MHz, CDCl3) 7.23 (t, J = 
2.0 Hz, 1H, H14), 6,57-6.52 (m, 2H, H12 and H13), 5.11 (br s, 1H, H10a), 4.91 
(t, J = 1.6 Hz, 1H, H10b), 4.56 (dt, J = 16.5, 1.3 Hz, 1H, H11a), 4.31 (dt, J = 
16.3, 1.1 Hz, 1H, H11b), 3.77 (s, 3H, H17), 2.53-2.33 (m, 3H, H1 and H4a), 
2.10 (s, 3H, H8), 2.00-1.88 (m, 2H, H2a and H4b), 1.80-1.62 (m, 2H, H2b and 
H3a), 1.62-1.51 (m, 1H, H3b); δC (100 MHz, CDCl3) 208.6 (C7), 206.7 (C6), 
165.1 (C16), 143.1 (C9), 126.8 (C14), 122.7 (C12), 117.2 (C10), 116.1 (C15), 
110.2 (C13), 72.3 (C5), 52.0 (C11), 51.0 (C17), 41.0 (C1), 33.3 (C4), 26.9 
(C2), 26.1 (C8), 22.0 (C3); HRMS (ESI) Found: [M+Na]+, 326.1348. 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 

























mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
3:1-1:1] afforded 314d (31 mg, 41%) as a dark orange oil. RF 0.10 
[Petrol:EtOAc 4:1]; νmax (film)/cm−1 2939, 1697 (C=O), 1647; δH (400 MHz, 
CDCl3) 6.56-6.48 (m, 2H, H12 and H13), 5.08 (s, 1H, H10a), 4.60 (t, J = 1.4 
Hz, 1H, H10b), 4.52 (dt, J = 17.5, 1.8 Hz, 1H, H11a), 4.23 (dt, J = 17.4, 1.5 
Hz, 1H, H11b), 2.68 (t, J = 6.2 Hz, 2H, H18), 2.60-2.40 (m, 4H, H4a, H16 and 
H17a), 2.17 (s, 3H, H8), 2.14-2.09 (m, 2H, H1), 2.04-1.93 (m, 2H, H4b and 
H17b), 1.91-1.70 (m, 4H, H2 and H3); δC (100 MHz, CDCl3) 208.5 (C6), 206.7 
(C7), 194.2 (C15), 144.2 (C19), 142.5 (C9), 122.9 (C12), 120.9 (C14), 115.7 
(C10), 105.9 (C13), 72.0 (C5), 48.9 (C11), 41.1 (C16), 37.7 (C4), 33.5 (C17), 
27.0 (C2), 26.1 (C8), 23.7 (C1), 22.0 (C3), 21.4 (C18); HRMS (ESI) Found: 












Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 313e (44 mg, 0.24 mmol) were added to 
a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Toluene (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 120 °C. The mixture was stirred at 120 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 314e (49 mg, 
57%) as a dark orange solid. RF 0.29 [Petrol:EtOAc 4:1]; m.p. 144–146 °C; 
νmax (film)/cm−1 2946, 1727 (C=O), 1699 (C=O); δH (400 MHz, CDCl3) 6.96 (s, 
2H, H13), 5.61 (dt, J = 17.0, 2.0 Hz, 1H, H11a), 5.43 (dt, J = 16.9, 1.6 Hz, 1H, 
H11b), 4.84 (t, J = 1.8 Hz, 1H, H10a) 4.17 (t, J = 1.9 Hz, 1H, H10b), 3.82 (s, 
6H, H15), 2.80-2.65 (m, 1H, H4a), 2.44-2.34 (m, 1H, H4b), 2.28 (s, 3H, H8), 
2.31-2.26 (m, 2H, H1), 2.09-1.89 (m, 2H, H2), 1.86-1.70 (m, 2H, H3); δC (100 
MHz, CDCl3) 209.4 (C6), 206.6 (C7), 160.6 (C14), 144.1 (C9), 127.6 (C12), 
117.0 (C10), 113.9 (C13), 72.2 (C5), 51.7 (C15), 47.9 (C11), 40.9 (C4), 32.5 
(C1), 27.6 (C3), 27.1 (C8), 21.5 (C2); HRMS (ESI) Found: [M+Na]+, 384.1406. 

































Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 313f (50.2 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Toluene (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 120 °C. The mixture was stirred at 120 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 314f (56 mg, 
60%) as a light yellow solid. RF 0.56 [Petrol:EtOAc 4:1]; m.p. 75–78 °C; νmax 
(film)/cm−1 3188, 2953, 1697 (C=O), 1636; δH (400 MHz, CDCl3) 7.46 (d, J = 
1.8 Hz, 1H, H17), 7.33 (d, J = 1.9 Hz, 1H, H15), 4.98-4.96 (m, 1H, H10a), 
4.94-4.91 (m, 2H, H11), 4.42-4.39 (m, 1H, H10b), 3.77 (s, 3H, H12), 2.58 (d, J 
= 7.0 Hz, 2H, H19), 2.54 (dd, J = 8.2, 6.3 Hz, 2H, H1), 2.47-2.39 (m, 1H, H4a), 
2.25 (s, 3H, H8), 2.26-2.19 (m, 1H, H20), 2.14-2.03 (m, 1H, H4b), 1.98-1.82 
(m, 2H, H2), 1.84-1.73 (m, 2H, H3a), 1.70-1.58 (m, 1H, H3b), 0.94 (d, J = 6.4 
Hz, 6H, H21); δC (100 MHz, CDCl3) 208.8 (C6), 207.2 (C7), 195.3 (C18), 
160.8 (C13), 143.2 (C9), 132.4 (C17), 125.3 (C16), 123.2 (C14), 117.7 (C15), 



























(C4), 27.1 (C2), 26.5 (C20), 25.4 (C8), 22.7 (C21), 21.9 (C3); HRMS (ESI) 







Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 313g (55 mg, 0.24 mmol) were added to 
a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Toluene (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 120 °C. The mixture was stirred at 120 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 91-4:1] afforded 314g (93 mg, 
95%) as a red oil. RF 0.22 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2950, 1701 
(C=O), 1638; δH (400 MHz, CDCl3) 7.85-7.80 (m, 2H, H20), 7.56 (tt, J = 7.3, 
2.3 Hz, 1H, H22), 7.50-7.46 (m, 3H, H14 and H21), 7.44 (d, J = 2.1 Hz, 1H, 
H12), 5.03-4.97 (m, 3H, H10a and H11), 4.49-4.47 (m, 1H, H10b), 3.80 (s, 3H, 
H17), 2.56 (dd, J = 7.8, 6.3 Hz, 2H, H1), 2.50-2.43 (m, 1H, H4a), 2.27 (s, 3H, 
H8), 2.14-2.05 (m, 1H, H4b), 2.00-1.87 (m, 2H, H2), 1.85-1.76 (m, 1H, H3a), 





























(C18), 160.9 (C16), 143.2 (C9), 139.0 (C19), 134.4 (C14), 131.9 (C22), 128.9 
(C20), 128.4 (C21), 123.6 (C13), 123.3 (C15), 119.6 (C12), 114.2 (C10), 72.1 
(C5), 51.5 (C17), 51.0 (C11), 41.0 (C1), 33.4 (C4), 27.1 (C2), 26.5 (C8), 21.9 
(C3); HRMS (ESI) Found: [M+Na]+, 430.1609. C24H25NO5 requires [M+Na]+, 






Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 313h (37 mg, 0.24 mmol) were added to 
a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Toluene (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 120 °C. The mixture was stirred at 120 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 314h (46 mg, 
58%) as an orange solid. RF 0.19 [Petrol:EtOAc 4:1]; m.p. 96–99 °C; νmax 
(film)/cm−1 2953, 1720 (C=O), 1697 (C=O), 1668, 1518; δH (400 MHz, CDCl3) 
9.75 (s, 1H, H19), 7.00 (d, J = 4.2 Hz, 1H, H15), 6.96 (d, J = 4.4 Hz, 1H, H17), 
5.49 (dt, J = 17.3, 2.2 Hz, 1H, H11a), 5.35 (dt, J = 17.3, 2.0 Hz, 1H, H11b), 
4.89-4.87 (m, 1H, H10a), 4.19-4.17 (m, 1H, H10b), 3.83 (s, 3H, H12), 2.73-

























2H, H4), 2.07-1.96 (m, 1H, H2a), 1.96-1.87 (m, 1H, H2b), 1.86-1.79 (m, 1H, 
H3a), 1.79-1.69 (m, 1H, H3b); δC (100 MHz, CDCl3) 209.2 (C6), 207.8 (C7), 
181.0 (C18), 160.6 (C13), 143.7 (C9), 135.3 (C16), 129.0 (C14), 121.3 (C17), 
117.5 (C15), 113.8 (C10), 72.1 (C5), 51.9 (C12), 48.1 (C11), 40.9 (C1), 32.7 
(C4), 27.4 (C2), 27.0 (C8), 21.5 (C3); HRMS (ESI) Found: [M+K]+, 370.1062. 
C18H21NO5 requires [M+K]+, 370.1051.   
 
Methyl-1-(2-(1-acetyl-2-oxocyclohexyl)allyl)-4-butyl-1H-pyrrole-2-




Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 313i (43.4 mg, 0.24 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Toluene (1.5 mL) was added and the sealed tube was 
added to an oil bath preheated to 120 °C. The mixture was stirred at 120 °C 
for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 314i (51 mg, 
59%) as a yellow oil. RF 0.51 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2927, 1697 
(C=O); δH (400 MHz, CDCl3) 6.79 (d, J = 1.9 Hz, 1H, H15), 6.68 (d, J = 1.9 Hz, 



























(t, J = 2.2 Hz, 1H, H10b), 3.75 (s, 3H, H12), 2.65-2.48 (m, 2H, H1), 2.42 (t, J = 
8.1 Hz, 1H, H18), 2.45-2.38 (m, 1H, H4a), 2.26 (s, 3H, H8), 2.17-2.08 (m, 1H, 
H4b), 1.94-1.78 (m, 3H, H2 and H3a), 1.75-1.60 (m, 1H, H3b), 1.52 (sept, J = 
7.7 Hz, 2H, H19), 1.33 (sext, J = 7.7 Hz, 2H, H20), 0.90 (t, J = 7.2 Hz, 3H, 
H21); δC (100 MHz, CDCl3) 209.2 (C6), 207.4 (C7), 161.2 (C13), 144.1 (C9), 
127.8 (C17), 124.8 (C14), 121.3 (C16), 117.7 (C15), 114.2 (C10), 72.1 (C5), 
50.9 (C12), 50.0 (C11), 41.0 (C18), 33.0 (C1), 33.0 (C4), 27.2 (C2), 26.8 (C8), 
26.2 (C19), 22.7 (C20), 21.8 (C3), 13.9 (C21); HRMS (ESI) Found: [M+Na]+, 
382.1993. C21H29NO4 requires [M+Na]+, 382.1989.      






Carbonate 303b (64.8 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 































4:1] afforded 317a (69 mg, 72%) as a yellow solid. RF 0.24 [Petrol:EtOAc 4:1]; 
m.p.149–152 °C; νmax (film)/cm−1 2946, 1697 (C=O), 1533; δH (400 MHz, 
CDCl3) 8.17-8.12 (m, 1H, H21), 8.04 (dd, J = 8.1, 1.3 Hz, 1H, H3), 7.76 (s, 1H, 
H16), 7.52 (td, J = 7.5, 1.4 Hz, 1H, H4), 7.42-7.38 (m, 1H, H5), 7.33 (t, J = 7.8 
Hz, 1H, H20),  7.29-7.22 (m, 3H, H6, H19 and H22), 4.98 (q, J = 1.3 Hz, 1H, 
H14a), 4.83 (t, J = 1.7 Hz, 2H, H15), 4.52 (q, J = 0.9 Hz, 1H, H14b), 3.89 (s, 
3H, H25), 3.11-2.96 (m, 2H, H8), 2.70 (ddd, J = 14.3, 7.3, 6.1 Hz, 1H, H9a), 
2.43 (ddd, J = 14.0, 7.0, 5.1 Hz, 1H, H9b), 2.31 (s, 3H, H12);  δC (100 MHz, 
CDCl3) 204.8 (C11), 195.7 (C1), 165.3 (C24), 142.8 (C2), 140.7 (C13), 136.8 
(C23), 134.9 (C16), 134.2 (C4), 131.7 (C7), 128.8 (C6), 128.0 (C3), 127.1 
(C20), 126.4 (C18), 123.2 (C22), 122.1 (C19), 121.6 (C21), 116.5 (C14), 
110.4 (C5), 107.7 (C17), 68.4 (C10), 50.9 (C25), 49.1 (C15), 29.7 (C9), 27.7 







Carbonate 303c (60 mg, 0.240 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 

























with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 327b (65 mg, 71%) as a pale yellow solid. RF 0.20 [Petrol:EtOAc 
4:1]; m.p. 81–83 °C; νmax (film)/cm−1 2950, 1758, 1723 (C=O), 1684 (C=O); δH 
(400 MHz, CDCl3) 8.20-8.15 (m, 1H, H18), 7.78 (s, 1H, H20), 7.52-7.46 (m, 
1H, H15), 7.32-7.25 (m, 2H, H16 and H17), 4.97 (q, J = 1.0 Hz, 1H, H12a), 
4.77 (dt, J = 17.6, 1.5 Hz, 1H, H13a), 4.62 (dt, J = 17.5 Hz, 1.6 Hz, 1H, H13b), 
4.54-4.52 (m, 1H, H12b), 3.91 (s, 3H, H23), 3.04 (sept, J = 6.7 Hz, 1H, H8), 
2.54 (t, J = 6.5 Hz, 2H, H1), 2.51-2.44 (m, 1H, H4a), 2.14-2.05 (m, 1H, H4b), 
1.98-1.74 (m, 4H, H2 and H3), 1.19 (d, J = 6.5 Hz, 3H, H9), 1.14 (d, J = 6.7 
Hz, 3H, H10); δC (100 MHz, CDCl3) 213.1 (C7), 209.0 (C6), 165.3 (C22), 
141.1 (C11), 136.9 (C14), 134.9 (C20), 126.3 (C19), 123.1 (C16), 122.0 
(C17), 121.5 (C18), 115.8 (C12), 110.6 (C15), 107.7 (C21), 72.5 (C5), 50.9 
(C23), 49.0 (C13), 41.1 (C1), 37.1 (C8), 32.9 (C4), 26.6 (C2), 22.0 (C3), 21.2 













Carbonate 303f (61.9 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 317c (78 mg, 83%) as an orange oil. RF 0.24 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2948, 1697 (C=O), 1677 (C=O), 1533; δH (400 MHz, CDCl3) 
8.18-8.13 (m, 1H, H17), 7.91-7.85 (m, 2H, H3), 7.77 (s, 1H, H13), 7.58 (tt, J = 
7.6, 1.4 Hz, 1H, H1), 7.47 (t, J = 7.9 Hz, 2H, H2), 7.43-7.39 (m, 1H, H18), 
7.30-7.22 (m, 2H, H16 and H19), 5.11 (s, 1H, H11a), 4.92 (d, J = 17.9 Hz, 1H, 
H12a), 4.79 (d, J = 17.9 Hz, 1H, H12b), 4.55 (s, 1H, H11b), 3.90 (s, 3H, H22), 
2.24 (s, 3H, H9), 1.80 (s, 3H, H7); δC (100 MHz, CDCl3) 206.1 (C8), 199.6 
(C5), 165.4 (C21), 143.6 (C10), 136.8 (C20), 135.5 (C4), 135.1 (C13), 133.4 
(C1), 129.1 (C3), 128.7 (C2), 126.4 (C15), 123.1 (C16), 122.0 (C19), 121.6 
(C17), 115.0 (C11), 110.5 (C18), 107.6 (C14), 68.5 (C6), 51.9 (C22), 49.1 
(C12), 27.5 (C9), 21.0 (C7); HRMS (ESI) Found: [M+H]+, 390.1675. 


































Carbonate 303h (61 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and methyl-indole-3-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 317d (54 mg, 56%) as an orange solid. RF 0.10 [Petrol:EtOAc 
4:1]; m.p. 104–107 °C; νmax (film)/cm−1 2935, 1716 (C=O), 1692 (C=O), 1531; 
δH (400 MHz, CDCl3)  8.13-8.08 (m, 1H, H13), 7.68 (s, 1H, H18), 7.24-7.16 
(m, 3H, H12, H14 and H15), 4.89 (q, J = 1.4 Hz, 1H, H9a), 4.81 (t, J = 1.7 Hz, 
2H, H10), 4.45 (q, J = 1.9 Hz, 1H, H9b), 4.13 (q, J = 7.1 Hz, 2H, H6), 3.84 (s, 
3H, H20), 3.14 (s, 2H, H4), 2.22 (s, 6H, H1), 1.22 (t, J = 7.3 Hz, 3H, H7); δC 
(100 MHz, CDCl3) 203.6 (C2), 170.8 (C5), 165.3 (C19), 141.7 (C8), 136.6 
(C11), 134.8 (C18), 126.4 (C16), 123.2 (C13), 122.1 (C14), 121.8 (C12), 





























(C10), 39.6 (C4), 27.6 (C1), 14.0 (C7); HRMS (ESI) Found: [M+Na]+, 







Carbonate 303d (73.0 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 317e (59 mg, 56%) as a dark orange oil. RF 0.40 [Petrol:EtOAc 
4:1]; νmax (film)/cm−1 2946, 1697 (C=O); δH (400 MHz, CDCl3) 8.09-8.02 (m, 
1H, H17), 8.00-7.96 (m, 2H, H2), 7.87-7.83 (m, 2H, H1), 7.65 (s, 1H, H13), 
7.51-7.47 (m, 2H, H8), 7.41-7.36 (m, 3H, H7 and H9), 7.24-7.18 (m, 3H, H16, 
H18 and H19), 4.99 (q, J = 0.7 Hz, 1H, H11a), 4.78 (t, J = 1.6 Hz, 2H, H12), 
4.64 (q, J = 0.7 Hz, 1H, H11b), 3.80 (s, 3H, H22); δC (100 MHz, CDCl3) 198.3 
































(C13), 134.3 (C20), 129.1 (C8), 128.4 (C9), 128.2 (C7), 126.4 (C15), 124.0 
(C2), 123.0 (C16), 122.0 (C18), 121.4 (C19), 117.9 (C11), 110.3 (C17), 107.7 
(C14), 66.6 (C5), 50.9 (C22), 48.9 (C12); HRMS (ESI) Found: [M+H]+, 




        
 
Carbonate 303e (49 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 317f (44 mg, 54%) as a yellow oil. RF 0.12 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2946, 1692 (C=O), 1533; δH (400 MHz, CDCl3) 8.17-8.11 (m, 
1H, H13), 7.72 (s, 1H, H9), 7.29-7.19 (m, 3H, H12, H14 and H15), 4.97 (q, J = 
1.4 Hz, 1H, H7a), 4.62 (q, J = 1.9 Hz, 1H, H7b), 4.56 (t, J = 1.3 Hz, 2H, H8), 
3.88 (s, 3H, H18), 2.70-2.57 (m, 4H, H2), 1.99-1.82 (m, 2H, H1), 1.51 (s, 3H, 
H5); δC (100 MHz, CDCl3) 207.5 (C3), 165.2 (C17), 142.3 (C6), 136.7 (C16), 
135.0 (C9), 126.4 (C11), 123.2 (C12), 122.3 (C14), 121.7 (C13), 115.8 (C7), 

























(C1), 17.4 (C5); HRMS (ESI) Found: [M+H]+, 340.1537. C20H21NO4 requires 
[M+H]+, 340.1543.  






Carbonate 303m (57.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 317g (72 mg, 81%) as a red oil. RF 0.19 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1  2940, 1695 (C=O), 1533; δH (400 MHz, CDCl3)  8.13-8.07 (m, 1H, 
H16), 7.72 (s, 1H, H12), 7.32-7.26 (m, 1H, H17), 7.21-7.15 (m, 2H, H15 and 
H18), 5.03 (br s, 1H, H10a), 4.95 (dt, J = 17.4, 1.5 Hz, 1H, H11a), 4.79 (dt, J = 
17.2, 1.5 Hz, 1H, H11b), 4.50-4.47 (m, 1H, H10b), 4.10 (q, J = 7.2 Hz, 2H, 
H7), 3.82 (s, 3H, H21), 2.53-2.37 (m, 2H, H1a and H3a), 2.33-2.21 (m, 2H, 
H1b and H3b), 1.99-1.81 (m, 2H, H2), 1.20 (t, J = 6.8 Hz, 3H, H8); δC (100 


























135.1 (C12), 126.4 (C14), 123.0 (C15), 122.0 (C18), 121.5 (C16), 114.9 
(C10), 110.5 (C17), 107.5 (C13), 64.4 (C4), 62.1 (C7), 50.9 (C21), 48.7 (C11), 
37.9 (C3), 33.7 (C1), 19.5 (C2), 14.0 (C8); HRMS (ESI) Found: [M+H]+, 
382.2007. C23H27NO4 requires [M+H]+, 382.2013. 
 




Carbonate 303t (61.7 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-indole-carboxylate (311b) (42 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 317hb (35 mg, 88%) as an orange solid. RF 0.08 [Petrol:EtOAc 
4:1]; m.p. 135–137 °C; νmax (film)/cm−1 2946, 1705 (C=O), 1654; δH (400 MHz, 
CDCl3) 8.23-8.17 (m, 2H, H6 and H19), 7.76 (s, 1H, H1), 7.76 (s, 1H, H14), 
7.47-7.42 (m, 1H, H16), 7.35-7.28 (m, 5H, H3, H4, H5, H17 and H18), 5.51 (q, 
J = 0.9 Hz, 1H, H12a), 5.19 (q, J = 1.5 Hz, 1H, H12b), 5.12 (t, J = 1.1 Hz, 2H, 

























165.0 (C22), 139.1 (C11), 136.4 (C15), 136.3 (C6), 134.2 (C7), 132.3 (C14), 
126.7 (C1), 126.6 (C20), 123.8 (C4), 123.5 (C17), 122.7 (C3), 122.4 (C18), 
122.1 (C2), 122.0 (C19), 113.7 (C12), 110.8 (C16), 109.7 (C5), 109.6 (C8), 
108.6 (C21), 51.2 (C10), 51.1 (C23), 49.6 (C13); HRMS (ESI) Found: [M+Na]+, 






Carbonate 303b (64.8 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-pyrrole carboxylate 
(313b) (30 mg, 0.24 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 318a (56 mg, 66%) as a pale yellow solid. RF 0.60 [Petrol:EtOAc 
4:1]; m.p. 92–95 °C; νmax (film)/cm−1 2939, 1694 (C=O); δH (400 MHz, CDCl3) 
8.06 (dd, J = 7.9, 1.3 Hz, 1H, H2), 7.49 (td, J = 7.5, 1.5 Hz, 1H, H3), 7.32 (tt, J 
= 8.0, 0.6 Hz, 1H, H4), 7.24 (d, J = 8.1 Hz, 1H, H5), 6.96 (dd, J = 4.1, 2.0 Hz, 

























H17), 5.30-5.23 (m, 1H, H15a), 4.87 (t, J = 1.6 Hz, 1H, H14a), 4.84-4.83 (m, 
1H, H15b), 4.38-4.36 (m, 1H, H14b), 3.76 (s, 3H, H21), 3.15 (ddd, J = 17.0, 
9.9, 4.9 Hz, 1H, H7a), 3.01 (ddd, J = 17.5, 5.9, 4.7 Hz, 1H, H7b), 2.70-2.61 
(m, 1H, H8a), 2.48 (ddd, J = 14.2, 6.5, 4.6 Hz, 1H, H8b), 2.37 (s, 3H, H12); δC 
(100 MHz, CDCl3) 205.8 (C10), 195.9 (C11), 161.2 (C20), 143.5 (C1), 143.3 
(C13), 133.9 (C3), 132.0 (C6), 129.7 (C18), 128.8 (C5), 127.9 (C2), 126.9 
(C4), 122.0 (C19), 118.2 (C16), 115.0 (C14), 108.8 (C17), 68.6 (C9), 51.1 
(C21), 50.3 (C15), 29.3 (C7), 28.1 (C12), 25.7 (C8); HRMS (ESI) Found: 
[M+K]+, 390.1105. C21H21NO4 requires [M+K]+, 390.1102.                                                                              
 




Carbonate 303c (60 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and methyl-1H-2-pyrrole carboxylate (313b) 
(30 mg, 0.24 mmol) were added to a dried tube under argon. The tube was 
fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1] 


























νmax (film)/cm−1 2946, 1697 (C=O); δH (400 MHz, CDCl3) 6.96 (dd, J = 4.0, 1.8 
Hz, 1H, H13), 6.90 (dd, J = 2.5, 1.9 Hz, 1H, H15), 6.17 (dd, J = 3.9, 2.6 Hz, 
1H, H14), 5.12 (dt, J = 17.1, 1.9 Hz, 1H, H12a), 4.88-4.86 (m, 1H, H11a), 4.68 
(d, J = 17.0, 1.5 Hz, 1H, H12b), 4.41 (t, J = 1.9 Hz, 1H, H11b), 3.77 (s, 3H, 
H18), 3.0 (sept, J = 6.3 Hz, 1H, H8), 2.74-2.64 (m, 1H, H1a), 2.47-2.39 (m, 
1H, H1b), 2.36-2.29 (m, 1H, H4a), 2.26-2.17 (m, 1H, H4b), 2.01-1.90 (m, 2H, 
H3), 1.86-1.73 (m, 2H, H2), 1.13 (d, J = 6.8 Hz, 3H, H9a), 1.09 (d, J =6.8 Hz, 
3H, H9b); δC (100 MHz, CDCl3) 213.3 (C6), 209.8 (C7), 161.2 (C17), 143.2 
(C10), 129.7 (C15), 122.0 (C16), 118.1 (C13), 114.7 (C11), 108.7 (C14), 72.7 
(C5), 51.0 (C18), 50.2 (C12), 41.1 (C1), 37.4 (C8), 33.3 (C4), 28.9 (C3), 21.5 
(C2), 20.8 (C9); HRMS (ESI) Found: [M+Na]+, 354.1660. C19H25NO4 requires 
[M+Na]+, 354.1676.   
 
Methyl 1-(3-acetyl-3-methyl-2-methylene-4-oxopentyl)-1H-pyrrole-3-
carboxylate  (318c): 
 
 
Carbonate 300 (47.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-carboxylate (313b) (30 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 



















and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 318c (40 mg, 60%) as a yellow solid. RF 0.22 [Petrol:EtOAc 4:1]; 
m.p. 58–61 °C; νmax (film)/cm−1 2991, 1716 (C=O), 1692 (C=O), 1531; δH (400 
MHz, CDCl3) 6.96 (dd, J = 4.0, 1.8 Hz, 1H, H10), 6.86 (dd, J = 2.5, 1.8 Hz, 1H, 
H12), 6.18 (dd, J = 3.9, 2.5 Hz, 1H, H11), 4.95-4.92 (m, 1H, H8a), 4.89 (t, J = 
1.6 Hz, 2H, H9),  4.38 (dt, J = 1.9, 0.6 Hz, 1H, H8b), 3.76 (s, 3H, H15), 2.23 
(s, 6H, H1 and H6), 1.64 (s, 3H, H4); δC (100 MHz, CDCl3) 206.9 (C2 and C5), 
161.2 (C14), 144.3 (C7), 129.7 (C12), 121.8 (C13), 118.2 (C10), 113.9 (C8), 
108.6 (C11), 70.1 (C3), 51.0 (C15), 50.0 (C9), 27.0 (C1 and C6), 18.4 (C4);  
HRMS (ESI) Found: [M+Na]+, 300.1192. C15H29NO4 requires [M+Na]+, 






Carbonate 303f (62 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-pyrrole carboxylate 
(313b) (30 mg, 0.24 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 























4:1] afforded 318d (45 mg, 55%) as a pale yellow solid. RF 0.75 [Petrol:EtOAc 
4:1]; m.p. 91–93 °C; νmax (film)/cm−1 2948, 1707 (C=O), 1654; δH (400 MHz, 
CDCl3) 7.95-7.92 (m, 2H, H3), 7.53 (tt, J = 7.5, 2.1 Hz, 1H, H1), 7.45-7.40 (m, 
2H, H2), 6.98 (dd, J = 4.1, 1.9 Hz, 1H, H13), 6.87 (dd, J = 2.5, 1.9 Hz, 1H, 
H15), 6.19 (dd, J = 3.9, 2.6 Hz, 1H, H14), 5.24 (dt, J = 17.0, 2.4 Hz, 1H, 
H12a), 4.98-4.91 (m, 2H, H11a and H12b), 4.39-4.35 (m, 1H, H11b), 3.79 (s, 
3H, H18), 2.25 (s, 3H, H8), 1.79 (s, 3H, H9); δC (100 MHz, CDCl3) 206.1 (C7), 
200.3 (C5), 161.3 (C17), 145.6 (C10), 135.3 (C4), 132.9 (C1), 129.9 (C3), 
129.7 (C15), 128.3 (C2), 122.0 (C16), 118.2 (C13), 114.5 (C11), 108.7 (C14), 
68.7 (C6), 51.0 (C18), 50.2 (C12), 27.4 (C8), 20.5 (C9); HRMS (ESI) Found: 







Carbonate 303h (61 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-carboxylate (313b) (30 
mg, 0.24 mmol) were added to a dried tube under argon. The tube was fitted 
with a septum and purged further with argon. Toluene (1.5 mL) was added 
and the sealed tube was added to an oil bath preheated to 120 °C. The 


























and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 318e (62 mg, 74%) as a red oil. RF 0.15 [Petrol:EtOAc 4:1]; νmax 
(film)/cm−1 2952, 1733 (C=O), 1701 (C=O), 1533; δH (400 MHz, CDCl3) 6.96 
(dd, J = 4.0, 1.8 Hz, 1H, H11), 6.76 (dd, J = 2.6, 1.8 Hz, 1H, H13), 6.17 (dd, J 
= 4.0, 2.6 Hz, 1H, H12), 4.98 (q, J = 1.7 Hz, 1H, H9a), 4.87 (t, J = 1.9 Hz, 2H, 
H10), 4.36-4.32 (m, 1H, H9b), 4.15 (q, J = 7.3 Hz, 2H, H6), 3.75 (s, 3H, H16), 
3.19 (s, 2H, H4), 2.30 (s, 6H, H1), 1,26 (t, J = 7.2 Hz, 3H, H7); δC (100 MHz, 
CDCl3) 204.5 (C2), 170.8 (C5), 161.1 (C15), 142.7 (C8), 129.3 (C13), 121.7 
(C14), 118.3 (C11), 115.3 (C9), 108.8 (C12), 71.6 (C3), 61.1 (C6), 51.0 (C16), 
50.0 (C10), 37.4 (C4), 27.8 (C1), 14.0 (C7); HRMS (ESI) Found: [M+Na]+, 







Carbonate 303d (73 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-pyrrole carboxylate 
(313b) (30 mg, 0.24 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 




























and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 318f (79 mg, 85%) as an orange oil. RF 0.40 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2948, 1699 (C=O), 1593; δH (400 MHz, CDCl3) 8.03 (dd, J = 
5.7, 3.1 Hz, 2H, H2), 7.89-7.83 (m, 2H, H1), 7.49-7.45 (m, 2H, H8), 7.39-7.34 
(m, 2H, H7), 7.30 (tt, J = 7.2, 2.4 Hz, 1H, H9), 6.87 (dd, J = 4.0, 1.9 Hz, 1H, 
H13), 6.67 (dd, J = 2.6, 1.9 Hz, 1H, H15), 6.07 (dd, J = 3.9, 2.6 Hz, 1H, H14), 
5.07 (t, J = 1.5 Hz, 2H, H12), 5.02 (t, J = 1.5 Hz, 1H, H11a), 4.59 (t, J = 1.8 
Hz, 1H, H11b), 3.75 (s, 3H, H18);  δC (100 MHz, CDCl3) 198.4 (C4), 161.0 
(C17), 143.4 (C10), 140.9 (C3), 136.1 (C1), 134.6 (C6), 129.3 (C15), 128.8 
(C8), 128.4 (C7), 128.2 (C9), 124.0 (C2), 122.4 (C16), 118.0 (C13), 116.5 
(C11), 108.6 (C14), 67.1 (C5), 51.0 (C18), 50.2 (C12); HRMS (ESI) Found: 






Carbonate 303e (49 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-pyrrole carboxylate 
(313b) (30 mg, 0.24 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 






















and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 318g (50 mg, 72%) as a yellow solid. RF 0.41 [Petrol:EtOAc 4:1]; 
m.p. 84–87 °C; νmax (film)/cm−1 2939, 1725 (C=O), 1690 (C=O); δH (400 MHz, 
CDCl3) 6.96 (dd, J = 4.0, 1.8 Hz, 1H, H9), 6.73 (dd, J = 2.6, 1.8 Hz, 1H, H11), 
6.17 (dd, J = 4.0, 2.6 Hz, 1H, H10), 4.79 (t, J = 1.8 Hz, 2H, H8), 4.77-4.75 (m, 
1H, H7a), 4.21 (dt, J = 2.7, 0.8 Hz, 1H, H7b), 3.77 (s, 3H, H14), 3.03-2.94 (m, 
2H, H2a), 2.62-2.53 (m, 2H, H2b), 2.27-2.18 (m, 1H, H1a), 1.81-1.69 (m, 1H, 
H1b), 1.42 (s, 3H, H5); δC (100 MHz, CDCl3) 207.7 (C3), 161.1 (C13), 145.7 
(C6), 129.4 (C9), 121.9 (C11), 118.3 (C12), 112.5 (C7), 108.8 (C10), 71.3 
(C4), 51.1 (C14), 49.7 (C8), 39.7 (C2), 18.2 (C5), 17.6 (C1); HRMS (ESI) 






Carbonate 303m (57.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-1H-2-pyrrole carboxylate 
(313b) (30 mg, 0.24 mmol) were added to a dried tube under argon. The tube 
was fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 
mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 




















4:1] afforded 318h (42 mg, 55%) as an orange oil. RF 0.35 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2978, 1750 (C=O), 1701 (C=O); δH (400 MHz, CDCl3) 6.95 
(dd, J = 4.0, 1.7 Hz, 1H, H12), 6.84 (d, J = 2.8, 2.1 Hz, 1H, H14), 6.16 (dd, J = 
4.1, 2.7 Hz, 1H, H13), 5.20 (dt, J = 16.9, 1.4 Hz, 1H, H11a), 4.90-4.95 (m, 2H, 
H10a and H11b), 4.34 (t, J = 1.6 Hz, 1H, H10b), 4.21-4.12 (m, 2H, H7), 3.76 
(s, 3H, H17), 2.64-2.54 (m, 1H, H1a), 2.45-2.35 (m, 3H, H1b and H3), 2.05-
1.93 (m, 2H, H2), 1.29 (t, J = 7.3 Hz, 1H, H8); δC (100 MHz, CDCl3) 212.1 
(C5), 170.0 (C6), 161.2 (C16), 142.0 (C9), 129.7 (C14), 121.9 (C15), 118.1 
(C12), 113.1 (C10), 108.4 (C13), 65.1 (C4), 61.9 (C7), 51.0 (C17), 50.1 (C11), 
37.8 (C3), 33.3 (C1), 19.4 (C2), 14.0 (C8); HRMS (ESI) Found: [M+Na]+, 






Ester 303t (61.7 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), Xantphos 
(13.9 mg, 0.024 mmol) and methyl-1H-2-pyrrole carboxylate (313b) (30 mg, 
0.24 mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. Toluene (1.5 mL) was added and the 
sealed tube was added to an oil bath preheated to 120 °C. The mixture was 

























concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 19:1-9:1] 
afforded 318i (49 mg, 61%) as a clear oil. RF 0.60 [Petrol:EtOAc 19:1]; νmax 
(film)/cm−1 2983, 1727 (C=O), 1705 (C=O); δH (400 MHz, CDCl3) 6.95 (dd, J = 
4.0, 1.8 Hz, 1H, H9), 6.88 (dd, J = 2.6, 2.0 Hz, 1H, H11), 6.17 (dd, J = 3.9, 2.6 
Hz, 1H, H10), 5.18 (t, J = 1.6 Hz, 2H, H8), 5.03 (t, J = 1.6 Hz, 1H, H7a), 4.34 
(t, J = 1.9 Hz, 1H, H7b), 4.25 (q, J = 7.0 Hz, 4H, H2), 3.77 (s, 3H, H14), 1.69 
(s, 3H, H5), 1.30 (t, J = 7.1 Hz, 6H, H1); δC (100 MHz, CDCl3) 170.6 (C3), 
161.2 (C13), 144.2 (C6), 129.5 (C11), 122.2 (C9), 117.9 (C12), 112.9 (C7), 
108.5 (C10), 61.7 (C2), 58.5 (C4), 51.0 (C14), 50.1 (C8), 20.8 (C5), 14.0 (C1); 
HRMS (ESI) Found: [M+Na]+, 360.1407. C17H23NO6 requires [M+Na]+, 






Carbonate 303p (50.5 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and methyl-1H-2-pyrrole carboxylate (313b) 
(30 mg, 0.24 mmol) were added to a dried tube under argon. The tube was 
fitted with a septum and purged further with argon. Toluene (1.5 mL) was 
added and the sealed tube was added to an oil bath preheated to 120 °C. The 



















and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1-
4:1] afforded 318j (69 mg, 99%) as a brown oil. RF 0.67 [Petrol:EtOAc 2:1]; 
νmax (film)/cm−1 2922, 1761 (C=O), 1701 (C=O), 1533; δH (400 MHz, CDCl3) 
6.98 (dd, J = 4.0, 1.8 Hz, 1H, H10), 6.81 (dd, J = 2.6, 1.9 Hz, 1H, H12), 6.19 
(dd, J = 3.9, 2.6 Hz, 1H, H11), 5.24-5.22 (m, 1H, H8a), 5.06 (dt, J = 17.0, 1.8 
Hz, 1H, H9a), 4.83 (dt, J = 16.9, 1.7 Hz, 1H, H9b), 4.47-4.45 (m, 1H, H8b), 
4.30 (ddd, J = 13.1, 7.9, 5.2 Hz, 1H, H2a), 4.25-4.18 (m, 1H, H2b), 3.76 (s, 
3H, H15), 3.04 (ddd, J = 13.2, 7.2, 5.3 Hz, 1H, H3a), 2.53-2.45 (m, 1H, H3b), 
2.41 (s, 3H, H6); δC (100 MHz, CDCl3) 200.6 (C5), 173.0 (C1), 161.2 (C14), 
141.5 (C7), 129.6 (C12), 121.7 (C13), 118.6 (C10), 114.8 (C8), 108.8 (C11), 
66.1 (C2), 65.7 (C4), 51.1 (C15), 50.1 (C9), 30.2 (C3), 25.7 (C6); HRMS (ESI) 






Carbonate 303r (81 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and methyl-1H-2-pyrrole carboxylate (313b) 
(30 mg, 0.24 mmol) were added to a dried tube under argon. The tube was 
fitted with a septum and purged further with argon. Toluene (1.5 mL) was 




























mixture was stirred at 120 °C for 2 hours, then cooled to room temperature 
and concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 4:1] 
afforded 318k (57 mg, 56%) as a light brown oil. RF 0.12 [Petrol:EtOAc 4:1]; 
νmax (film)/cm−1 2953, 1701 (C=O), 1533; δH (400 MHz, CDCl3) 6.96 (dd, J = 
4.0, 1.8 Hz, 1H, H15), 6.93 (dd, J = 2.6, 1.9 Hz, 1H, H16), 6.17 (dd, J = 3.9, 
2.6 Hz, 1H, H14), 5.26 (dt, J = 17.0, 2.0 Hz, 1H, H13a), 5.04-5.02 (m, 1H, 
H12a), 4.91 (dt, J = 16.7, 1.4 Hz, 1H, H13b), 4.39-4.38 (m, 1H, H12b), 3.80 
(s, 3H, H19), 3.76 (s, 3H, H10), 3.72-3.65 (m, 2H, H4), 2.53-2.43 (m, 1H, 
H6a), 2.27 (ddd, J = 13.2, 6.1, 3.9 Hz, 1H, H6b), 2.02-1.86 (m, 2H, H5); δC 
(100 MHz, CDCl3) 170.7 (C8), 169.1 (C9), 161.3 (C18), 153.1 (C3), 143.2 
(C11), 130.0 (C15), 121.8 (C17), 118.1 (C14), 114.2 (C12), 108.6 (C16), 83.3 
(C2), 62.3 (C7), 53.0 (C19), 51.0 (C10), 49.9 (C13), 46.2 (C4), 28.6 (C6), 27.9 
(C1), 19.0 (C5); HRMS (ESI) Found: [M+Na]+, 443.1771. C21H28N2O7 requires 




                                                          
 
 
Carbonate 266 (53.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and imidazole (16.3 mg, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 



















was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [EtOAc:EtOAc + 1% Et3N] afforded 320a (29 
mg, 49%) as an orange solid. RF 0.23 [EtOAc]; m.p. 92–94 °C; νmax (film)/cm−1 
3386, 3117, 2946, 2924, 2873, 1695 (C=O), 1641, 1507; δH (400 MHz, CDCl3) 
7.43 (t, J = 1.1 Hz, 1H, H13), 7.03 (t, J = 1.2 Hz, H14), 6.87 (t, J = 1.3 Hz, 1H, 
H12), 5.14 (q, J = 0.8 Hz, 1H, H10a), 4.92-4.91 (m, 1H, H10b), 4.61 (dt, J = 
16.6, 1.1 Hz, 1H, H11a), 4.36 (dt, J = 16.8, 1.1 Hz, 1H, H11b), 2.56-2.40 (m, 
3H, H1 and H4a), 2.10 (s, 3H, H8), 2.0-1.91 (m, 2H, H2a and H4b), 1.87-1.78 
(m, 1H, H3a), 1.77-1.66 (m, 1H, H2b), 1.64-1.54 (m, 1H, H3b); δC (100 MHz, 
CDCl3) 208.5 (C6), 207.6 (C7), 142.8 (C9), 137.9 (C13), 129.5 (C14), 119.6 
(C12), 117.1 (C10), 72.3 (C5), 48.7 (C11), 41.0 (C1), 33.4 (C4), 26.8 (C2), 
26.0 (C8), 21.9 (C3); HRMS (ESI) Found: [M+H]+, 247.1441. C14H18N2O2 





                                                         
 
Carbonate 266 (53.3 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and benzimidazole (28.3 mg, 0.24 mmol) 
were added to a dried tube under argon. The tube was fitted with a septum 
and purged further with argon. Toluene (1.5 mL) was added and the sealed 





















120 °C for 2 hours, then cooled to room temperature and concentrated in 
vacuo. Flash column chromatography [EtOAc + 1% Et3N] afforded 320b (30 
mg, 42%) as an orange solid. RF 0.10 [Petrol:EtOAc 1:1]; m.p. 90–92 °C; νmax 
(film)/cm−1 3093, 2958, 2942, 2860, 1697 (C=O), 1645, 1615;  δH (400 MHz, 
CDCl3) 7.89 (s, 1H, H12), 7.82-7.78 (m, 1H, H14), 7.50-7.45 (m, 1H, H15), 
7.33-7.26 (m, 2H, H16 and H17), 5.07 (q, J = 1.2 Hz, 1H, H10a), 4.91 (dt, J = 
17.5, 1.5 Hz, 1H, H11a), 4.69 (q, J = 0.8 Hz, 1H, H10b), 4.60 (dt, J = 17.5, 1.6 
Hz, 1H, H11b), 2.64-2.48 (m, 3H, H1 and H4a), 2.23 (s, 3H, H8), 2.09-1.97 
(m, 2H, H2a and H4b), 1.93-1.86 (m, 1H, H3a), 1.83-1.73 (m, 1H, H2b), 1.73-
1.60 (m, 1H, H3b); δC (100 MHz, CDCl3) 208.5 (C6), 206.7 (C7), 143.7 (C12), 
143.5 (C18), 141.3 (C9), 133.9 (C13), 123.3 (C15), 122.2 (C16), 120.2 (C14), 
115.9 (C10), 110.2 (C17), 72.2 (C5), 46.7 (C11), 41.1 (C1), 33.6 (C4), 26.9 
(C2), 26.2 (C8), 22.1 (C3); HRMS (ESI) Found: [M+H]+, 297.1598. C18H20N2O2 





Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 
Xantphos (13.9 mg, 0.024 mmol) and pyrazole (16.3 mg, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 



















was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 1:1 + 1% Et3N-EtOAc + 1% 
Et3N] afforded 320c (30 mg, 51%) as a yellow solid. RF 0.14 [Petrol:EtOAc 
1:1]; m.p. 61–63 °C; νmax (film)/cm−1 2935, 1699 (C=O), 1558; δH (400 MHz, 
CDCl3) 7.50 (dd, J = 1.8, 0.5 Hz, 1H, H14), 7.41 (dd, J = 2.5, 0.6 Hz, 1H, H12), 
6.25 (t, J = 2.1 Hz, 1H, H13), 5.12 (t, J = 0.9 Hz, 1H, H10a), 4.97 (t, J = 1.5 
Hz, 1H, H10b), 4.81 (dt, J = 16.3, 1.2 Hz, 1H, H11a), 4.66 (dt, J = 16.3, 1.1 
Hz, 1H, H11b), 2.51 (dd, J = 7.7, 6.0 Hz, 2H, H1), 2.44-2.36 (m, 1H, H4a), 
2.12 (s, 3H, H8), 2.06-1.98 (m, 1H, H4b), 1.96-1.87 (m, 1H, H2a), 1.86-1.68 
(m, 2H, H2b and H3a), 1.67-1.55 (m, 1H, H3b); δC (100 MHz, CDCl3) 208.9 
(C6), 207.0 (C7), 142.6 (C9), 139.6 (C14), 130.5 (C12), 117.9 (C10), 105.9 
(C13), 72.3 (C5), 54.1 (C11), 41.0 (C1), 33.1 (C4), 26.9 (C2), 26.3 (C8), 21.8 
(C3); HRMS (ESI) Found: [M+Na]+, 269.1267. C14H18N2O2 requires [M+Na]+, 
269.1261.   
 
2-(3-(1H-indazol-1-yl)prop-1-en-2-yl)-2-acetylcyclohexanone and 2-(2-(1H-




Carbonate 266 (53.1 mg, 0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol), 












































added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 1:1 + 1% Et3N-EtOAc +1% Et3N] 
afforded an inseparable 1.8:1 mixture of 320da and 320db (35.5 mg, 50%) as 
a yellow solid. RF 0.25 [Petrol:EtOAc 1:1]; m.p. 66–68 °C; νmax (film)/cm−1 
2944, 1701 (C=O), 1643; δH (400 MHz, CDCl3, resonances due to the 320db 
annotated by an asterisk) 8.02 (d, J = 1.0 Hz, 1H, H12), 7.99 (dd, J = 1.0 Hz, 
1H*, H12), 7.74-7.69 (m, 1H, H17), 7.74-7.69 (m, 1H*, H17), 7.64 (dt, J = 8.5, 
1.0 Hz, 1H*, H15), 7.57 (dd, J = 8.6, 1.0 HZ, 1H, H15), 7.41-7.36 (m, 1H, 
H16), 7.29-7.23 (m, 1H*, H16), 7.17-7.12 (m, 1H, H14), 7.09-7.04 (m, 1H*, 
H14), 5.15 (s, 1H*, H11a), 5.12-5.05 (m, 1H, H10a), 5.12-5.05 (m, 1H*, H9a), 
5.02 (s, 1H, H11a), 4.98-4.93 (m, 1H*, H11b), 4.90-4.84 (m, 1H*, H9b), 4.87 
(dt, J = 17.3, 1.5 Hz, 1H, H11b), 4.61 (t, J = 1.8 Hz, 1H, H10b), 2.57 (dd, J = 
7.9, 6.3 Hz, 2H, H1), 2.56-2.51 (m, 2H*, H1), 2.48-2.40 (m, 1H*, H3a), 2.47-
2.40 (m, 1H, H3a), 2.19 (s, 3H, H8), 2.16-2.10 (m, 1H, H3b), 2.16 (s, 3H*, H8), 
2.07-1.99 (m, 1H*, H3b), 1.99-1.91 (m, 1H, H4a), 1.99-1.91 (m, 1H*, H4a), 
1.90-1.74 (m, 2H, H2a and H4b), 1.89-1.73 (m, 2H*, H2a and H4b), 1.75-1.55 
(m, 1H, H2b), 1.75-1.55 (m, 1H*, H2b); δC (100 MHz, CDCl3, resonances due 
to the 320db annotated by an asterisk)  208.9 (C6), 208.8 (C6*), 207.0 (C7), 
207.0 (C7*), 148.9 (C10*), 142.0 (C18*), 141.8 (C9), 139.2 (C18), 133.6 
(C12), 126.6 (C16), 126.0 (C16*), 124.1 (C12*), 124.0 (C13), 122.0 (C13*), 
121.9 (C14*), 120.9 (C17), 120.8 (C15), 120.2 (C15*), 118.0 (C11*),  117.4 
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(C17*), 116.3 (C10), 109.7 (C14), 72.5 (C5*), 72.2 (C5), 55.5 (C9*), 51.1 
(C11), 41.0 (C1), 41.0 (C1*), 33.2 (C3), 33.2 (C3*), 27.0 (C4), 26.9 (C4*), 26.3 
(C8), 26.3 (C8*), 21.9 (C2), 21.9 (C2*); HRMS (ESI) Found: [M+Na]+, 







Carbonate 315 (48mg, 0.24 mmol) Pd2(dba)3 (11 mg, 0.012 mmol), Xantphos 
(13.9 mg, 0.024 mmol) and 2-acetylcyclohexanone (31 μL, 0.24 mmol) were 
added to a dried tube under argon. The tube was fitted with a septum and 
purged further with argon. Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 
°C for 2 hours, then cooled to room temperature and concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 9:1-4:1] afforded 305 (32 mg, 
88%) as a 1.2:1 mixutre of diastereoisomers rather than the desired cross-
coupled product 316. RF  0.32 [Petrol:EtOAc 4:1]; m.p. 123–126 oC; νmax 
(film)/cm−1 2931, 2848, 1697 (C=O); δH (400 MHz, CDCl3, resonances due to 
the the diastereoisomer of 305b annotated by an asterisk) 5.03-4.99 (m, 1H 
and 1H*, H10a and H10a*), 4.93 (s, 1H and 1H*, H10b and H10b*), 2.68-2.24 
(m, 8H and 8H*, H1, H4, H11 and H14, H1*, H4*, H11* and H14*), 2.22, 2.19 























1H* H17a and H17a*), 2.00-1.82 (m, 2H and 2H*, H2a and H2a* H17b and 
H17b*), 1.78-1.54 (m, 7H and 7H*, H2b, H3, H15, H16 and H2b*, H3*, H15* 
and H16*); δC (100 MHz, CDCl3, resonances due to the the diastereoisomer of 
305b annotated by an asterisk) 210.0 (C1*), 209.9 (C1), 209.8 (C13*), 209.7 
(C13), 209.1 (C7), 209.1 (C7*), 208.3 (C14), 207.9 (C14*), 140.6 (C9*), 140.3 
(C9), 117.3 (C10), 117.0 (C10*), 73.9 (C5), 73.8 (C5*), 67.0 (C12), 66.9 
(C12*), 41.3 (C1*), 41.0 (C1), 41.0 (C14*), 41.0 (C14), 37.1 (C11), 36.6 
(C11*), 36.2 (C4), 35.3 (C4*), 33.3 (C17*), 33.1 (C17), 27.5 (C3*), 27.4 (C3), 
27.2 (C16), 27.1 (C16*), 26.7 (C8), 26.6 (C8*), 26.5 (C19), 26.3 (C19*), 21.9 
(C15*), 21.8 (C15), 21.8 (C2), 21.7 (C2*); HRMS (ESI) Found: [M+H]+, 
319.1906. C19H26O4 requires [M+H]+, 319.1904.  
10.2.7. Mechanistic Studies 




According to a literature procedure,117 to a solution of propargyl carbonate  
(333 mg, 1.5 mmol) in acetonitrile (8 mL) was added solid potassium 
carbonate (310 mg, 2.25 mmol). The suspension was stirred at room 
temperature for 30 minutes. Deuterium oxide (2 mL) was added via syringe 
and the solution was stirred at room temperature for 1 hour. The mixture was 
extracted with CH2Cl2 (10 mL), dried (MgSO4) and concentrated in vacuo to 
















by 1H NMR spectroscopy indicated 97% deuterium incorporation. νmax 
(film)/cm−1 2940, 1988 (C–D), 1757 (C=O), 1649; δH (400 MHz, CDCl3) 4.78 
(s, 2H, H10), 2.37-2.31 (m, 4H, H4 and H7), 2.28 (s, 3H, H1), 1.77-1.59 (m, 
4H, H5 and H6). HRMS (ESI) Found: [M+Na]+, 246.0844. C12H13DO2 requires 









      
 
 
To a solution of propargyl carbonate 303c (203 mg, 0.81 mmol) in acetonitrile 
(8 mL) was added solid potassium carbonate (167 mg, 1.20 mmol). The 
suspension was stirred at room temperature for 30 minutes. Deuterium oxide 
(2 mL) was added via syringe and the mixture was stirred at room temperature 
for 1 hour. The mixture was extracted with CH2Cl2 (10 mL), dried (MgSO4) and 
concentrated in vacuo to afford deuterated alkyne [D]-303c (170 mg, 83%) as 
a pale yellow oil. Analysis by 1H NMR spectroscopy indicated 96% deuterium 
incorporation. RF 0.54 [Petrol:EtOAc 4:1];  νmax (film)/cm−1 2935, 2564, 1975 
(C–D), 1793, 1692 (C=O); δH (400 MHz, CDCl3) 4.78 (s, 2H, H11), 2.93 (sept, 
J = 7.0 Hz, 1H, H2), 2.41-2.31 (m, 4H, H5 and H8), 1.80-1.64 (m, 4H, H6 and 
H7), 1.07 (d, J = 6.9 Hz, 6H, H1); δC (100 MHz, CDCl3) 206.6 (C3), 151.8 



















25.7 (C8), 22.2 (C7), 21.7 (C6), 18.3 (C1); HRMS (ESI) Found: [M+Na]+, 
274.1153. C14H17DO4 requires [M+Na]+, 274.1160.  
 
d1-Methyl 1H-pyrrole-2-carboxylate-1 ([D]-313b): 
 
 
A suspension of sodium hydride (60 wt % in mineral oil, 70 mg, 1.75 mmol) in 
tetrahydrofuran (10 mL) was cooled to 0 °C. A solution of pyrrole 313b (200 
mg, 1.6 mmol) in tetrahydrofuran (5 mL) was added dropwise, and the mixture 
was stirred at 0 °C for 30 min. Deuterium oxide (2 mL) was added dropwise, 
and the mixture was stirred at room temperature for 1 h. The reaction was 
quenched with H2O (10 mL) and extracted with EtOAc (10 mL). The organic 
layer was dried (MgSO4) and concentrated in vacuo to afford [D]-313b (152 
mg, 76%) as a purple solid. Analysis by 1H NMR spectroscopy indicated 68% 
deuterium incorporation. RF 0.60 [Petrol:EtOAc 4:1]; m.p. 74–77 °C; νmax 
(film)/cm–1 3287, 2924, 2458 (N–D), 1668, 1530; δH (400 MHz, CDCl3) 9.09 
(br s, 0.32H, H7), 6.96 (dd, J = 2.7, 1.5 Hz, 1H, H5), 6.92 (dd, J = 3.7, 1.5 Hz, 
1H, H6), 6.27 (dd, J = 3.7, 2.6 Hz, 1H, H4), 3.86 (s, 3H, H1); δC (75 MHz, 





















[D]-266 (26.8 mg, 0.12 mmol), carbonate 303c (30 mg, 0.12 mmol), Pd2(dba)3  
(11 mg, 0.012 mmol), Xantphos (13.9 mg, 0.024 mmol) and 3-methyl-2-
pyrrole-1H-carboxylate (313b) (30 mg, 0.24 mmol) were added to a dried tube 
under argon. The tube was fitted with a septum and purged further with argon. 
Toluene (1.5 mL) was added and the sealed tube was added to an oil bath 
preheated to 120 °C. The mixture was stirred at 120 °C for 2 hours, then 
cooled to room temperature and concentrated in vacuo. Flash column 
chromatography [Petrol:EtOAc 9:1-4:1] afforded [D]-314b (27 mg, 74%)  and 
318b (24.5 mg  62%).  [D]-314b: νmax (film)/cm−1  2946,  1694 (C=O), 1531; 
HRMS (ESI) Found: [M+Na]+, 327.1425. C17H2DNO4 requires [M+Na]+, 
























Deuterated carbonate [D]-303c (60 mg, 0.24 mmol), pyrrole (313b) (30 mg, 
0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol) and Xantphos (13.9 mg, 0.024 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. Toluene (1.5 mL) was added and the 
sealed tube was added to an oil bath preheated to 120 °C. The mixture was 
stirred at 120 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1–4:1] 
afforded [D]-318b (46 mg, 58%). Analysis by 1H NMR spectroscopy indicated 
48% deuterium incorporation at the vinylic position and 48% at the allylic 
position. HRMS (ESI) Found: [M+Na]+, 355.1727. C19H24DNO4 requires 
[M+Na]+, 355.1739. 
 
[D]-318b was also obtained by the reaction of carbonate 303c (60 mg, 0.24 
mmol) with deuterated pyrrole [D]-313b (30 mg, 0.24 mmol), Pd2(dba)3 (11 
mg, 0.012 mmol) and Xantphos (13.9 mg, 0.024 mmol), which were added to 
a dried tube under argon.  Toluene (1.5 mL) was added and the sealed tube 
was added to an oil bath preheated to 120 °C. The mixture was stirred at 120 








Flash column chromatography [Petrol:EtOAc 9:1–4:1] afforded [D]-318b (50 
mg, 63%). Analysis by 1H NMR spectroscopy indicated 27% deuterium 
incorporation at the vinylic position and 23% at the allylic position. HRMS 








Deuterated carbonate [D]-303c (60 mg, 0.24 mmol), pyrrole [D]-313b (30 mg, 
0.24 mmol), Pd2(dba)3 (11 mg, 0.012 mmol) and Xantphos (13.9 mg, 0.024 
mmol) were added to a dried tube under argon. The tube was fitted with a 
septum and purged further with argon. 1,4-Dioxane (1.5 mL) was added and 
the sealed tube was added to an oil bath preheated to 80 °C. The mixture was 
stirred at 80 °C for 2 hours, then cooled to room temperature and 
concentrated in vacuo. Flash column chromatography [Petrol:EtOAc 9:1–4:1] 
afforded [D2]-318b (52 mg, 65%). Analysis by 1H NMR spectroscopy indicated 
75% deuterium incorporation at the vinylic position and 82% at the allylic 
position. HRMS (ESI) Found: [M+Na]+, 356.1790. C19H23D2NO4 requires 















Carbonate 266 (35.5 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), 
Xantphos (9.2 mg, 0.0160 mmol) and phenol (15 mg, 0.16 mmol) were added 
to a dried tube under argon. The tube was fitted with a septum and purged 
further with argon. Dioxane (1 mL) was added and the sealed tube was added 
to an oil bath preheated to 80 °C. The mixture was stirred at 80 °C for 2 hours, 
then cooled to room temperature and concentrated in vacuo. Flash column 
chromatography [Petrol:EtOAc 9:1] afforded 268 (41 mg, 71%, r.r. > 19:1) as a 
colourless oil. RF 0.40 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2939, 2111, 1697 
(C=O), 1597; δH (400 MHz, CDCl3) 7.31-7.25 (m, 2H, H14), 6.96 (tt, J = 7.4 
Hz, 1H, H15), 6.91-6.86 (m, 2H, H13), 5.68 (t, J = 1.2 Hz, 1H, H10a), 5.23 (s, 
1H, H10b), 4.58 (dt, J = 12.3, 1.0 Hz, 1H, H11a), 4.48 (dd, J = 12.2, 0.8 Hz, 
1H, H11b), 2.67-2.59 (m, 1H, H1a), 2.55-2.48 (m, 1H, H1b), 2.46-2.39 (m, 1H, 
H4a), 2.26 (s, 3H, H8), 2.15-2.07 (m, 1H, H4b),1.93-1.82 (m, 2H, H2), 1.82-
1.66 (m, 2H, H3); δC (100 MHz, CDCl3) 209.1 (C6), 206.7 (C7), 158.2 (C12), 
142.2 (C9), 129.5 (C14), 121.2 (C15), 119.4 (C10), 114.6 (C13), 71.6 (C5), 
69.2 (C11), 40.8 (C1), 32.4 (C4), 27.3 (C8), 27.1 (C2), 21.8 (C3); HRMS (ESI) 
Found: [M+H]+, 273.1475. C17H20O3 requires [M+H]+, 273.1485. Synthesis of 






















The formation of 268 was also carried out under enantioselective conditions: 
Carbonate 266 (35.5 mg, 0.16 mmol), Pd2(dba)3 (7.3 mg, 0.008 mmol), (R)-
Xylyl-P-PHOS L19 (7.3 mg, 0.0096 mmol) and phenol (15 mg, 0.16 mmol), 
were added to a dried tube under argon. The tube was fitted with a septum 
and purged further with argon. Tetrahydrofuran (1 mL) was added and the 
sealed tube was stirred at 60 °C for 2 hours, then concentrated in vacuo. 
Flash column chromatography [Petrol:EtOAc 19;1-9:1] afforded 268 (19 mg, 
44% yield, r.r. > 19:1). Chiral HPLC: AD-H column, 1 mL/min, 9:1 Hexane:IPA, 
tA (major) = 6.0 min, tB (minor) = 6.5 min, 19% ee. [α]D25 +0.8 (c 0.1, CHCl3, 
19% ee). 
 




To a suspension of sodium hydride (60 wt% mineral oil, 440 mg, 11 mmol) in 
tetrahydrofuran (25 mL) was added a solution of cyclohexanone (1.03 mL, 10 
mmol) in tetrahydrofuran (10 mL) dropwise and the mixture was stirred at 
room temperature temperature for 75 minutes. The reaction was cooled to 0 
oC and methyl difluoroacetate (0.97 mL, 11 mmol) was added dropwise over a 
period of 15 minutes and the reaction mixture was warmed to room 















quenched by the addition of aq. NH4Cl (30 mL) and aq. HCl (1 N, 30 mL) and 
the mixture was extracted with Et2O (3 x 20 mL). The combined organic 
phases were washed with brine (30 mL), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Petrol:Et2O 199:1] afforded 354 (401 
mg, 50%) as a clear oil. RF 0.72 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 2942, 
1572 (C=O); δH (400 MHz, CDCl3) 15.25 (s, 1H, H9), 6.06 (t, J = 52.3 Hz, 1H, 
H8), 2.48-2.43 (m, 4H, H1 and H4), 1.80-1.71 (m, 4H, H2 and H3); δC (100 
MHz, CDCl3) 188.8 (C6), 184.1 (J = 22.7 Hz, C7), 110.2 (J = 240.7 Hz, C8), 
105.8 (C5), 31.8 (C1), 22.2 (C4), 21.6 (C2), 20.9 (C3); HRMS (ESI) Found: 
[M+H]+, 177.0719. C18H11F2O6 requires [M+Na]+, 177.0722. Synthesis of this 
compound has been reported in the literature.142       
 
2-(2,2-Difluoroacetyl)cyclohex-1-enyl prop-2-ynyl carbonate (337a) and 
(Z)-2,2-Difluoro-1-(2-oxocyclohexylidene)ethyl prop-2-ynyl carbonate 
(337b):                  
 
 
To a solution of 354 (120 mg, 0.68 mmol) in tetrahydrofuran (13 mL) was 
added potassium tert-butoxide (83 mg, 0.75 mmol). Propargyl chloroformate 
(0.073 mL, 0.75 mmol) was added dropwise upon stirring and the reaction 
mixture was stirred at room temperature for 18 hours. The reaction was 























mixture was extracted with Et2O (3 x 20 mL). The combined organic phases 
were washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo to 
afford an inseparable mixture of 337a and 337b (134 mg, 76% yield) as a 
yellow solid. RF 0.71 [Petrol:EtOAc 4:1]; νmax (film)/cm−1 3257, 2950, 2125 
(C≡C), 1769, 1646 (C=O); δH (400 MHz, CDCl3, resonances due to 337a 
quoted) 6.20 (t, J = 52.7 Hz, 1H, H1), 4.81 (d, J  = 1.6 Hz, 2H, H10), 2.59 (t,  J 
= 2.4 Hz, 2H, H12), 2.54-2.50 (m, 2H, H7), 2.42-2.39 (m, 2H, H4), 1.81-1.75 
(M, 2H, H6), 1.72-1.65 (m, 2H, H5); δC (100 MHz, CDCl3, resonances due to 
337a quoted) 187.2 (J = 22.5 Hz, C2), 159.1 (C8), 150.8 (C9), 122.5 (C3), 
109.4 (J = 242.3 Hz, C1), 76.5 (C12), 75.9 (C11) 56.4 (C10), 28.3 (C7), 23.8 
(C4), 21.8 (C6) 21.1 (C5); HRMS (ESI) Found: [M+NH4]+, 276.1044. 
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12. Appendices  
12.1.1. Crystal Structure of 304a.  
 
314a (CCDC 1411246).                     
 
Identification code  2015ncs0412a 
Empirical formula  C17H24O4 
Formula weight  292.36 
Temperature  100(2) K 
Wavelength  0.6889 Å 
Crystal system  Monoclinic 
Space group  P21/n  
Unit cell dimensions a = 6.0924(2) Å       α = 90° 
 b = 27.0824(6) Å     β = 97.770(2)° 
 c = 9.3335(2) Å        γ = 90° 
Volume 1525.86(7) Å3 
Z 4 0.083 mm-1 
Density (calculated) 1.273 Mg / m3 
Absorption coefficient 0.083 mm-1 
F(000) 632.0 
Crystal Chip; colourless 
Crystal size 0.03 × 0.03 × 0.01 mm3 
θ range for data collection 2.256 − 31.788° 
Index ranges −9 ≤ h ≤ 9, −40 ≤ k ≤ 41, −14 ≤ l ≤ 13 
Reflections collected 30947 
Independent reflections 5401 [Rint = 0.0605] 
Completeness to θ = 24.415° 99.7 %  
Absorption correction Semi−empirical from equivalents 
Max. and min. transmission 1.00000 and 0.81133 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5401 / 0 / 194 






Final R indices [F2 > 2σ(F2)] R1 = 0.0486, wR2 = 0.1144 
R indices (all data) R1 = 0.0674, wR2 = 0.1282 
Extinction coefficient n/a 



























12.1.2. Crystal Structure of 312d 
 
322d (CCDC 1443121)	   
 
Identification code VF101 
Empirical formula C22H25NO4 
Formula weight 367.43 
Temperature/K 179.98(10) 
Crystal system triclinic 









ρcalc g/cm3 1.285 
μ/mm‑1 0.713 
F(000) 392.0 
Crystal size/mm3 0.341 × 0.294 × 0.251 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 7.132 to 154.874 
Index ranges -9 ≤ h ≤ 9, -12 ≤ k ≤ 12, -15 ≤ l ≤ 15 
Reflections collected 23526 
Independent reflections 3986 [Rint = 0.0212, Rsigma = 0.0113] 
Data/restraints/parameters 3986/12/265 
Goodness-of-fit on F2 1.048 
Final R indexes [I>=2σ (I)] R1 = 0.0416, wR2 = 0.1085 
Final R indexes [all data] R1 = 0.0433, wR2 = 0.1101 






































12.1.3. Crystal structure of 314b 
 
324b (CCDC 1443120)	   
 
Identification code VF100 
Empirical formula C17H21NO4 
Formula weight 303.35 
Temperature/K 99.9(2) 
Crystal system triclinic 









ρcalc g/cm3 1.314 
μ/mm‑1 0.765 
F(000) 324.0 
Crystal size/mm3 ? × ? × ? 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 10.74 to 147.794 
Index ranges -8 ≤ h ≤ 8, -9 ≤ k ≤ 10, -17 ≤ l ≤ 17 
Reflections collected 11458 
Independent reflections 3051 [Rint = 0.0197, Rsigma = 0.0144] 
Data/restraints/parameters 3051/0/209 
Goodness-of-fit on F2 1.037 
Final R indexes [I>=2σ (I)] R1 = 0.0332, wR2 = 0.0853 
Final R indexes [all data] R1 = 0.0343, wR2 = 0.0861 
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Formula Predictor Report - 150616_MK228.lcd Page 1 of 1
Data File: C:\LabSolutions\Data\Chemistry\Franckevicius\150616_MK228.lcd
Elmt Val. Min Max Elmt Val. Min Max Elmt Val. Min Max Use Adduct
H 1 0 200 N 3 0 0 S 2 0 0 H
2H 1 0 4 O 2 0 15 Br 1 0 0 Na
C 4 0 200 F 1 0 0 Re 2 0 0
Error Margin (ppm): 10 DBE Range: -2.0 - 1000.0 Electron Ions: both
HC Ratio: unlimited Apply N Rule: no Use MSn Info: no
Max Isotopes: all Isotope RI (%): 1.00 Isotope Res: 4000
MSn Iso RI (%): 75.00 MSn Logic Mode: AND Max Results: 500

































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
1 62.36 C21 H20 2H4 O4 [M+Na]+ 367.1813 367.1818 -0.5 -1.36 62.93 10.0
Formula Predictor Report - 150616_MK228.lcd Page 1 of 1
Data File: C:\LabSolutions\Data\Chemistry\Franckevicius\150616_MK228.lcd
Elmt Val. Min Max Elmt Val. Min Max Elmt Val. Min Max Use Adduct
H 1 0 200 N 3 0 0 S 2 0 0 H
2H 1 0 4 O 2 0 15 Br 1 0 0 Na
C 4 0 200 F 1 0 0 Re 2 0 0
Error Margin (ppm): 10 DBE Range: -2.0 - 1000.0 Electron Ions: both
HC Ratio: unlimited Apply N Rule: no Use MSn Info: no
Max Isotopes: all Isotope RI (%): 1.00 Isotope Res: 4000
MSn Iso RI (%): 75.00 MSn Logic Mode: AND Max Results: 500




































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
5 90.92 C21 H24 O4 [M+Na]+ 363.1559 363.1567 -0.8 -2.20 93.74 10.0
12.2. Mass Spectrometry Data 
 













































Formula Predictor Report - 150616_MK228.lcd Page 1 of 1
Data File: C:\LabSolutions\Data\Chemistry\Franckevicius\150616_MK228.lcd
Elmt Val. Min Max Elmt Val. Min Max Elmt Val. Min Max Use Adduct
H 1 0 200 N 3 0 0 S 2 0 0 H
2H 1 0 4 O 2 0 15 Br 1 0 0 Na
C 4 0 200 F 1 0 0 Re 2 0 0
Error Margin (ppm): 10 DBE Range: -2.0 - 1000.0 Electron Ions: both
HC Ratio: unlimited Apply N Rule: no Use MSn Info: no
Max Isotopes: all Isotope RI (%): 1.00 Isotope Res: 4000
MSn Iso RI (%): 75.00 MSn Logic Mode: AND Max Results: 500

































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE







































Formula Predictor Report - 150616_MK229.lcd Page 1 of 1
Data File: C:\LabSolutions\Data\Chemistry\Franckevicius\150616_MK229.lcd
Elmt Val. Min Max Elmt Val. Min Max Elmt Val. Min Max Use Adduct
H 1 0 200 N 3 0 0 S 2 0 0 H
2H 1 0 4 O 2 0 15 Br 1 0 0 Na
C 4 0 200 F 1 0 0 Re 2 0 0 K
Error Margin (ppm): 20 DBE Range: -2.0 - 1000.0 Electron Ions: both
HC Ratio: unlimited Apply N Rule: no Use MSn Info: no
Max Isotopes: all Isotope RI (%): 1.00 Isotope Res: 4000
MSn Iso RI (%): 75.00 MSn Logic Mode: AND Max Results: 500

































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
1 98.85 C21 H23 2H O4 [M+H]+ 342.1805 342.1810 -0.5 -1.46 100.00 10.0
B. Deuterium scrambling experiment with [D]-300 and 30	  1b.  
 
 










































































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
1 71.06 C19 H25 N O4 [M+Na]+ 354.1666 354.1676 -1.0 -2.82 74.45 8.0
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Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE








































































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
1 66.88 C19 H24 2H N O4 [M+Na]+ 355.1727 355.1739 -1.2 -3.38 71.11 8.0




























































































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
1 51.21 C19 H24 2H N O4 [M+Na]+ 355.1752 355.1739 1.3 3.66 54.86 8.0


















































































Rank Score Formula (M) Ion Meas. m/z Pred. m/z Df. (mDa) Df. (ppm) Iso DBE
1 84.86 C19 H23 2H2 N O4 [M+Na]+ 356.1790 356.1801 -1.1 -3.09 89.54 8.0




















































12.3. Chiral HPLC Traces 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Chromatogram
MK341-f g i l mk 341 002.lcd
min
mAU







1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm






















 S   





















     





















     





















     





















     
     
Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK341-f g i l
Sample ID : MK341 f g i l analysis002
Data File : mk 341 002.lcd
Batch File : mk341 first set.lcb
Vial# : 2
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 29/06/2016 09:45:59















































25 1PDA Multi 1 206nm,4nm2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : mk344-THF
Sample ID : mk344-THF
Data File : mk344-THF.lcd
Batch File : mk341 solvent screen.lcb
Vial# : 7
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 04/10/2016 13:51:53




















































1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK184-1-ODH
Sample ID : MK184-1-ODH
Data File : mk184-1-ODH.lcd
Batch File : MK199 and MK349.lcb
Vial# : 5
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 16/12/2016 12:16:07

















15 1PDA Multi 1 206nm,4nm2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK352-ODH
Sample ID : MK352-ODH
Data File : MK352-ODH.lcd
Batch File : MK199 and MK349.lcb
Vial# : 7
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 16/12/2016 12:56:49
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MK354 racemate mk354 racemate.lcd
min
mAU






1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK354 racemate
Sample ID : MK354 racemate
Data File : mk354 racemate.lcd
Batch File : MK199 and MK349.lcb
Vial# : 4
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 23/11/2016 12:15:41















































1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : mk352
Sample ID : mk352
Data File : mk354 enantioselective.lcd
Batch File : MK199 and MK349.lcb
Vial# : 5
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 22/11/2016 12:50:25





     304s
     ee 9%
333 	  
Chromatogram
MK353-ADH a MK353 ADH a.lcd
min
mAU







150 1PDA MulƟ 1 206nm,4nm
2PDA MulƟ 2 227nm,4nm
3PDA MulƟ 3 251nm,4nm
4PDA MulƟ 4 277nm,4nm
5PDA MulƟ 5 292nm,4nm
















































































































  V  
Sample Name : MK353-ADH a
Sample ID : MK353-ADH a
Data File : MK353 ADH a.lcd
Batch File : MK199 and MK349.lcb
Vial# : 5
InjecƟ on Volume : 2
Method File : Method1.lcm
Date Acquired : 24/11/2016 13:36:23





































































MK353-ADH b MK353 ADH b.lcd
min
mAU




1PDA Multi 1 206nm,4nm 
2PDA Multi 2 227nm,4nm 
3PDA Multi 3 251nm,4nm 
4PDA Multi 4 277nm,4nm 

































































































Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK353-ADH b
Sample ID : MK353-ADH b
Data File : MK353 ADH b.lcd
Batch File : MK199 and MK349.lcb
Vial# : 6
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 24/11/2016 13:56:46










MK355 racemate ADH mk355 racemate ADH.lcd
min
mAU






250 1PDA MulƟ 1 206nm,4nm
2PDA MulƟ 2 227nm,4nm
3PDA MulƟ 3 251nm,4nm
4PDA MulƟ 4 277nm,4nm
5PDA MulƟ 5 292nm,4nm


















































































































  V  
Sample Name : MK355 racemate ADH
Sample ID : mk355 racemate ADH
Data File : mk355 racemate ADH.lcd
Batch File : MK199 and MK349.lcb
Vial# : 7
InjecƟ on Volume : 2
Method File : Method1.lcm
Date Acquired : 24/11/2016 14:17:09



































































MK355 chiral ADH mk355 Chiral ADH.lcd
min
mAU








1PDA MulƟ 1 206nm,4nm
2PDA MulƟ 2 227nm,4nm
3PDA MulƟ 3 251nm,4nm
4PDA MulƟ 4 277nm,4nm
5PDA MulƟ 5 292nm,4nm

















































































































  V  
Sample Name : MK355 chiral ADH
Sample ID : MK355 chiral ADH
Data File : mk355 Chiral ADH.lcd
Batch File : MK199 and MK349.lcb
Vial# : 5
InjecƟ on Volume : 2
Method File : Method1.lcm
Date Acquired : 09/12/2016 13:14:53





































MK253-2-ODH MK253-2-ODH  less polar.lcd
min
mAU





30 1PDA Multi 1 206nm,4nm2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK253-2-ODH
Sample ID : MK253-2-ODH
Data File : MK253-2-ODH  less polar.lcd
Batch File : MK199 and MK349.lcb
Vial# : 3
Injection Volume : 2
Method File : Method2.lcm
Date Acquired : 16/12/2016 16:08:48





































MK368-ODH mk368-ODH  less polar.lcd
min
mAU






125 1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
5PDA Multi 5 292nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK368-ODH
Sample ID : MK368-ODH
Data File : mk368-ODH  less polar.lcd
Batch File : MK199 and MK349.lcb
Vial# : 4
Injection Volume : 2
Method File : Method2.lcm
Date Acquired : 16/12/2016 16:29:09








MK342 part 1 MK342 race 002.lcd
min
mAU





15 1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK342 part 1
Sample ID : MK342 part 2
Data File : MK342 race 002.lcd
Batch File : mk342 part 1.lcb
Vial# : 2
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 26/08/2016 18:08:41




































































MK342 part 1 MK342 dd.lcd
min
mAU




1PDA Multi 1 206nm,4nm
2PDA Multi 2 227nm,4nm
3PDA Multi 3 251nm,4nm
4PDA Multi 4 277nm,4nm
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Lancaster University Department of Chemistry - HPLC Analysis
Sample Name : MK342 part 1
Sample ID : MK342 part 15
Data File : MK342 dd.lcd
Batch File : mk342 part 1.lcb
Vial# : 15
Injection Volume : 2
Method File : Method1.lcm
Date Acquired : 26/08/2016 22:33:18

















1PDA MulƟ 1 206nm,4nm
2PDA MulƟ 2 227nm,4nm
3PDA MulƟ 3 251nm,4nm
4PDA MulƟ 4 277nm,4nm
5PDA MulƟ 5 292nm,4nm








































































































Sample Name : MK199
Sample ID : MK199
Data File : mk199.lcd
Batch File : MK199 and MK349.lcb
Vial# : 2
InjecƟ on Volume : 2
Method File : Method1.lcm
Date Acquired : 21/11/2016 16:11:33





































































1PDA MulƟ 1 206nm,4nm
2PDA MulƟ 2 227nm,4nm
3PDA MulƟ 3 251nm,4nm
4PDA MulƟ 4 277nm,4nm
5PDA MulƟ 5 292nm,4nm













































































































Sample Name : MK349
Sample ID : MK349
Data File : mk349.lcd
Batch File : MK199 and MK349.lcb
Vial# : 3
InjecƟ on Volume : 2
Method File : Method1.lcm
Date Acquired : 21/11/2016 16:31:54
Date Processed : 23/05/2017 17:27:00
                 302m
                ee 11%
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